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Abstract
Cellular signalling and membrane trafficking critically depend on the assembly
of proteins into large complexes via transient protein-protein and protein-lipid
interactions. For this purpose, involved proteins possess different adaptor do-
mains, which are combined based on a modular principle in a single poly-
peptide chain. A prevalent interaction mode constitutes binding of adaptor do-
mains to linear motifs, which are frequently located in intrinsically disordered
regions. The typically low affinity and promiscuous nature, with which lin-
ear motifs bind their targets, establishes reversibility and flexibility within the
system. Additional membrane-interaction modules, such as F-BAR (Fes-Cip4-
homology Bin-Amphiphysin-Rvs) domains, assist not only in the localisation
of these multi-protein complexes, but can also affect membrane shape, which
is a prerequisite for membrane trafficking. In this thesis, I have investigated
linear motifs in the variable regions of two F-BAR domain-containing pro-
teins, srGAP3 (Slit-Robo GTPase-activating protein 3) and Syndapin1 (synaptic
Dynamin-associated protein 1), with respect to binding partners and functional
implications of the formed complexes.
SrGAP proteins have been implicated in different aspects of neuronal devel-
opment and were identified as downstream effectors in the Slit-Robo pathway,
in which they transmit the signal to the actin cytoskeleton, thereby affecting
targeting of axons and neuronal migration. These findings were mainly based
on the characterisation of their highly conserved globular domains, while the
function of the variable C-terminal region (CTR) remained elusive. My bioin-
formatic analysis predicts that this region of srGAP proteins is intrinsically
disordered and contains linear motifs for the interaction with 14-3-3 proteins
as well as Src-homology 3 (SH3) domains. 14-3-3 proteins typically engage
in phospho-dependent interactions, while SH3 domains recognise proline-rich
motifs. Employing different biochemical and biophysical methods, I show that
the CTR of the family member srGAP3 confers binding to the SH3 domains of
the endocytic proteins Endophilin-A1, Endophilin-A2, and Amphiphysin, as
well as the Ras signalling adaptor Grb2 under in vivo conditions and in vitro.
Moreover, a single proline-rich motif in the CTR is sufficient for all of these in-
teractions. Furthermore, I provide evidence that the CTR binds the 14-3-3 iso-
forms γ and θ/τ in vivo and I identify two phosphorylated positions involved
in the formation of these complexes. These results therefore not only uncover
a potential function of srGAP3 in endocytosis and Ras signalling, but also sug-
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gest that the CTR is subject to phosphoregulation and may act as an adaptor
platform connecting srGAP3 with different protein networks.
Syndapins have likewise been implicated in endocytic processes, in which they
function as auxiliary factors during vesicle formation. Vesicle trafficking re-
quires the separation and fusion of membranes through a concerted action of
membrane-bending proteins, the lipid composition, and the actin cytoskeleton,
which have to be precisely regulated in time and space. The F-BAR domain
of Syndapin1 exhibits potent membrane sculpting activity, which is regulated
through an autoinhibitory clamp between the C-terminal SH3 domain and the
N-terminal F-BAR domain and is activated upon binding of ligands to the SH3
domain. I show that binding of the Eps15-homology domain-containing pro-
tein 1 (EHD1) to two Asn-Pro-Phe motifs located in the central variable region
of Syndapin1 constitutes an alternative route for release of the autoinhibition.
The Syndapin1-EHD1 complex plays a role in endocytic receptor recycling and,
therefore, I propose that activation of Syndapin1 by EHD1 is a crucial step in the
molecular mechanism underlying membrane trafficking processes governed by
this protein complex.
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M . . . . . . . . . . . . . . . . . mol/l
mCherry . . . . . . . . . . monomeric variant of red fluorescent protein
MES . . . . . . . . . . . . . . 2-(N-morpholino)ethanesulfonic acid
mol% . . . . . . . . . . . . . molar percentage
MS . . . . . . . . . . . . . . . . mass spectrometry
MW . . . . . . . . . . . . . . . molecular weight
Myc . . . . . . . . . . . . . . . myelocytomatosis oncogene
N . . . . . . . . . . . . . . . . . stoichiometry
N-BAR . . . . . . . . . . . . Bin-Amphiphysin-Rvs domain with additional N-terminal
helix
N-terminus . . . . . . . amino terminus
n.d. . . . . . . . . . . . . . . . non detectable
Neuro2A . . . . . . . . . . mouse neuroblastoma cell line
NMR . . . . . . . . . . . . . nuclear magnetic resonance
Nonidet P-40 . . . . . . octyl phenoxypolyethoxylethanol
NP-40 . . . . . . . . . . . . . nonyl phenoxypolyethoxylethanol
NPF . . . . . . . . . . . . . . peptide motif comprising asparagine-proline-phenylalanine
NPF1 . . . . . . . . . . . . . NPF motif closer to N-terminus
NPF2 . . . . . . . . . . . . . NPF motif closer to C-terminus
ODx . . . . . . . . . . . . . . optical density at x nm
P-value . . . . . . . . . . . probability of obtaining test statistics given that null hy-
pothesis is true
PAGE . . . . . . . . . . . . . polyacrylamide gel electrophoresis
PBS . . . . . . . . . . . . . . . phosphate-buffered saline
PBS-T . . . . . . . . . . . . . phosphate-buffered saline supplemented with Tween-20
PDB ID . . . . . . . . . . . identifier of protein structure in the protein data bank,
http://www.pdb.org
PE . . . . . . . . . . . . . . . . phosphatidylethanolamine
PEI . . . . . . . . . . . . . . . polyethylenimine
PKx . . . . . . . . . . . . . . . protein kinase x
PMSF . . . . . . . . . . . . . phenylmethylsulphonyl fluorid
Protein G . . . . . . . . . bacterial immunoglobulin-binding protein G
PS . . . . . . . . . . . . . . . . phosphatidylserine
PSI . . . . . . . . . . . . . . . . position-specific iterative
PtdIns(x)Py . . . . . . . phosphatidylinositol phosphorylated at position(s) x, lead-
ing to y phospho-groups
Px . . . . . . . . . . . . . . . . postnatal day x
PxxP . . . . . . . . . . . . . . peptide motif comprising two prolines enclosing any two
other amino acids
Ras . . . . . . . . . . . . . . . rat sarcoma GTPase
RFP . . . . . . . . . . . . . . . red fluorescent protein
Rho . . . . . . . . . . . . . . . Ras homologous GTPase
Robo . . . . . . . . . . . . . . roundabout receptor
RTK . . . . . . . . . . . . . . . receptor tyrosine kinase
Rvs . . . . . . . . . . . . . . . reduced viability upon starvation protein from Saccharo-
myces cerevisiae
S-tag . . . . . . . . . . . . . . protein tag derived from Ribonuclease A
SDS . . . . . . . . . . . . . . . sodium dodecyl sulfate
SH . . . . . . . . . . . . . . . . Src homology domain
SH3C . . . . . . . . . . . . . C-terminal SH3 domain
SH3N . . . . . . . . . . . . . N-terminal SH3 domain
Sos1 . . . . . . . . . . . . . . son of sevenless 1
srGAP . . . . . . . . . . . . Slit-Robo GTPase-activating protein
Strap . . . . . . . . . . . . . . serine-threonine kinase receptor-associated protein
SUMO . . . . . . . . . . . . small ubiquitin-like modifier protein
TM . . . . . . . . . . . . . . . . melting temperature
TEMED . . . . . . . . . . . N,N,N’,N’-tetramethylethylenediamine
Tris . . . . . . . . . . . . . . . tris(hydroxymethyl)-amino-methane
U . . . . . . . . . . . . . . . . . units (enzyme activity)
Vps26A . . . . . . . . . . . vacuolar protein sorting-associated protein 26A
Vps35 . . . . . . . . . . . . . vacuolar protein sorting-associated protein 35
w/v . . . . . . . . . . . . . . weight per volume
w/w . . . . . . . . . . . . . . weight per weight
WD40 domain . . . . domain composed of tandem copies of structural motif of
approximately 40 residues usually ending with tryptophan-
aspartic acid dipeptides
WRC . . . . . . . . . . . . . . WAVE-regulatory complex, multi-protein complex involved
in actin polymerisation
1. GENERAL INTRODUCTION
Brain function relies on the activity of highly interconnected networks of neur-
ons, which communicate with each other via electrochemical signals. To per-
form this task, neurons possess a highly polarised morphology with branched
dendrites, which mainly serve the signal reception, and axons, which form long
projections and transmit the signal via synapses to downstream cells. Special-
ised molecular features, such as voltage-gated ion channels for the formation
of action potentials of axons [1] or Golgi outpost in dendrites [2] encode the
functional differentiation of the compartments and are characteristic for this
cell type [2]. Furthermore, the positioning of these cells and their connection
pattern as well as the network maintenance critically depend on complex sig-
nalling and membrane trafficking processes [2, 3].
Synaptic transmission at chemical synapses relies on the release of neurotrans-
mitters into the synaptic cleft through fusion of synaptic vesicles with the pre-
synaptic membrane [4–7] and binding of these transmitters to specific recept-
ors in the postsynaptic membrane [1]. To date, four different pathways for
compensatory re-uptake of synaptic vesicle membranes have been described:
clathrin-mediated endocytosis [8], kiss-and-run endocytosis [9], activity-depen-
dent bulk endocytosis [10, 11], and an ultrafast clathrin-independent pathway
[12]. In neurons, endocytosis and endocytic recycling are not only fundamental
to the synaptic vesicle cycle, but also required for correct positioning of neur-
onal membrane proteins and receptors, which will eventually determine, how
a neuron responds to incoming signals or guidance molecules [3, 13]. Selective
removal of axonal proteins from somatodentritic compartments, for example,
is known to enable axonal targeting of proteins that initially were subject to
non-specific sorting into both, the somatodentritic and axonal compartments
[3, 14, 15]. Neurons can also adjust the sensitivity, with which they react to ex-
ternal guidance molecules, through desensitization via endocytic uptake of the
respective receptors [16, 17].
The endosomal system (Fig. 1.1) serves as a sorting station for endocytosed
cargo as well as for newly arriving transport vesicles from the trans-Golgi net-
work [3]. However, neuronal endosomes are not well described, but expec-
ted to be much more diverse and adjusted to fulfil neuron-specific functions,
such as long-distance retrograde axonal transport (see above) [3, 18]. Each en-
dosomal compartment is characterised by the presence of specific phosphol-
ipids and proteins, which establish its identity by promoting compartment-
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specific protein complex assembly and signalling [18, 19]. EH-domain contain-
ing (EHD) proteins (see chapter 8 for specific introduction) and the GTPases
of the ADP-ribosylation factor (Arf) and the Ras-related in brain (Rab) families
are key players in these membrane trafficking processes [20–22].
Endocytosed vesicles fuse with the early endosome (Fig. 1.1), which is charac-
terised by a mildly acidic lumen that facilitates release of ligands from endocyt-
osed receptors [19, 23]. Cargo sorted into the tubular fraction of the early en-
dosome can either enter the fast recycling route back to the plasma membrane,
the slow recycling pathway via the endocytic recycling compartment (ERC), or
retrograde transport to the trans-Golgi network. Cargo tagged for degradation
is sorted into the lumen of the early endosome, which will subsequently - via
multivesicular bodies - fuse with lysosomes (Fig. 1.1, reviewed in [18, 19, 23,
24]). Surface levels of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) receptors at the postsynaptic membrane, for example, are regulated
via endocytosis and either subsequent recycling, when the uptake is triggered
through N-methyl-D-aspartate (NMDA) receptor activation, or subsequent de-
gradation, when bound to external ligands (reviewed in [25]).
Vesicle trafficking processes are energetically expensive and require active mem-
brane-bending into, for example, tubular structures, which can subsequently
be separated from the source compartment through constriction and fission of
the stalk [27]. Fusion of vesicles with target membranes represents the reverse
process [28]. For these purposes, membrane-interacting proteins act in concert
with specific lipids and the actin cytoskeleton to drive such complex membrane
rearrangements in response to specific cellular signals [29, 30].
1.1. Modular Architecture of Signalling Proteins
Efficient signalling critically depends on the assembly of higher-order com-
plexes [31], which not only form at the site of signal reception, but also dur-
ing the transmission process in the cytosol or nucleus [32]. For this purpose,
many signalling proteins possess a modular architecture employing different
adaptor domains for the interaction with other proteins, nucleic acids, or phos-
pholipids [33]. In fact, the cell regulates a large variety of processes using a
limited set of these domains in a combinatorial manner [33]. Combinations of
these independently folded units in a single polypeptide chain enables linking
of downstream targets as well as cross-talk between different pathways and en-
sures a modulated response to various incoming signals through signal integ-
ration [32, 33]. Another feature of signalling proteins, especially of regulatory
hubs, is their enrichment in intrinsically disordered regions that are character-
ised by the absence of a stable 3D structure in isolation [34–36], but the presence
of alternative functional modules, such as linear motifs [37]. In the following
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Rapid recycling 
route 
Slow recycling 
route 
(ERC) 
(MVB) 
Figure 1.1.: Pathways of endocytic recycling. Cargo can be recycled after endocyt-
osis via clathrin-dependent or clathrin-independent mechanisms. The major sorting
compartments as well as trafficking routes are indicated. A detailed description of
the recycling pathway can be found in the text. MVB, multi-vesicular body; TGN,
trans-Golgi network; ERC, endocytic recycling compartment. The figure was adap-
ted from Hsu, Bai and Li [26].
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subsections, I will therefore introduce the concept of intrinsic disorder as well
as linear motifs and outline the structure and function of adaptor domains that
are relevant to this work.
1.1.1. Intrinsic Disorder and Linear Motifs
The structure-function paradigm was first challenged in the 1970s, when pro-
tein regions were discovered, which lacked recognisable structural elements,
albeit being functional [38–40]. Such so called “intrinsically disordered” [41] or
“natively unfolded” [42] regions can be as short as a few residues or even span
full proteins [37, 40, 43]. Although “intrinsic disorder” describes a set of vari-
ous conformational states [37], they share the absence of hydrophobic residues
to form an ordered hydrophobic core [37] as well as the presence of charged
and polar residues [44]. The absence of any structural element can, for ex-
ample, be instrumental to the function of flexible linkers connecting two glob-
ular domains [37]. Other functions of intrinsically disordered regions usually
involve binding to proteins or small molecules, which is often accompanied by
different degrees of disorder-to-order transitions [37]: Intrinsically disordered
regions have been associated with chaperone activities, allosteric modulation,
or complex assembly [37]. Binding either involves larger regions undergoing
disorder-to-order transitions, called molecular recognition features (MoRF), or
smaller entities, called linear motifs [37].
Short linear motifs are between 3 to 11 residues long and usually bind to glob-
ular domains, such as proline-rich motifs to Src-homology 3 domains or phos-
phorylated motifs to 14-3-3 proteins (see below) [45, 46]. The interactions serve
a number of different purposes: They either affect the localisation as well as the
stability of the protein or mediate the recruitment of binding partners and the
formation of multi-protein complexes [37, 45]. Linear motifs mostly reside in
intrinsically disordered regions [47], in which multiple motifs often occur close
in space, even in overlapping segments [37, 45]. This opens up the opportun-
ity for switch-like regulation of complex formation [48, 49] through mutually
exclusive binding to neighbouring motifs and/or post-translational modifica-
tions [36, 45]. The interface of protein-peptide complexes is generally smaller
compared to structured interfaces [47, 50], which often results in weaker affin-
ities [45], but multiple motifs in one polypeptide chain can be used in a cooper-
ative fashion to increase the affinity and/or specificity [45].
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1.1.2. Protein-Protein Interaction Domains
The Src-Homology 3 Domain
Src-homology 3 (SH3) domains confer binding to proline-rich sequences and
play a role in numerous cellular processes in eukaryotes, such as signal trans-
duction, actin cytoskeletal dynamics, cellular movement, or membrane traf-
ficking [51]. They are 60 to 70 residues long and fold into five anti-parallel β-
strands that form two β-sheets, which are linked by the RT-loop, the n-Src-loop,
a distal loop and a 310-helix (Fig. 1.2A, p. 7) [52–54]. The binding surface con-
sists of two shallow grooves for accommodation of the canonical PxxP ligand
sequence, which adopts a left-handed type II polyproline helix conformation
[52, 54–56]. An additional specificity pocket determines the binding orientation
of the ligand by recognising positively charged residues preceding (type I, con-
sensus [RK]xxPxxP) or following (type II, consensus PxxPx[KR]) the PxxP core
(Fig. 1.2A, p. 7) [57–59]. In addition to these canonical SH3 domain-ligands,
which mostly bind with low affinities in the micromolar range [51], an increas-
ing number of non-PxxP peptides (such as RxxK motifs [60]) and even struc-
tured domains (such as ubiquitin-like domains [61] or Dbl-homology domains
[62]) have been reported to bind SH3 domains [63]. These atypical ligands of-
ten exploit different and more extensive contacts with the specificity pocket
[63, 64], which can result in unusual high binding affinities in the nanomolar
range [63]. However, high affinity SH3-mediated interactions are not always
correlated with high specificity and SH3 domains employ a panel of different
mechanisms, such as sterical hindrance through flanking regions [65] or multi-
valent interactions [45, 66], to selectively bind their targets [51, 63]
The Eps15-Homology Domain
The Eps15-homology domain [67, 68] is present in metazoans, plants, and cer-
tain fungi [69] and usually found in proteins involved in membrane trafficking
and endocytosis [69–71]. Its fold consists of two helix-loop-helix (EF hand) mo-
tifs connected by a short antiparallel β-sheet (Fig. 1.2B, p. 7) [69, 72]. Moreover,
EF hand motifs are known to bind calcium [73] and some, but not all EH do-
mains share this ability [69]. Most ligand peptides follow the sequence Asn-
Pro-Phe (NPF), which adopts a type I β-turn and deeply inserts into the bind-
ing pocket (Fig. 1.2B, p. 7) [69, 72, 74]. Alternative ligand sequences, such as
Asp-Pro-Phe motifs [75], have also been described [69]. Like SH3 domains, EH
domains usually engage in low affinity interactions in the micromolar range
[69, 72, 76], in which specificity might be ensured by flanking regions [76] as
well as unconventional binding modes [77]. Stonin2, for example, carries two
NPF motifs that simultaneously bind the second EH domain of Eps15 in a high
affinity complex by engaging an additional hydrophobic pocket [77].
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14-3-3 Proteins
14-3-3 proteins play an important role in many cellular pathways, such as ap-
optosis, metabolism, cell cycle progression, or transcription and are conserved
among eukaryotes [78]. In mammals, this protein family comprises seven iso-
forms (β, γ, , η, σ, θ/τ, and ζ) [79], which bind to their targets as rigid, saddle-
shaped homo- or heterodimers (Fig. 1.2C, p. 7) [79–81]. Their property to func-
tion as independent protein interaction modules sets them apart from other
adaptor domains, although a structurally similar domain in the protein Smg7
with potentially similar function has been identified [79, 82]. Binding motifs
typically contain a phosphorylated serine or threonine residue and follow the
consensus RSx[pS]xP in mode I or Rx[F/Y]x[pS]xP in mode II [80, 83–85]. In
vivo ligands can, however, contain sequence motifs that substantially diverge
from this consensus [79, 81]. The target motifs are mainly phosphorylated by
basophilic kinases, such as cAMP-dependent protein kinase (PKA) or protein
kinase B (PKB) [78, 81, 86], and often occur in multiple copies in a single poly-
peptide chain, thereby allowing simultaneous docking of the two binding sites
in the 14-3-3 dimer [87].
1.1.3. Lipid Interaction Domains
Correct positioning and activation of signalling complexes relies - in addition
to protein-protein and protein-nucleic acid interactions - on tethering of the
complexes on specific membranes [30]. For this purpose, many signalling pro-
teins are equipped with phospholipid interaction domains [33]. Pleckstrin-
homology (PH) domains [89] and Phox (PX) domains [90], for example, re-
cognise specific phosphoinositides (PtdIns), which allow targeting to specific
membrane types [30]. The PX domain of yeast Vam7 (vacuolar morphogenesis
protein 7), for example, specifically binds PtdIns(3)P, which is important for its
localisation at vacuolar membranes [90].
BAR domains (initially identified in the proteins BIN, Amphiphysin, Rvs [91])
constitute another class of membrane interaction modules, which have not only
been associated with membrane binding, but also membrane reshaping (com-
pare general introduction on vesicle trafficking, p. 2) [92]. Domains of this
superfamily [92, 93] fold into rigid, crescent-shaped dimers [92–94], which con-
sist of a six-helical bundle with three helices in each monomer and helical tips
protruding from this central core [92, 95] (Fig. 1.3). The membrane interaction
surface is mostly located on the concave site [95–99] and composed of positively
charged amino acid patches, which enable binding to the negatively charged
headgroups of phospholipids [95, 99–101]. The degree of intrinsic curvature is
a distinguishing feature of individual BAR domain subfamilies (Fig. 1.3) and
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Figure 1.2.: Structures of different adaptor domains and adaptor proteins in com-
plex with ligands. Domains are shown in cartoon representation and in rainbow
coloring from blue (N-terminus) to red (C-terminus). The peptides are illustrated as
grey sticks. A: Src-homology 3 (SH3) domain of rat beta-PIX in complex with a pep-
tide derived from AIP-4 (RPSRPPPPTP) in class I orientation. The N- and C-termini
of the peptide as well as the RT-loop and the n-Src loop of the SH3 are labelled.
SH3 domain residues important for binding are shown as colored sticks. PDB code:
2P4R [88]. B: The second Eps15-homology domain of human Eps15 in complex with
an NPF peptide derived from Hrb. The conserved Trp at the bottom of the bind-
ing pocket is shown in colored stick representation and the Ca2+ ion as dark grey
sphere. PDB code: 1FF1 [72]. C: The human 14-3-3γ homodimer in complex with
the RAIpSLP peptide (pS denotes a phosphorylated serine), PDB code: 2B05. Struc-
tures were visualised with PyMOL, Version 1.4.1., Schrödinger, LLC.
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BAR domains have been suggested to induce or stabilise bent membrane topo-
logies by imposing this inherent curvature in a scaffolding mechanism onto the
underlying lipid bilayer [92, 95]. This largely results in stabilised membrane
curvatures that correspond to their own intrinsic shape (Fig. 1.3) and has been
used to classify BAR modules in the following subcategories [27, 92]:
BAR and N-BAR (for BAR domains carrying an N-terminal amphiphatic helix)
domains, such as in Arfaptin, Endophilin, or Amphiphysin, are strongly curved
and support highly bent invaginations, which are, for example, found at the
constricted neck of endocytic pits (compare introduction on endocytosis, 1.2.1,
p. 10) [95, 96].
F-BAR (Fes-Cip4-homology BAR) domains, such as in Fes-Cip4-homology do-
main only (FCHo), are more shallowly curved and mainly stabilise weakly bent
membrane topologies, such as in nascent endocytic pits [98].
I-BAR (for inverse BAR) domains constitute a special subgroup, as their mainly
flat structure with the membrane-interaction surface located on the convex side
allows them to support flat membrane sheets [102] or protrusions [103, 104].
Furthermore, the morphogenic activity of BAR domains can be modulated by
additional features, such as hydrophobic helices of N-BAR domains or wedge
loops in the F-BAR domains of Syndapins (Fig. 1.3, indicated by black tri-
angles), which insert into one leaflet of the lipid bilayer [95, 96, 99]. Neigh-
bouring phosphoinositide-binding domains, such as the PX domain in sorting
nexin (SNX) 9 [105] or the PH domain in amyloid precursor protein-like (APPL)
[106]) assist in targeting to specific compartments (see above) [30].
What could be the mechanism underlying BAR domain-mediated membrane
deformation? Lipid bilayers are continuous structures that tend to adopt a cir-
cular shape and deviations from this morphology can only be achieved by act-
ive processes that are able to overcome the membrane bending rigidity [107].
Asymmetrically distributed lipids between the inner and outer leaflet can, for
example, exert considerable membrane stress on the bilayer, as large, negat-
ively charged headgroups will occupy more space, which eventually leads to
bulging [29, 30, 107, 108]. Therefore, locally confined attraction of negatively
charged phospholipids by BAR domains could contribute to the deformation
process [29]. Furthermore, BAR domains have been reported to assemble in
spiral- or chain-like lattices around lipid tubes [97, 109, 110] and cooperation
among many dimers in a rigid scaffold could provide sufficient stability to res-
ist relaxation of the lipid bilayer [29, 92, 107]. The most effective mechanism
for membrane deformation, however, constitutes the insertion of hydrophobic
helices, such as those found in N-BAR domains [96, 98], into one leaflet of the
bilayer [107]. The insertion will cause local membrane asymmetry and mem-
brane stress [107], which can even promote separation of a single continuous
8
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Figure 1.3.: Overview of different BAR domain modules. BAR modules adopt folds
with different degrees of curvature. BAR modules (one monomer in yellow and
the other in blue) from different subfamilies viewed from the side (left) and from
top (right). N-BAR, BAR domain with N-terminal amphipatic helix; F-BAR, Fes-
Cip4-homology BAR domain, I-BAR, inverse BAR. Additional domains, such as
Pleckstrin-homology (PH) and Phox (PX) are in grey. The membrane is depicted
as a grey line. PDB ID are given in brackets. Arrowheads mark positions within the
BAR modules for hydrophobic insertion into membranes. This figure and the figure
legend were adopted from Qualmann, Koch and Kessels [92].
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lipid bilayer into two separate entities (“fission” or “vesiculation”, compare
p. 2) [107, 111, 112].
Furthermore, curvature formation can be facilitated through a concerted action
of membrane bending proteins and oriented actin polymerisation [107]. On
the one hand, coupling of membrane deformation with actin polymerisation
is established indirectly through recruitment of actin regulators via additional
adaptor domains, such as the SH3 domains of Syndapins, which will be dis-
cussed in chapter 8. On the other hand, actin regulation can be an inherent
feature of certain BAR modules. The I-BAR domains of the IRSp53/MIM fam-
ily (Fig. 1.3), for example, carry F-actin-bundling activity and bind the Rho
GTPase Rac1, which is involved in actin polymerisation (see section 1.2.2 for
introduction on Rho GTPases) [104, 113].
1.2. Multi-Protein Complexes in Membrane
Trafficking and Signal Transduction
The organisation of signalling proteins in multi-protein complexes through mul-
tiple transient and low-affinity interactions allows cooperative decision making
[48]. The longer assembly time of a large complex and its dependence on the
presence of all binding partners might not only account for reported threshold
responses in certain signalling pathways [31], but could also provide an effi-
cient “noise filter” for stochastic signal fluctuations [31, 48]. In the following
subsections, I will outline two exemplary pathways to describe the basic con-
cepts of (1) directionality through cooperativity and (2) facilitated assembly of
signalling complexes through scaffolds [48].
1.2.1. Example 1: Clathrin-Mediated Endocytosis
Among membrane trafficking pathways, clathrin-mediated endocytosis is the
best studied example [27]. It relies on a complex machinery (Fig. 1.4, p. 12),
which is sequentially recruited via transient protein interactions to the nas-
cent endocytic pit dependent on the presence of specific phosphoinositides and
membrane curvatures [27].
Recruitment of the shallow curved F-BAR proteins, such as FCHo1 [114] (see in-
troduction on BAR modules, Fig. 1.3, p. 9), and adaptor proteins like
AP-2 and clathrin nucleate the invagination process and promote formation
of PtdIns(4,5)P2 by phosphatidylinositol 4-phosphate 5-kinase type I [27, 115].
During maturation of the clathrin-coated pit through assembly of the clathrin
lattice, additional F-BAR proteins, such as Formin-binding protein 17 [109], and
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the highly curved N-BAR proteins Endophilin and Amphiphysin [95, 96] are se-
quentially added [27, 116], which further constrict the neck through a concerted
action of scaffolding and wedging towards fission (compare section 1.1.3 for
BAR domain-mediated membrane deformation) [27, 92, 116]. Subsequent re-
cruitment of the 5-phosphatase Synaptojanin by Endophilin to the late stage of
pit formation leads to conversion of PtdIns(4,5)P2 to PtdIns(4)P [27, 117], which
is then phosphorylated to PtdIns(3,4)P2 by phosphatidylinositol 3-kinase C2α
[27, 118]. This phosphoinositide conversion is believed to render the pathway
irreversible [27] and triggers recruitment of the BAR-domain proteins SNX 9
and SNX 18 via their PX domain (compare introduction on lipid interaction do-
mains, 1.1.3, p. 6) [27, 118]. SNX9 and SNX18 connect the late endocytic pit with
the actin machinery [118] and might assist Endophilin and Amphiphysin in the
recruitment of the GTPase Dynamin [27, 116, 119]. Finally, Dynamin assembles
in helices around the neck and GTP-hydrolysis then promotes conformational
changes in these Dynamin oligomers that lead to scission of the vesicle in a
sling-like mechanism (reviewed in [27]).
1.2.2. Example 2: Rho GTPase-Regulated Actin Dynamics
Rho GTPases constitute important regulators of actin cytoskeletal dynamics
and comprise a family of 20 proteins in mammals, of which RhoA, Rac, and
Cdc42 are the best studied examples [120]. Most Rho GTPases cycle between an
active GTP-bound state, which allows them to activate numerous downstream
effectors, and an inactive GDP-bound state (Fig. 1.5, p. 13) [120]. The trans-
ition to the active form is promoted by guanine nucleotide exchange factors
(GEF), while GTPase-activating proteins (GAP) facilitate GTP hydrolysis and
therefore inactivation (Fig. 1.5, p. 13).
Active Rac, which serves as an example here, transmits the signal to the actin
machinery through three pathways (Fig. 1.5, p. 13) [120]: Firstly, it can activate
Formins, such as mDia2 (mammalian diaphanous 2) [120, 121], which promote
actin polymerisation at the fast-growing (barbed) end of actin filaments [120].
Secondly, it can activate the WAVE-regulatory complex (WRC) [120, 122], which
is a multi-protein complex [123] mediating formation of branched filaments
through the Arp2/3 (actin-related protein) complex [124, 125]. Through bind-
ing of active Rac and the Arp2/3 complex, the WRC acts as a signalling scaffold,
which brings together up- and downstream effectors in a single complex [126].
Moreover, the WRC component WAVE also binds to Slit-Robo-GAP3 (srGAP3),
which was found to attenuate Rac-mediated actin polymerisation [127] (com-
pare specific introduction chapter 4 for srGAP proteins). Finally, GTP-bound
Rac can activate the p21-activated kinase (PAK), which leads to phosphoryla-
tion and therefore inactivation of Cofilin by the LIM domain kinase (LIMK),
thereby preventing Cofilin-mediated actin depolymerisation [120, 128].
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Figure 1.4.: Clathrin-mediated endocytosis. Illustrated are the scission-promoting
GTPase Dynamin, the BAR module-containing proteins Fes-Cip4-homology do-
main only (FCHo), Formin-binding protein 17 (FBP17), sorting nexin (SNX) 9 and
18, Endophilin, and Amphiphysin, the adaptor proteins AP-2 and clathrin as well
as the phosphatase Synaptojanin and the lipid-specific kinases phosphatidylinos-
itol 4-phosphate 5-kinase type I (PIPKI) and phosphatidylinositol 3-kinase C2α
(PI3KC2α). The phosphoinositide-conversion pathway is indicated. Further inform-
ation can be found in the text. The figure was adopted from Daumke, Roux and
Haucke [27].
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Figure 1.5.: Rho GTPase-mediated actin reorganisation. Illustrated is a model for
regulation of actin dynamics by the Rho GTPase Rac. Activation is indicated by
green arrows, whereas red arrows depict deactivating or inhibiting signals. GTPase-
activating proteins (GAP) promote inactivation (GDP-bound state), whereas guan-
ine nucleotide exchange factors (GEF) promote activation (GTP-bound state) of Rac.
GTP-bound Rac can activate actin polymerisation either via formins, such as mDia2
(diaphanous homolog 3), or the WAVE-regulatory complex (WRC), which activ-
ates the Arp2/3 (actin-related protein) complex. Note that formins attach actin
monomers at the barbed end, whereas Arp2/3 promotes formation of branched fil-
aments. Active Rac might likewise stabilise formed filaments via activation of the
PAK kinase/LIM domain Kinase (LIMK) cascade, which leads to phosphorylation
and therefore inactivation of Cofilin.
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1.3. Aims and Scope
The general goal of this thesis is the characterisation of protein-peptide interac-
tions mediated by variable regions in two F-BAR protein families (see introduc-
tion on F-BAR domains, 1.1.3, p. 6): Slit-Robo GAPs (srGAP) and Syndapins.
In particular, I focussed on the brain-specific isoforms of the respective fam-
ilies, srGAP3 and Syndapin1. The first project aims at the characterisation of
the C-terminal region of srGAP3, which is presumably natively unfolded. As
such regions often engage in protein-protein interactions (see introduction on
intrinsic disorder, 1.1.1, p. 4), I attempted to identify binding partners as well
as to biochemically characterise the formed complexes with respect to bind-
ing surfaces and biophysical parameters. This work should provide a basis for
subsequent studies on the functional implications of these protein complexes
in the framework of neurodevelopmental processes regulated by srGAP3. The
second project aims at elucidating the mechanistic implication of a known in-
teraction between the NPF motifs of Syndapin1 and the EH domain of EHD1
[129] (see introduction on EH domains, 1.1.2, p. 5) with respect to the mem-
brane deforming potential of the F-BAR domain of Syndapin1 [99, 130, 131]
(see introduction on F-BAR domains, 1.1.3, p. 6). Complex formation between
Syndapin1 and EHD1 is involved in endocytic receptor recycling [129] (see in-
troduction on endosomal recycling, Fig. 1.1, p. 3) and this work intends to de-
liver first insight into the underlying molecular mechanism, though does not
aim at fully describing it.
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2. CONTRIBUTIONS
This thesis covers two projects, which were both initiated by Yvonne Groemp-
ing, who supervised the experimental process and with whom I developed the
main working hypotheses.
Characterisation of the C-terminal region of srGAP3
The basic concept for this project was provided by Yvonne Groemping, who
suggested that the C-terminal regions of srGAP proteins could act as adaptor
platform, which integrates the individual isoforms in different pathways. I
cloned, expressed, and purified the C-terminal region of srGAP3. The initial
pulldown experiment was carried out together with Anitha Jeganantham, who
analysed srGAP1 and therefore provided the respective C-terminal construct
of this protein. The mass spectrometric analysis was carried out by the Pro-
teome Center Tübingen. Yvonne Groemping, Anitha Jeganantham and I evalu-
ated the data and chose the set of candidate proteins for validation. Bijàn Mir-
Montazeri suggested to use a GFP-nanobody for the validation experiment and
drew my attention to the Chromotek GmbH. I designed our fluorescence-based
co-immunoprecipitation assay in analogy to Chromotek’s GFP-multiTrap as-
say. I devised the nanobody construct, developed the employed vector series,
and established the assay. Purified GFP and mCherry were provided by Mar-
tin Schückel. I also established the cell culture experiments and the transfec-
tion protocols for our group in collaboration with Daniela Lazzaretti. Yvonne
Groemping, Martin Schückel, Beatrice Laudenbach, and I prepared the DNA
constructs required for this sub-project. I carried out the fluorescence-based
CoIP-assay and therefore identified the binding partners for the subsequent in-
depth characterisation. Martin Schückel assisted in several mammalian cell cul-
ture experiments. The biological sequence analysis of srGAP proteins and their
C-terminal regions was my work, but the strategy was provided by Moritz Am-
melburg. This analysis served as basis for the detailed investigation of the iden-
tified protein complexes. Together with Yvonne Groemping, I developed the
experimental set-up for the identification of linear motifs mediating complex
formation with SH3 domains. I cloned, expressed, and purified the proteins
and carried out the isothermal titration experiments. Martin Schückel assisted
in the repeated purification of several constructs. Furthermore, I prepared the
samples for the phosphorylation analysis of srGAP3, while the mass spectro-
metry experiments were carried out by the Proteome Center Tübingen. I eval-
uated the provided data set with regard to potential 14-3-3-binding sites, gen-
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erated the respective DNA constructs to test relevant motifs for 14-3-3-binding,
and carried out the interaction assays. Parts of this project are included in a
publication written by me and Yvonne Groemping. Parts exclusively written
by me were adopted from the manuscript. Dagmar Sigurdardottir provided
advice for structuring and writing of the manuscript.
Regulation of Syndapin1 by EHD1
The second project was initiated by Yvonne Groemping and Julia Rumpf.
Yvonne Groemping proposed the idea that the variable linker region of Synda-
pin1 is involved in the autoinhibition. Julia Rumpf established the electron
microscopy assay in collaboration with Heinz Schwarz and made the initial
observation that complex formation between Syndapin1 and EHD1 leads to tu-
bule formation on liposomes. The crystal structures of the Syndapin1 F-BAR
domain in isolation and in the autoinhibited state, which were published by
other groups during this time, immediately suggested that EHD1 might activ-
ate Syndapin1. I adjusted the electron microscopy assay in collaboration with
Matthias Flötenmeyer and Heinz Schwarz and recorded and analysed the elec-
tron microscopic data set included in this thesis. The investigation of the effect
of a single EH domain of EHD1, as well as truncated forms of Syndapin1, and
the liposome co-pelleting assay were my work. The interpretation of the data
as well as the improvement of lipid biochemistry protocols was a collaborative
effort of Yvonne Groemping, Aleksander Czogalla, and me. The DNA con-
structs for these experiments were mainly generated by Julia Rumpf, Yvonne
Groemping, and Theresia Niese. Julia Rumpf, Martin Schückel and I expressed
and purified the proteins. Julia Rumpf and Martin Schückel carried out iso-
thermal titration experiments for the analysis of complex formation with the
full-length proteins as well as fragments thereof, while I carried out the control
experiments. Dagmar Sigurdardottir provided advice for structuring of this
thesis.
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3. GENERAL MATERIALS AND
METHODS
This chapter covers general methods of molecular biology, cell biology, bio-
chemistry, and biophysics that were applied in both projects. Basic procedures
are outlined, whereas specific adjustments of these protocols are explained in
detail in the individual materials and methods sections. Methods that were
only relevant to either of the two projects are also described in the respective
materials and methods sections.
3.1. Molecular Biology Methods
3.1.1. General Cloning Procedures
Polymerase Chain Reaction (PCR)
DNA, which coded for target genes, was amplified from a plasmid template by
polymerase chain reaction (PCR) [132] (see Tab. 3.1 for standard conditions).
Specific oligonucleotides for the amplification of the target DNA are given in
the appendix (Tab. B.3, p. 167). If the amplification was unsuccessful with
standard conditions, a Touchdown PCR protocol [133] was applied instead.
Restriction Digest
Fragments and vectors were processed by restriction digest with type II re-
striction endonucleases (enzymes from NEB and Thermo Scientific) using the
restriction sites that were either introduced via oligonucleotides or already pre-
sent in the template DNA. The digestion of vectors and PCR fragments was
performed according to the manufacturer’s protocol and the 5’-phosphate of
the digested vector was removed with alkaline phosphatase (FastAP, Thermo
Scientific). Digested products were subsequently purified with a PCR puri-
fication kit (Qiagen) or via gel electrophoresis (see below) and subsequent gel
extraction with a gel extraction kit (Qiagen).
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Table 3.1.: Standard PCR conditions.
REACTION MIXTURE PCR PROGRAMME
Component Amount cend Step Temperature Time
Forward Primer (40 µM) 1.25 µl 1 µM
Reverse Primer (40 µM) 1.25 µl 1 µM 1. Initial Melting 98 °C 3 min
GC Buffer (5x)a 10 µl 1x 2. Melting 98 °C 10 sec
dNTPs (10 mM)a 2.5 µl 0.5 mM 3. Annealing 55 °C 30 sec
Phusion Polymerase (2 U/µl)a 0.5 µl 1 U 4. Elongation 72 °C 15-30 sec/kbb
Formamide (100 %) 1 µl 3 % 5. Final Elongation 72 °C 10 min
DMSO (100 %) 1 µl 3 %
MgSO4 (50 mM)
a 1 µl 1 mM
Template DNA 200 ng - repeat steps 2 to 4 29x
H2O ad 50 µl -
a from Thermo Scientific
b kb: kilobase
Ligation
Inserts were ligated into vectors at 21 °C for 3 to 16 h with the following condi-
tions:
Vector 20 fmol
Insert 60-100 fmol
T4 DNA Ligase Buffer (10x, Thermo Scientific) 1 µl
T4 DNA-Ligase (Thermo Scientific) 1 µl
H2O ad 10 µl
Isolation and Analysis of Plasmid DNA
A single colony of transformed bacteria was grown in 4 ml of LB medium con-
taining selective antibiotics (see 3.2.1). Plasmid DNA was isolated using the
QIAprep Spin Miniprep Kit (Qiagen).
The correct insertion of the respective PCR fragment was verified by digesting
the isolated plasmid DNA with the same restriction enzymes used for cloning
or by colony PCR with the original amplification primers (standard PCR condi-
tions: Tab. 3.1). The resulting fragments were analysed by gel electrophoresis.
For that purpose, 5 µl of sample were mixed with 1 µl of sample buffer (Thermo
Scientific) containing 10 mM Tris/HCl (pH 7.6), 0.03 % bromphenol blue,
0.03 % xylene cyanol FF, 60 % gylcerol and 60 mM EDTA. Agarose gel (1 %
w/v) electrophoresis was performed with a constant voltage of 90 V in 1x TAE
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buffer (40 mM Tris-acetate, 1 mM EDTA, pH 8.0). Gels were stained with Stain
G (Serva).
3.1.2. Site-directed Mutagenesis
Point mutations were either introduced with the QuickChange Site-directed
Mutagenesis Kit (Agilent Technologies) according to the manufacturer’s pro-
tocol or with the method of Edelheit, Hanukoglu and Hanukoglu [134] em-
ploying two single-primer amplification reactions. Mutation-containing oligo-
nucleotides were designed with PrimerX:
http://www.bioinformatics.org/primerx/.
3.1.3. Sequencing
All DNA constructs were verified through direct sequencing by the in-house
sequencing facility.
3.2. Cell Culture Techniques
3.2.1. Microbiological Cell Culture Techniques
All cloning procedures were carried out with the E. coli strain TOP10, whereas
protein expressions were performed with the strains BL21 Gold (DE3) and
Rosetta 2 (DE3). The genotypes of the strains can be found in the appendix,
Tab. A.1, p. 161. Bacteria were rendered chemically competent with CaCl2 as
described by Seidman et al. [135].
For transformations, 10 µl of a ligation reaction or 1 µl of conventional plas-
mid DNA were added to 50 µl of competent cells and incubated for 30 min
on ice. The cells were exposed to 42 °C for 45 to 70 sec to induce the DNA
uptake and subsequently cooled down. After the addition of 400 µl LB me-
dium (10 g/l bactotryptone, 10 g/l NaCl, 5 g/l yeast extract, pH 7.5), the cells
were incubated for 1 h at 37 °C. Subsequently, 100 - 450 µl were plated onto
LB agar plates containing appropriate selective antibiotics (ampicillin, cend =
100 µg/ml; kanamycin, cend = 50 µg/ml; chloramphenicol, cend = 34 µg/ml).
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3.2.2. Mammalian Cell Culture Techniques
Adherent HEK293T cells [136] were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10 % fetal bovine serum, 100 U/ml peni-
cillin, 100 µg/ml streptomycin, and 2 mM L-Glutamine (all from Invitrogen) at
37 °C in a humidified atmosphere with 5 % CO2. The HEK293T cells were a gift
from Bijàn Mir-Montazeri (LMU München).
Transient transfections were performed with polyethylenimine (PEI, linear,
25 kDa, Sigma) [137]. HEK293T cells were seeded in medium without antibiot-
ics in 100 mm dishes (Greiner Bio-One) and cultured till 90 % confluency. 20 µg
of DNA was mixed with PEI in a DNA/PEI ratio of 1:5 (w/w) in DMEM, in-
cubated for 15 min at room temperature, and added dropwise to the cells. The
DNA/PEI ratio was optimised according to Ehrhardt et al. [138]. The medium
was exchanged after 6 h. For smaller dishes, the amount of DNA was adjusted
accordingly. The transfection agent was kindly provided by C. Söllner (MPI für
Entwicklungsbiologie, Tübingen).
For fluorescence microscopy, HEK293T cells were grown on round coverslips,
which were coated with Poly-L-Lysine (P1274, Sigma) according to the man-
ufacturer’s protocol. The cells were washed with phosphate-buffered saline
(PBS), fixed with 2 % paraformaldehyde, and mounted in Fluoromount-G
(SouthernBiotech).
3.3. Protein Biochemistry Methods
3.3.1. SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE)
Protein samples were analysed by discontinuous SDS gel electrophoresis [139]
mainly using a 10 % separating gel (375 mM Tris/HCl (pH 8.8), 0.1 % (w/v)
SDS, 15 % (w/v) acrylamide, 0.4 % (w/v) bisacrylamide, 0.08 % (w/v) APS,
4 mM TEMED) and a 4.5 % stacking gel (125 mM Tris/HCl (pH 6.8), 4.5 %
(w/v) acrylamide, 0.12 % (w/v) bisacrylamide, 0.06 % (w/v) SDS, 0.1 % (w/v)
APS and 4.8 mM TEMED). Samples were mixed with sample buffer (32.5 mM
Tris/HCl (pH 6.8), 50 mM DTT, 1 % SDS, 5 % glycerol, 0.02 % bromphenol
blue) and denatured at 95 °C for 5 min. Proteins were separated at a constant
current of 50 mA in SDS running buffer composed of 25 mM Tris/HCl (pH 8.9),
200 mM Glycine and 0.1 % (w/v) SDS and stained with Coomassie Brilliant
Blue.
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3.3.2. Protein Expression and Purification
For heterologous expression of proteins the E. coli strains BL21 Gold (DE3) and
Rosetta 2 (DE3) were used. Cultures were grown at 37 °C in LB medium con-
taining selective antibiotics to an OD600 of 0.6 to 0.8, at which protein expression
was induced with 0.1 to 0.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG).
Proteins were expressed at 21 to 28 °C for 5 or 16 h, depending on the respective
protein construct (see below). After cell harvest, cell pellets were resuspended
in lysis buffer and stored at -80 °C.
Bacteria were lysed with a sonifier (Branson 250, BRANSON Ultraschall) and
the soluble fraction separated from cell debris by ultracentrifugation. All pro-
teins were purified by affinity chromatography, an optional ion exchange chro-
matography step, and subsequent size exclusion chromatography using ÄKTA
liquid chromatography systems (GE Healthcare). The purification scheme and
buffer conditions were adjusted for each protein according to the parameters
from the ProtParam tool (Expert Protein Analysis System (ExPASy) proteom-
ics server, http://www.expasy.org/). All steps were monitored by SDS-PAGE
and the folding status of protein domains evaluated by CD spectroscopy (see
3.4.1). Proteins were concentrated in AMICON Ultra centrifugal filters (Mil-
lipore), snap frozen, and stored at -80 °C. The protein concentration was de-
termined at 280 nm in an UV/vis spectrophotometer (Nanodrop 1000, Peqlab)
using the extinction coefficient obtained from the ProtParam tool.
3.4. Biophysical Methods
3.4.1. Circular Dichroism
Circular dichroism spectroscopy can be applied to estimate the overall compos-
ition of secondary structure and the folding status of a protein, since each sec-
ondary structure element gives rise to a distinct spectrum (reviewed in [140]).
CD spectra were recorded with a spectropolarimeter (Jasco J-810, Jasco) in the
far-UV region (195-250 nm), where the peptide bond depicts the main absorb-
ing entity (reviewed in [140]). Proteins were diluted to a final concentration of
0.2 mg/ml in potassium phosphate buffer (10 mM, pH 7.4) containing
200 mM Na2SO4. Measurements were carried out at 20 °C in a cuvette with
a cell length of 0.1 cm. The band width was set to 1 nm, the response time to
0.5 sec, and the scanning speed to 100 nm/min. The data of five consecutive
measurements was averaged and the resulting spectra, which were corrected
for buffer contributions, were analysed with the Spectra Manager II software
(Jasco).
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Temperature stability and folding state of proteins were assessed by following
the denaturation of proteins with increasing temperature. Sigmoidal melting
curves indicate cooperative unfolding, which is a characteristic of folded pro-
teins. For this purpose, the change in ellipticity from 20 to 90 °C was measured
at a wavelength associated with the largest difference between native and un-
folded state (compare [140]). The response time was set to 2 sec, the band width
to 3 nm, and the temperature slope to 1 °C/min. The melting temperature was
calculated from the inflection point of the melting curve. Curves were plotted
with SigmaPlot (version 12.3, Systat Software Inc.).
3.4.2. Isothermal Titration Calorimetry
Isothermal titration calorimetry (ITC) depicts a label-free technique for the in-
vestigation of the thermodynamic properties of binding reactions [141] or en-
zyme kinetics [142]. It measures the heat change upon complex formation when
one component is titrated into the other, thereby providing information about
the affinity, the binding enthalpy, and the stoichiometry of the reaction [141].
Measurements were carried out in a VP-ITC calorimeter (GE Healthcare) at
20 °C. Prior to measurements, all proteins were extensively dialysed against
measurement buffer using Slide-A-Lyzer Cassettes (Thermo Fisher Scientific).
Protein concentrations were determined as described under 3.3.2. The ligand
was titrated under constant stirring at 300 rpm into the cell in 28 steps of 10 µl,
and a spacing between titration steps of 240 sec. Data analysis was performed
with MicroCal Origin for ITC (Version 7) assuming a single-site binding model.
The integrated heat signal was corrected for the heat of dilution (obtained from
reference titrations of syringe component into buffer or GST) and fitted to the
following quadratic equation, thus creating the binding isotherm (reviewed in
[143]):
∆Q(i) = Q(i)dVi
V0
[Q(i)+Q(i − 1)
2
]−Q(i − 1)
with Vi being the volume of ligand titrated at step i and Q the heat content. In
a one-site binding model this is:
Q = nMt∆HV0
2
⎡⎢⎢⎢⎢⎣1+ Xt,inMt + 1nKMt −
¿ÁÁÁÀ(1+ Xt,i
nMt
+ 1
nKMt
)2 − 4Xt,i
nMt
⎤⎥⎥⎥⎥⎦
with Xt being the bulk concentration of titrant at the titration step i, Mt the bulk
concentration of analyte, n the number of available binding sites for the titrant
in one analyte molecule, V0 the cell volume at the beginning of the titration, ∆H
the molar enthalpy and K the association constant.
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Part I.
Characterisation of the C-Terminal
Region of SrGAP3

4. INTRODUCTION
Parts of this chapter are included in publication: Wuertenberger and Groemp-
ing. "A single PXXP motif in the C-terminal region of srGAP3 mediates bind-
ing to multiple SH3 domains." in FEBS Letters (2015).
Neuronal migration and axonal targeting are important processes that estab-
lish a certain brain architecture and are driven - among other factors - by guid-
ance cues formed by secreted or transmembrane proteins [17, 144]. Slit-Robo
signalling is involved in several neurodevelopmental processes and was iden-
tified as crucial pathway in mediating the repulsion of commissural axons that
have crossed the midline (an imaginary line, which separates the left from the
right hemisphere) [145]. Robo (roundabout [146]) receptors bind to the secreted
Slit protein and mediate its repulsive effects [147–150] by affecting actin cyto-
skeletal dynamics [17, 144].
The Slit-Robo GTPase-activating proteins (srGAP) act downstream of Robo re-
ceptors [151–153] and transmit the signal via Rho GTPases to the actin cyto-
skeleton [151] (compare introduction on Rho GTPases, section 1.2.2, p. 11).
This family comprises the proteins srGAP1, srGAP2, srGAP3, and the more
distantly related ARHGAP4, which share a common domain architecture com-
prising an N-terminal F-BAR domain followed by a GAP domain, and an SH3
domain (Fig. 4.1) [151].
Despite the high degree of sequence conservation in these globular domains
[151, 154], srGAP proteins seem to be involved in different aspects of neur-
onal development [145, 151, 152, 155–158]. This observation might partially
be related to non-overlapping expression patterns in the developing and adult
brain [159, 160], but was also suggested to depend on different functional as-
sociations on a molecular level [145]. SrGAP3, which is also termed “mental
disorder GAP” (MEGAP) [161] or “WAVE-associated RacGAP protein” (WRP)
Figure 4.1.: Domain architecture of srGAP proteins. F-BAR, Fes-Cip4-homology-
BAR (Bin-Amphiphysin-Rvs) domain; GAP, GTPase-activating domain; SH3,
Src-homology 3 domain. The domain boundaries of srGAP3 (H. sapiens, isoform
1) are indicated.
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[127], was, for example, found to regulate commissural axon pathfinding (see
above, [152]) and the migration of neuronal progenitors out of the subventricu-
lar zone [157]. However, the functions of srGAP3 are likely to be more complex,
since knockout mice present various neurological defects ranging from impair-
ments in cognitive function and development of hydrocephalus to changed
synaptic activity [145, 157, 161–163]. Most notably, disruption of the srGAP3
gene has been associated with a severe form of mental retardation [161]. More-
over, srGAP3 is mainly expressed in brain tissue and to a lower extent in kidney
[161], whereas srGAP1 and srGAP2 show a broader tissue distribution [151].
On a molecular level, srGAP3 employs its unique domain composition to reg-
ulate actin cytoskeletal as well as microtubule dynamics and the formation of
cellular protrusions [127, 145, 164, 165]: Via its F-BAR domain it is targeted to
membranes [165] and facilitates filopodia formation, which was found to be
crucial for dendritic spine initiation [163]. In fact, all F-BAR domains of the
srGAP family seem to promote the formation of protrusions rather than inva-
ginations [154, 156], which sets them apart from conventional F-BAR modules
(compare introduction on BAR domains, section 1.1.3, p. 6), although the mo-
lecular details underlying these findings remain to be elucidated. The SH3 do-
main mediates complex formation with Robo1 and Robo2 [152, 166], WAVE1
[127], or Lamellipodin [165], thereby enabling signal transmission (see above)
and - together with the GAP domain - negative regulation of Rac1-dependent
actin polymerisation [127, 151, 161, 164, 165] (compare introduction on Rho
GTPases, section 1.2.2, p. 11).
While all of these studies mainly focussed on the N-terminal domains, the func-
tion of the less conserved C-terminal region (CTR) [151] remained elusive. In
this research project, I therefore attempted to characterise the C-terminal region
of srGAP3.
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5.1. Bioinformatics
Amino acid sequences of the srGAP family of proteins (srGAP1, 2, and 3,
ARHGAP4) were gathered with PSI-BLAST [167] employing searches against
the non-redundant protein database (nr) or retrieved from the Reference Sequen-
ces Database provided by the National Centre for Biotechnology Information
(NCBI) and from the KEGG Orthology Database (group K07526). Remote homo-
logs were identified through transitive sequence profile searches with
HHsenser [168]. An overview of the employed databases and bioinformatic
tools and the corresponding web links are listed in Tab. 5.1, p. 29. The longest
isoform was selected - if applicable - and duplicate sequences were removed,
thus leading to a curated set of 247 sequences. The Bioinformatics Toolkit of the
MPI for Developmental Biology [169] provided the platform for the integrative
sequence analysis outlined below.
Domain boundaries were determined with HHpred [170] searches for homo-
logous proteins of human srGAP3 in three different databases: the Protein Data
Bank clustered to a maximum pairwise sequence identity of 70 %, the Structural
Classification of Proteins database clustered to a pairwise sequence identity of
95 %, and the protein families (Pfam) database [169, 170]. Sequences were
realigned using the implemented maximum accuracy algorithm of HHpred
[170] and the derived domain boundaries locally refined through secondary
structure prediction with PSIPRED [171] and JPRED [172]. Pairwise sequence
comparisons of the srGAP sequences from H. sapiens were performed with a
global alignment employing the Needleman-Wunsch algorithm provided by
the European Molecular Biology Open Software Suite (EMBOSS, EMBOSS
Needle tool for protein alignment) [173–175].
In order to delineate sequence relationships between the C-terminal regions of
srGAP proteins, amino acid sequences were compared through clustering and
visualisation with CLANS [176] employing BLAST [177] with a BLOSUM80
matrix for all-against-all comparisons, and a variable P-value cut-off. Multiple
sequence alignments of subclusters and selected sequence sets were produced
with MSAProbs [178], MUSCLE [179, 180], T-Coffee [181], or the implemen-
ted maximum accuracy algorithm of HHpred [170]. Interactive processing of
these alignments based on secondary structure and linear motif predictions
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(see below) helped to improve their accuracy when comparing highly diver-
gent sequences. Secondary structure and disorder in the C-terminal region of
srGAP proteins were predicted by incorporating the results of a panel of dif-
ferent prediction servers: D2P2 [182], DisProt [183], MoRFpred [184], Predict-
Protein [185], and Quick2D [169]. The amino acid sequence of human srGAP3
or alignments of respective subclusters from the CLANS map served as input.
Coiled-coils were predicted using the consensus of COILS/PCOILS [186] and
MARCOIL [187] and heptad repeats were assigned manually.
Candidate linear motifs located in the C-terminal region of srGAP were re-
trieved from the Eukaryotic Linear Motif (ELM) resource, which searches for
functional sites in proteins using regular expressions [188, 189], and Scans-
ite [190, 191], which uses a matrix of selectivity values derived from oriented
peptide library screens to predict optimal binding sites for a variety of ad-
aptor domains [80, 192, 193]. Both methods thus depend on datasets of well-
characterised domain/motif-interaction types, which precludes the de novo iden-
tification of motifs. As de novo predictor, I employed SLiMPred [194], which
uses machine learning on known ELM instances and additional physico-chemi-
cal features of the amino acid sequence to predict linear motifs in disordered re-
gions and folded domains [194]. Experimentally verified phosphorylation sites
in srGAP3 were collected from the PhosphoSite database [195].
5.2. Molecular Biology Methods
5.2.1. Cloning Strategies and DNA Constructs
For expressions in mammalian cells, a modified pEGFPC2 (Clontech) vector
series comprising six constructs was generated, which are termed pEGFPC23C
and pmCherryC23C (see Tab. B.2, p. 164): Each vector contained one of three
frames, a PreScission Protease (GE Healthcare, here "3C") cleavage site up-
stream of the multiple cloning site, and eGFP or mCherry, which resulted in
the N-terminal tagging of proteins (Fig. 5.1).
The srGAP3 plasmid (isoform 1, H. sapiens) was a kind gift from G. Rappold
(Universität Heidelberg). Full-length srGAP3 (amino acids (aa) 1-1099) was
subcloned into pEGFPC23C and pmCherryC23C. The candidate interaction
partners for the fluorescence-based co-immunoprecipitation assay (see 5.3.5)
were solely cloned into the pmCherryC23C vectors. DNA templates used for
subcloning of target genes were obtained from Addgene, from BioCat GmbH,
or kindly provided by other research groups (as enlisted in Tab. B.1, p. 163).
The respective PCR primers, gene identifiers (http://www.ncbi.nlm.nih.gov/),
and restriction sites can be similarly found in the appendix (Tab. B.3, p. 167).
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Table 5.1.: Bioinformatic tools and databases.
Bioinformatic Tool a URL
MPI Bioinformatics Toolkit http://toolkit.tuebingen.mpg.de/
COILS/PCOILS http://toolkit.tuebingen.mpg.de/pcoils
CLANS http://toolkit.tuebingen.mpg.de/clans
D2P2 database http://d2p2.pro/
DisProt database http://www.disprot.org/
ELM resource http://elm.eu.org/
EMBOSS Needle tool http://www.ebi.ac.uk/Tools/psa/emboss_needle/
HHpred http://toolkit.tuebingen.mpg.de/hhpred
HHsenser http://toolkit.tuebingen.mpg.de/hhsenser
JPRED http://www.compbio.dundee.ac.uk/www-jpred/
KEGG Orthology database http://www.genome.jp/kegg/ko.html
MARCOIL http://toolkit.tuebingen.mpg.de/marcoil
MoRFpred http://biomine-ws.ece.ualberta.ca/MoRFpred/index.html
MSAProbs http://toolkit.tuebingen.mpg.de/msaprobs
MUSCLE http://toolkit.tuebingen.mpg.de/muscle
NCBI http://www.ncbi.nlm.nih.gov/
PhosphoSite http://www.phosphosite.org/homeAction.do
PredictProtein http://ppopen.informatik.tu-muenchen.de/
PSIPRED http://bioinf.cs.ucl.ac.uk/psipred/
Quick2D http://toolkit.tuebingen.mpg.de/quick2_d
Scansite3 http://scansite3.mit.edu/#home
SLiMPred http://bioware.ucd.ie/~compass/biowareweb/Server_pages/slimpred.php
T-Coffee http://tcoffee.crg.cat/
a Detailed information on abbreviations can be found in the text.
For expression in E. coli, the C-terminal region of srGAP3 (aa 810-1099) was
cloned into the pETGST1c vector (provided by Gunter Stier, Heidelberg). Smal-
ler srGAP3 fragments (PxxP-fragment: aa 1047-1079, Linker: aa 470-508), and
the SH3 domains of Amphiphysin, Endophilin-A1, Endophilin-A2, and Grb2
were cloned into pGEX6P1 (GE Healthcare). The DNA sequence for the anti-
GFP-nanobody (subsequently abbreviated as GFP-nanobody, [compare 196])
was derived from the protein sequence published in Saerens et al. [197] and
Kubala et al. [198]. A codon-optimized DNA construct for expression in E. coli
cloned into pET29a was ordered from Genscript. It contained an additional
Thrombin cleavage site, which enabled the removal of the C-terminal His6-tag.
The srGAP3 mutant, which is deficient in SH3 domain-binding (srGAP3 AxxA-
fragment, compare Tab. B.3, p. 167), was constructed through cassette muta-
genesis: Oligonucleotides were phosphorylated with T4 Polynucleotidekinase
(NEB) and ligated to produce a fragment that could be incorporated via the
BamHI/AgeI sites into the digested pGEX6P1_srGAP3_PxxP-fragment cons-
truct (Tab. B.3, p. 167).
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Figure 5.1.: Vector map of the pEGFPC23C/pmCherryC23C vector series. Modified
from pEGFPC2 (Clontech), containing either the enhanced green fluorescent pro-
tein (eGFP) gene or a gene coding for the monomeric red fluorescent protein variant
mCherry. Their expression is under control of human cytomegalovirus immediate
early (CMV IE) promoter. The multiple cloning site (MCS) is positioned between a
Precission Protease (GE Healthcare) cleavage site ("3C") and the SV40 polyadenyla-
tion signal (SV40 poly A). Three different frames were obtained via the introduction
of "G" and "GG" at position 1328 (illustrated in the sequence below). The SV40 origin
enables the replication in mammalian cells, the pUC origin the replication in E. coli,
and f1 origin the single-stranded DNA production. A kanamycin resistance gene
(KanR) and a corresponding upstream promoter allow for selection in E. coli, and
a neomycin-resistance cassette consisting of the SV40 early promoter, the neomycin
resistance gene (NeoR), and the polyadenylation signal from Herpes simplex virus
thymidine kinase (HSV TK poly A) for selection in eukaryotic cells. The figure was
adapted from the Clontech vector map.
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5.3. Protein Biochemistry Methods
5.3.1. Protein Expression and Purification
The GFP-nanobody was expressed in E. coli BL21 Gold (DE3) cells. Protein ex-
pression was induced with 0.1 mM IPTG and the cells harvested after
16 h at 21 °C. The cells were lysed in 30 mM Hepes (pH 6.8), 300 mM NaCl,
3 mM β-Mercaptoethanol, 10 mM imidazole, 1 mM phenymethylsulfonyl flu-
oride (PMSF) , and cOmplete Protease Inhibitor Cocktail (Roche) and the crude
extract applied to a Ni Sepharose (GE Healthcare) column. After washing with
a high salt buffer (1 M NaCl) and removal of DnaK, which is frequently co-
purified with unfolded peptides, according to Thain et al. [199], bound protein
was eluted in a linear imidazole gradient and the S-tag and His6-tag cleaved
off with Thrombin (Sigma). Uncleaved fusion protein was removed with a
second Ni Sepharose column and the flow-through, which contained the free
nanobody, subjected to a Superdex 75 column (GE Healthcare). The pure pro-
tein was concentrated in 20 mM Hepes (pH 7.0), 150 mM NaCl, and 3 mM
β-Mercaptoethanol to 13 - 23 mg/ml.
GST-srGAP3-CTR was expressed in E. coli Rosetta 2 (DE3) with the same pro-
tocol as employed for the GFP-nanobody. The cells were lysed in 30 mM Hepes
(pH 6.8), 300 mM NaCl, 4 mM DTE, 4 mM Benzamidine, 2 mM EDTA, and
cOmplete Protease Inhibitor Cocktail and the cleared lysate subjected to a Gluta-
thione Sepharose 4B column (GE Healthcare). After washing with a high salt
buffer (1 M NaCl) and removal of DnaK according to Thain et al. [199], the
column was washed with 50 mM MES (pH 6.0), 50 mM NaCl, and 2 mM DTE
and bound protein eluted in a step gradient with 60 mM GSH. The protein was
further purified with cation exchange chromatography (Source S, GE Health-
care) using MES buffer and eluted in a linear salt gradient. The eluate was
subjected to a Superdex 200 column (GE Healthcare) in 20 mM Hepes (pH 6.8),
150 mM NaCl, and 2 mM DTE and the combined srGAP3-containing fractions
concentrated to 2 - 11 mg/ml.
The srGAP3 PxxP-fragment and srGAP3 AxxA-fragment were expressed as
GST-fusion proteins in E. coli BL21 Gold (DE3) cells with the same protocol as
employed for the GFP-nanobody. The cleared lysates were applied to a Gluta-
thione Sepharose 4B column in 50 mM Tris/HCl (pH 8.0), 300 mM NaCl, 4 mM
DTE, 4 mM Benzamidine, and cOmplete Protease Inhibitor Cocktail, washed
with a high salt buffer (1 M NaCl), and eluted in a linear GSH gradient. The elu-
ate was subjected to size exclusion chromatography (Superdex 75) and the GST-
tag cleaved off afterwards using PreScission Protease (GE Healthcare). GST
was removed with a second GSH column and a final heat denaturation step
(70 °C for 15 min, removal of precipitates by centrifugation for 10 min at 30000
rpm and 4 °C). The gel filtration eluate of the srGAP3 AxxA-fragment contained
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a non-proteinaceous contaminant (as assessed by UV spectrometry), presum-
ably including metal ions, which resulted in a brown color of the protein solu-
tion. This contaminant could be removed by addition of 10 mM EDTA during
heat denaturation and subsequent dialysis against EDTA-free buffer. The pro-
teins were concentrated in 50 mM Tris/HCl (pH 8.0), 200 mM NaCl, and 3 mM
β-Mercaptoethanol to a final concentration of 13 - 51 mg/ml.
GST-fusion proteins of SH3 domains were expressed in E. coli BL21 Gold (DE3)
cells. Protein expression was induced with 0.2 to 0.5 mM IPTG and continued
for 5 h at 21 - 25 °C. After harvest, the cells were lysed in 20 mM Hepes (pH
7.0), 300 mM NaCl, 4 mM DTE, 4 mM Benzamidine, 2 mM EDTA, and cOm-
plete Protease Inhibitor Cocktail. The crude extracts were subjected to a Gluta-
thione Sepharose 4B column and eluted after a high salt wash (1 M NaCl) in a
linear GSH gradient. The free SH3 domains were produced by incubation with
PreScission Protease and separated from the GST-tag via gel filtration (Super-
dex 75). The SH3 domains were concentrated in 20 mM Hepes (pH 7.0),
150 mM NaCl, and 3 β-Mercaptoethanol to 7 - 43 mg/ml. GST was obtained
as a byproduct of these SH3 domain purifications.
5.3.2. Western Blotting
Proteins were separated by SDS-PAGE with 10 % polyacrylamide gels and
transferred onto a nitrocellulose membrane (pore size 0.45 µm, Whatman) in
25 mM Tris, 150 mM Glycine, and 10 % isopropanol for 1.5 h at 25 V using
an XCell II Blot Module (Invitrogen). Effectual protein transfer was monitored
with Ponceau S (Sigma) staining and the membrane subsequently blocked with
blocking buffer (PBS with 0.1 % Tween 20 (Sigma), 3 % nonfat dry milk powder)
for 16 h at 4 °C. Proteins were detected by incubation of the membrane for 2 h at
room temperature with primary antibodies (mouse anti-RFP (3F5), rat anti-GFP
(3H9), ChromoTek GmbH, rabbit anti-srGAP3 (S1575), Sigma) diluted 1:1000
in blocking buffer. Membranes were washed three times with PBS-T and in-
cubated for 1 h at room temperature with HRP-conjugated secondary antibod-
ies (goat anti-mouse (115-035-146), goat anti-rat (112-035-143), goat anti-rabbit
(111-035-144), Jackson ImmuoResearch) diluted 1:3000 in blocking buffer. After
washing with PBS-T, bands were developed with Clarity Western ECL sub-
strate (Bio-Rad) and images acquired with a Fusion Sl Imaging System (Peqlab).
For the consecutive detection of two antigens, the membranes were stripped
with 60 mM Tris/HCl (pH 6.8), 2 % SDS, 100 mM β-Mercaptoethanol for
30 min at 50 °C, washed extensively with PBS-T, and reprobed with the second
primary antibody after blocking.
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5.3.3. GST Pull-Down and Mass Spectrometric Analysis
The GST pull-down with rat brain lysate from a rat of stage P14 was performed
as described by Rufer et al. [200] with the modification that bound proteins
were analysed by mass spectrometry instead of Western blotting. The assay
was carried out together with Anitha Jeganantham (MPI für Entwicklungsbio-
logie, Tübingen). We utilised GST-srGAP3-CTR, GST-srGAP1-CTR (H. sapiens,
residues 799-1085), and GST for these experiments in order to dissect binding
partners that were specifically associated with either srGAP family member.
GST-srGAP1-CTR was provided by A. Jeganantham. Pull-down fractions were
separated by SDS-PAGE and gel sections processed with in-gel tryptic digest
and subsequent NanoLC-MS/MS analysis by the Proteome Center Tübingen
(Easy-nLC coupled to an LTQ Orbitrap XL, Thermo Fisher Scientific). Data ana-
lysis was performed by Johannes Madlung (Proteome Center Tübingen) with
the MaxQuant software suite (version 1.0.14.3) [201] and the Mascot search en-
gine (version v.2.2, Matrix Science). We then estimated the general confidence
for the identification of true binding partners based on peptide counts and in-
tensity. Proteins were counted as srGAP-positive if the number of peptides
was at least twice as high as in the GST-control experiment. The identified
candidates were further classified as srGAP3- or srGAP1-specific based on an
analogous discrimination criterion.
5.3.4. Phosphorylation Analysis of srGAP3
We analysed the phosphorylation state of endogenous srGAP3 from rat brain
(stage P14) and of transiently expressed eGFP-srGAP3 from HEK293T cells us-
ing mass spectrometry.
For immunoprecipitations of endogenous srGAP3, the brain tissue was homo-
genized in lysis buffer containing phosphatase and protease inhibitors (20 mM
Tris/HCl (pH 7.5), 150 mM NaCl, 1 % Nonidet P-40 (Roche), 2 mM EDTA,
1 mM Na3PO4, 5 mM NaF, 3 mM Na4P2O7, 1 mM Na3VO4, 2 µl/ml diiso-
propyl fluorophosphate, and one tablet of cOmplete Protease Inhibitor Cock-
tail). Cell debris was removed by centrifugation and the lysate pre-cleared with
G-protein-coupled beads for 30 min at 4 °C. After removal of the beads, srGAP3
was precipitated by addition of 5 µg of anti-srGAP3 (rabbit) antibody (S1575,
Sigma) to 750 µl lysate and the immune complexes allowed to form for 16 h at
4 °C. The complexes were captured by incubation of the lysate with G-protein-
coupled beads for 2 h at 4 °C. Beads were pelleted by centrifugation, washed
eight times with lysis buffer, and the bound proteins isolated by heat denatur-
ation in SDS sample buffer.
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EGFP-srGAP3 was transiently expressed in HEK293T cells (see 3.2.2) and isol-
ated from the lysate in lysis buffer using GFP-binding protein-coupled beads
(GFP-Trap_A, ChromoTek GmbH) according to the manufacturer’s protocol.
Proteins were separated by SDS-PAGE and gel sections processed as described
for the GST pull-down samples (see 5.3.3) by the Proteome Center Tübingen.
Phosphopeptides were analysed in an LTQ Orbitrap XL with multistage ac-
tivation. The data analysis was carried out by Johannes Madlung (Proteome
Center Tübingen) with the MaxQuant software suite (version v.1.2.2.9) [201]
and the Andromeda search engine [202]. Phosphorylation sites were assigned
to a specific amino acid, if the localisation probability of this phosphorylation
event was above a threshold of 0.75.
5.3.5. Fluorescence-Based Co-Immunoprecipitation Assay
For interaction studies between srGAP3 and the identified candidate binding
partners, I established a fluorescence-based co-immunoprecipitation (Co-IP)-
assay in a 96-well format. It relies on the Co-IP of mCherry-tagged candidate
proteins with eGFP-tagged srGAP3 from HEK293T lysates and is similar to the
commercially available GFP-multiTrap (ChromoTek GmbH; compare [203]).
Lysate preparation
MCherry-tagged candidate proteins were co-transfected with either eGFP-
srGAP3 full-length or eGFP into HEK293T cells as described under general ma-
terials and methods, section 3.2.2 and harvested after 30 h. About 107 cells per
sample were lysed in lysis buffer containing phosphatase and protease inhib-
itors: 10 mM Tris/HCl (pH 7.5), 150 mM NaCl, 0.5 % Nonidet P-40 (Roche),
1 mM EDTA, 5 mM NaF, 3 mM Na4P2O7, 1 mM Na3VO4, 1 mM PMSF, and one
tablet of cOmplete Protease Inhibitor Cocktail. Lysates were cleared by centri-
fugation for 30 min at 13300 rpm at 4 °C and the volume between the sample
containing eGFP-srGAP3 and the eGFP-control adjusted to yield equal mCh-
erry fluorescence (measured with BioTek H4 microplate reader, excitation (Ex)
at 590 nm, emission (Em) at 610 nm). To test whether the two constructs were
co-expressed in the majority of cells, I monitored their expression with fluores-
cence microscopy (see 3.2.2 for sample preparation). The images were acquired
with a Zeiss LSM 510 Meta and a 63x oil objective. Images were processed
with Fiji [204]: The channels were spectrally unmixed [205], a composite image
generated and an unsharp mask with a radius of 1.0 and a mask weight of 0.3
applied to the individual pictures. The expression of the proteins was further
analysed by Western blotting as described under 5.3.2.
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Co-Immunoprecipitation
The GFP-nanobody was immobilised in amino-reactive 96-well plates (Nunc
Immobilizer Amino Black, Thermo Scientific) according to the supplier’s pro-
tocol. A detailed description of the optimisation of the coupling reaction and
the assay set-up can be found in the results section (see 6.3.1, p. 48). The
purified eGFP and mCherry, used for establishing the assay, was generously
provided by Martin Schückel (MPI für Entwicklungsbiologie, Tübingen). Na-
nobody-containing plates were incubated for 2 h at 4 °C with HEK293T lysates
(4 replicates per sample on each plate) and washed twice with PBS-T (0.2 %
Tween 20). Subsequently, the fluorescence signals were recorded in PBS in a
Mx microplate reader (BioTek) with the following settings: Ex 488 nm (9 nm slit
width)/ Em 509 nm (9 nm slit width) for eGFP, Ex 580 nm (9 nm slit width)/
Em 610 nm (13.5 nm slit width) for mCherry, Gain 150, read height 6 mm, and
10 reads with 40 data points. For evaluation of the data, I compared the
mCherry-fluorescence of Co-IPs containing eGFP-srGAP3 to the eGFP-control.
The statistical analysis of two (α-Cop) to four independent experiments was
performed with SigmaPlot (version 12.3, Systat Software Inc.).
5.4. Biophysical Methods
5.4.1. Isothermal Titration Calorimetry
All measurements were carried out at 20 °C and the ligand was titrated under
constant stirring at 300 rpm into the cell (cell volume 1.4295 ml) in 28 steps of
10 µl, and a spacing between titration steps of 240 sec. 200 to 1000 µM ligand
were titrated into 20 to 100 µM protein solution. Prior to measurements, all
proteins were extensively dialysed against 20 mM Hepes (pH 6.8 in titrations
with GST-srGAP3-CTR or pH 7.3 intitrations with shorter srGAP3 fragments),
150 mM NaCl, and 5 mM β-Mercaptoethanol.
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6.1. Bioinformatic Analysis of SrGAP Proteins
6.1.1. Phylogenetic Distribution of SrGAP Proteins
SrGAP proteins have been identified and studied in mammals as well as Caen-
orhabditis elegans [151], but the phylogenetic distribution of this protein fam-
ily has so far not been analysed in detail. My sequence analysis revealed that
srGAPs occur in metazoans, in which Bilateria represent the largest group, but
single sequences are also found in Cnidaria and Placozoa. Most sequences in
the bilaterian lineage belong to chordates, but they are also present in Echin-
odermata, Arthropoda, Nematoda, Annelida, Mollusca, and Platyhelminthes.
With searches for remote homologs using HHsenser [168], I further detected
srGAP genes in the genomes of two unicellular eukaryotes: the choanofla-
gellate Salpingoeca rosetta and the filasterean Capsaspora owczarzaki [206]. The
srGAP family is therefore conserved over large evolutionary distances, but
does not seem to be present ubiquitously. Drosophila species, for instance, lack
srGAP proteins and only contain representatives of the closest homologous
family: Nwk (Nervous Wreck) and FCHSD (FCH and double SH3 domains)
proteins (sequence analysis by Anitha Jeganantham, personal communication).
The two protein families share the F-BAR domain, but FCHSD and Nwk pos-
sess two SH3 domains instead of a GAP and a SH3 domain.
While the three N-terminal domains in srGAP proteins (Fig. 4.1, p. 25) are
well conserved, comparison of sequences of the human paralogs showed that
the C-terminal region (CTR, see Fig. 4.1, 25 for srGAP architecture) is most di-
vergent within the family, in which ARHGAP4 lacks any detectable similarity
(Tab. 6.1, similarly shown in [154, 207]). In order to analyse the amino acid
sequence relationships between the C-terminal regions, I clustered and visual-
ised the C-terminal sequences using CLANS (Fig. 6.1) [176]. Three sequences
from arthropods and a single mollusc sequence are devoid of C-terminal re-
gions and were thus excluded from further analyses. Chordate srGAP1, 2, and
3 formed the main cluster, in which the vertebrates composed the core (Fig.
6.1). Cephalochordata (Branchiostoma floridae) and Tunicata (Ciona intestinalis)
were positioned at the edge, but remained tightly associated with this cluster
at lower P-value cut-offs (P < 10-6). ARHGAP4 sequences clustered - as expec-
ted from calculated sequence identities (Tab. 6.1) - separately and were only
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Table 6.1.: Amino acid sequence identities of the human srGAP family. Se-
quence identities in percent of srGAP1, 2, 3 and ARHGAP4 from H. sapi-
ens were calculated from pairwise alignments using the EMBOSS Needle tool
(http://www.ebi.ac.uk/Tools/psa/emboss_needle/).
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srGAP2b – 58 39 – 70 46 – 51 56 – 85 56 – 35 12
srGAP3b – 39 – 50 – 58 – 52 – 9
ARHGAP4b – – – – –
a F-BAR, Fes-Cip4-homology-BAR (Bin-Amphiphysin-Rvs) domain; GAP, GTPase-activating domain; SH3,
Src-homology 3 domain; CTR, C-terminal region.
b Uniprot identifier (http://www.uniprot.org/): srGAP1, Q7Z6B7; srGAP2, O75044; srGAP3, O43295; AR-
HGAP4, P98171.
weakly connected to other vertebrate sequences. Furthermore, Lophotropho-
zoa and Arthropoda formed a Protostomia super-cluster, which weakly associ-
ated with chordate srGAP proteins, while Nematodes remained isolated (Fig.
6.1). Nematode srGAP proteins form a unique subgroup within the set of ana-
lysed sequences, as they were the only representatives within the bilaterian
clade that are devoid of the SH3 domain.
In summary, these results demonstrated that the degree of similarity between
C-terminal sequences mainly reflects the degree of the phylogenetic relation-
ship, which points towards little evolutionary constraints. In the available set
of sequences, paralogous srGAP proteins were restricted to the vertebrate clade
(Fig. 6.1, inset), which might support the idea that gene amplification events
during the emergence of this lineage potentially led to the expansion of para-
logous sequences. In contrast, the alternative scenario featuring early second-
ary loss of paralogous sequences in the protostomian clade lacks evidence from
the available data set.
6.1.2. Structural Predictions of the C-terminal Region
The following analyses focused on protein structure predictions for the C-termi-
nal regions of human srGAPs and only partially included data on srGAPs from
different origins. My secondary structure and disorder predictions (see Mater-
ials and Methods, 5.1, p. 27) revealed that the C-terminal region of srGAP pro-
teins likely lacks a defined 3D structure in isolation (Fig. 6.2, p. 42): Firstly, pre-
38
6.1. Bioinformatic Analysis of SrGAP Proteins
Figure 6.1.: Sequence relationships between C-terminal sequences of srGAP pro-
teins. Amino acid sequences were clustered with CLANS [176] at a P-value< 0.05. Each dot represents an amino acid sequence and grey lines denote simil-
arities between two sequences better than the cut-off. Darker lines correspond to
lower P-values. Colors indicate the phylogenetic origin and the main phyla were
assigned according to Aguinaldo et al. [208], Halanych et al. [209] and Dunn et al.
[210]. The map contains 224 sequences (singletons were excluded). The inset shows
paralogous srGAP sequences in shades of blue.
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dicted secondary structure elements are α-helical and mainly located in a short
conserved region, which also incorporates a predicted coiled-coil segment (Fig.
6.2). Secondly, homology searches employing HHpred [170] failed to detect any
similarities to known folded protein domains. Moreover, positively and negat-
ively charged amino acids are evenly distributed, which renders folding into a
collapsed globule structure through polar tracts [37] likewise improbable. It is,
on the other hand, known that such disordered segments can contain linear in-
teraction motifs [211], which can direct proteins to different pathways through
specific protein interactions (see introduction on intrinsic disorder, 1.1.1, p. 4)
[45]. Indeed, motif searches predicted numerous short linear interaction motifs
for binding of 14-3-3 proteins and SH3 domains within the C-terminal region
(Fig. 6.2, p. 42).
SH3 domains (see introduction on SH3 domains, 1.1.2, p. 5) were reported to
bind to proline-rich sequences that possess a type II polyproline helix conform-
ation [55, 212] and the orientation of the peptide mainly depends on the loca-
tion of a positively charged amino acid [58, 59]: According to the ELM resource
[188, 189] classification scheme, class I SH3-binding motifs can be described
by the regular expression [RKY]xxPxxP, while class II peptides are expressed
as PxxPx[KR]. Non-canonical class I motifs (class III in ELM scheme), in con-
trast, follow the rather generic consensus xxx[PV]xxP, which is associated with
lower predictive power. The bioinformatic analysis revealed that all three motif
classes are predicted within the C-terminal regions of human srGAP proteins,
whereby only two motifs are conserved between different paralogs (Fig. 6.2,
p. 42).
The second group of predicted linear motifs constitute 14-3-3-binding sites.
14-3-3 proteins (see introduction on 14-3-3s, 1.1.2, p. 6) form cradle-shaped
homo- or heterodimers and engage in phospho-dependent interactions, mainly
involving phosphorylated serines and threonines ([79, 84], while atypical non-
phosphorylated motifs have also been described [213–216]. The ELM resource
classifies motifs complying with the regular expression RxxSxP as type 1 and
RxxxS#p as type 2, in which # represents a hydrophobic amino acid and p a
semi-conserved proline. The serine residue in the center depicts the phos-
phorylated position. Type 3 motifs are the least specific with the consensus
[RHK][STALV]x([ST])x[PESRDFTQ]. I found that motifs of all three classes are
predicted within the CTR of human srGAP proteins, of which type 3 motifs
formed the largest group (Fig. 6.2, p. 42).
In fact, binding of 14-3-3 proteins is the only function assigned to the C-terminal
region of srGAPs so far [207]. In srGAP2, the motif surrounding the phos-
phorylated residue S930 mediated the interaction with 14-3-3s in HEK293T
cells, whereas the corresponding motif in srGAP3 involving the residues S947
and S948 failed to act likewise [207] (Fig. 6.2, p. 42). Which 14-3-3 isoforms or
which motifs in srGAP3 were involved in these interactions remained elusive.
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Unstructured regions are furthermore exceptionally rich in phosphorylation
sites [217], which provide a means of allosteric regulation of protein-protein in-
teractions or are involved in autoinhibitory mechanisms [48]. It is therefore not
surprising, that the C-terminal region of srGAP3 contains many phosphoryla-
tion sites and a subset of those is even located within predicted 14-3-3-interac-
tion motifs (Fig. 6.2, p. 42).
In summary, these results support the idea that the C-terminal region of srGAP
proteins is intrinsically disordered. Furthermore, mammalian srGAP1, 2, and
3 contain potential linear motifs, which could serve as interaction surface for
yet to be identified adaptor proteins. This concept provided the basis for the
experimental characterisation of the C-terminal region of srGAP3 outlined in
the following sections.
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PPGPV-SSEPASPLHTIVIRDPDAAMRRSSSSSTEMMTTFKPALSARLAGAQLRPPPMRPVRPVVQHRSSSSSSSGVGSPAVTPTEKMFPNSSADKSGTM 
(1099) 
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6.2. Identification of Potential C-terminal Binding
Partners in the Rat Brain
Paralogous srGAP proteins in mammals were reported to regulate different as-
pects of neural development [155, 157, 158, 163, 218], which is at least partially
attributed to dissimilar spatio-temporal regulation patterns [159, 160, 219], but
could also depend on the differential recognition of binding partners. In this
way, individual paralogs could be targeted to different cellular networks, where
they could exert specific functions that set them apart from cognate srGAPs.
My bioinformatic analysis revealed that the C-terminal region might function
as a protein-interaction surface that has the potential to drive the formation of
distinct complexes for paralogous srGAP proteins. Nevertheless, binding cap-
abilities and specificities of this segment are far from being understood and I
therefore aimed at the identification of C-terminal binding partners of srGAP3.
The human srGAP proteins 1, 2, and 3, but not ARHGAP4, were reported to
bind 14-3-3 proteins in HEK293T cells and complex formation was found to be
mediated by the C-terminal region [207]. Since other attempts to identify in-
teraction partners for the C-terminal region of srGAP3 using yeast-two-hybrid
screens were unsuccessful [220], I pursued a different, non-library-based strate-
gy: A candidate approach, in which potential binding partners were identified
from pull-down experiments with rat brain lysate and further validated in vivo
and in vitro.
The expression of srGAP3 is developmentally regulated and the highest ex-
pression levels in the rat brain occur between stage P1 and P14 [221]. On a
cellular level, srGAP3 is distributed between the nucleus and the cytoplasm in
the developing brain, but mostly relocates to the nucleus in adult rats [159].
As we intended to identify cytosolic srGAP3-binding proteins, we performed
GST pull-down experiments with brain lysate from a rat of stage P14. The
GST-tagged C-terminal regions of human srGAP3 and srGAP1 were tested in
parallel in order to detect specific proteins for either family member (see Ma-
terials and Methods, 5.3.3, for information on data analysis). GST-srGAP3-CTR
(construct architecture is displayed in Fig. 6.3) was purified to homogeneity as
assessed by SDS-PAGE (Fig. 6.4). Since the analysis of srGAP1 is the focus of
the PhD thesis of A. Jeganantham, I only display data for srGAP1-CTR, if it is
necessary for the interpretation of the results concerning srGAP3. SrGAP2 was
not under investigation in the research group at the time of this experiment and
therefore not included in the analysis.
Using mass spectrometry, we found numerous proteins specifically pulled
down by GST-srGAP3-CTR (see Tab. 6.2, p. 47 for exemplary results). In ac-
cordance with earlier studies [207], we identified six of the seven mammalian
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Figure 6.3.: Domain architecture of srGAP3 full-length and the C-terminal region
(CTR) fused to GST. F-BAR, Fes-Cip4-homology-BAR (Bin-Amphiphysin-Rvs) do-
main; GAP, GTPase-activating domain; SH3, Src-homology 3 domain. The domain
boundaries of srGAP3 (H. sapiens, isoform 1) and the construct boundaries of GST-
srGAP3-CTR are indicated in black and red, respectively.
Figure 6.4.: GST pull-down with rat
brain lysate. A: GST-srGAP3-CTR
(residues 810-1099, 57.8 kDa) was
purified to homogeneity as assessed
by SDS-PAGE. Double bands origin-
ated from mixed dimer formation
via GST with a GST-CTR-degradation
product. B: SDS gel of GST pull-
down of rat brain lysate with GST
(negative control), GST-srGAP1-CTR
(residues 799-1085), and GST-srGAP3-
CTR. Marked gel sections were ana-
lysed by mass spectrometry. Bands
containing bait proteins (black tri-
angles) were excluded from the ana-
lysis. GST-srGAP1-CTR was provided
by A. Jeganantham.
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14-3-3 proteins (β, γ, , η, θ/τ, and ζ [79]), but not the isoform σ, which provi-
ded evidence that srGAP3 also interacts with this protein family in the rat
brain. In addition, several SH3 domain-containing proteins (Amphiphysin,
Endophilin-A1, Endophilin-A2, Grb2) specifically associated with GST-srGAP3-
CTR (Tab. 6.2, p. 47), which supported the bioinformatical predictions (com-
pare Fig. 6.2, p. 42).
As my bioinformatical analysis was biased towards the prediction of known
motifs (compare Materials and Methods, p. 28) and the binding specificities of
many proteins that specifically associated with srGAP3 had not been character-
ised extensively, we decided not to restrict subsequent validation experiments
to 14-3-3s and SH3 domain-containing proteins. Instead, we selected candidate
proteins based on a panel of different criteria: the confidence, with which they
were identified in pull-downs with GST-srGAP3-CTR (at least ten peptides or
two orders of magnitude higher intensity compared to the control experiment),
reported protein-binding capabilities, reported cytosolic localisation, and the
availability of clones. This approach yielded a set of 19 proteins (marked with
arrows in Tab. 6.2, p. 47), which were mainly specific for srGAP3. The can-
didates either carried typical adaptor modules such as WD40 domains (α-Cop,
Strap) [222], SH3 domains (see above), the α-appendage of AP2 [223, 224], and
the C-terminal domain of EB1 [225], or had been shown to engage in protein-
protein interactions (14-3-3 [79], Vps26A [226], Vps35 [227, 228], Neurochon-
drin [229, 230], α-Centractin [231, 232]).
Since pull-down experiments employing tissue lysates will result in the isola-
tion of large multi-protein complexes, in which many proteins only indirectly
bind to the bait protein [233], I combined this initial analysis with a fluorescence-
based co-immunoprecipitation approach in order to dissect direct binding part-
ners (compare Discussion, 7.1, p. 73).
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6.3. Validation of the Interaction With SrGAP3 In
Vivo
6.3.1. Establishment of a Fluorescence-Based Co-IP Assay
To confirm the interaction of srGAP3 with the 19 full-length mammalian pro-
teins in vivo (marked by arrows in Tab. 6.2), I established a fluorescence-based
Co-IP assay in a 96-well format using eGFP-tagged srGAP3 and mCherry-tag-
ged candidate proteins (Fig. 6.5, see method description in section 5.3.5, p. 34
for more information).
Figure 6.5.: Set-up of the fluorescence-based Co-IP assay. MCherry-tagged candid-
ate binding partners are co-transfected with either eGFP-srGAP3 (1) or eGFP (2)
into HEK293T cells and subsequently a co-immunoprecipitation with the lysate is
performed in a 96-well format with an immobilised GFP-nanobody. The mCherry-
fluorescence signal serves as read-out.
Production of the GFP-Nanobody
Nanobodies have emerged as valuable tools in research and diagnostics (re-
viewed in [234]) and are derived from the antigen binding site of camelid heavy-
chain antibodies [235, 236]. The term "nanobody" - originally coined by the
company Ablynx - relates to their small size (around 15 kDa) and to the fact
that they only comprise a single polypeptide chain [235]. Several milligrams
of antibody can therefore easily be purified from E. coli and tailored to spe-
cific requirements through the attachment of protein tags (reviewed in [234]).
Rothbauer et al. [196] developed a nanobody directed against GFP, which was
applied in this study (sequence information from [198]). Fusing srGAP3 to
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eGFP via a short linker sequence permitted the oriented, yet flexible immob-
ilisation of srGAP3 via this GFP-nanobody on a solid support (Fig. 6.5).
The GFP-nanobody was expressed in E. coli BL21 Gold (DE3) and purified to
homogeneity as assessed by SDS-PAGE (Fig. 6.6). To test whether the puri-
fied GFP-nanobody correctly discriminated between eGFP and mCherry, I com-
pared binding of the nanobody to purified eGFP and mCherry using ITC. The
GFP-nanobody bound eGFP with a Kd of approximately 0.5 nM in a 1:1 stoi-
chiometry (data not shown), which is in accordance with the findings of
Saerens et al. [197] and Kubala et al. [198]. Binding to mCherry was undetect-
able in the employed concentration range and was therefore at least five orders
of magnitude weaker. For the purposes of this study, I concluded that the GFP-
nanobody specifically recognised eGFP in solution.
Figure 6.6.: Purity control of the
GFP-nanobody. SDS-PAGE
of the final protein pool of
the GFP-nanobody (13.6 kDa)
purification.
Immobilisation of the GFP-Nanobody
The GFP-nanobody was covalently coupled to 96-well plates with an amino-
reactive surface (Nunc Immobilizer Amino Black, Thermo Scientific). I optim-
ised the immobilisation conditions according to the supplier’s recommenda-
tions in two different buffers: Na2CO3 and PBS (Fig. 6.7). The highest amount
of coupled protein was obtained at 1000 µg/ml nanobody in 100 mM Na2CO3
(pH 9.7) incubated for 1.5 h at 25 °C (Fig. 6.7). From these results, it can be
concluded that the nanobody was mainly coupled via primary amines, which
is supported by the Na2CO3 buffer, and only weakly via thiols, which is sup-
ported by both, Na2CO3 and PBS. Increased nanobody concentrations resulted
in similar eGFP fluorescence signals after incubation with purified eGFP (data
49
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not shown), which suggested that 1000 µg/ml nanobody saturated the surface.
Unreacted sites were inactivated with ethanolamine.
Figure 6.7.: Optimising GFP-nanobody immobilisation conditions. The GFP-
nanobody was immobilised on Nunc Immobilizer Amino plates (Thermo Scientific)
in either Na2CO3 buffer (left) or PBS (right). Different protein concentrations, two in-
cubation times, and two different temperatures were tested. After washing, coupled
nanobody was detected by incubation of the wells with purified eGFP (20 µg/ml).
The residual eGFP-fluorescence was measured with a BioTek Mx Reader (Ex 488
nm/ Em 509 nm; AU, arbitrary units) is plotted. The standard deviation between
three technical replicates is shown. The statistical analysis was performed with
SigmaPlot (version 12.3, Systat Software Inc.).
Sensitivity of the Assay
I then determined the detection limit for eGFP expressed in mammalian cells.
For this purpose, I transfected HEK293T cells with an pEGFPC23C expres-
sion vector, incubated the immobilised GFP-nanobody with the cleared lysate
(for transfection conditions and sample processing see Materials and Methods,
3.2.2 and 5.3.5), and recorded the eGFP- and mCherry-fluorescence signal after
washing.
The immobilised GFP-nanobody successfully precipitated eGFP from HEK293T
cells (Tab. 6.3) and the resulting fluorescence signals were comparable to those
of purified eGFP (compare Fig. 6.7, left panel). Wells not coated with nano-
body, but inactivated with ethanolamine served as negative controls. They
were subjected to the same washing protocol as nanobody-containing wells
and then incubated with eGFP-containing lysate. The fluorescence intensities
of these wells were close to instrument background levels in the eGFP chan-
nel (compare negative controls of eGFP- and mCherry-containing lysates at
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Table 6.3.: Immobilised GFP-nanobody specifically recognises eGFP transiently ex-
pressed in HEK293T cells. HEK293T cell lysates containing either eGFP or mCherry
were applied to wells with (+) and without (–) GFP-nanobody. The fluorescence sig-
nals are given in arbitrary units.
HEK293T lysate
GFP-nanobody eGFP mCherry
Ex/Ema
488 nm/509 nm 586 nm/610 nm 488 nm/509 nm 586 nm/610 nm
+ 27402 ± 119b 49 ± 5 455 ± 22 119 ± 5
– 514 ± 70 47 ± 19 520 ± 70 81 ± 19
a Ex, excitation wavelength; Em, emission wavelength.
b Indicated is the standard deviation of three independent experiments.
Ex 488 nm/Em 509 nm, Tab. 6.3), which demonstrated the absence of unspe-
cific eGFP-binding to the plates. I then determined the sensitivity of the as-
say experimentally: Employing a dilution series of eGFP-containing lysates,
I measured the minimal amount of eGFP required to achieve at least 90 %
saturation of binding sites per well (≥ 10000 arbitrary units with Ex 488 nm/
Em 509 nm, data not shown). Only lysates fulfilling this criterion were included
in subsequent experiments to ensure that the amount of bound mCherry-tagged
binding partner was independent of the eGFP-concentration.
To test whether the blocking and washing protocol sufficiently inhibited unspe-
cific binding of the hydrophobic mCherry, I carried out the assay with mCherry
expressed in HEK293T cells. The mCherry-fluorescence intensities were sim-
ilar in presence and absence of GFP-nanobody, indicating that eGFP, but not
mCherry was specifically precipitated from cell lysates (Tab. 6.3). I noticed,
however, weak unspecific binding of mCherry to the plate (Tab. 6.3), which
could be eliminated by increasing the ethanolamine concentration from 10 nM
to 10 mM in subsequent experiments.
Expression Analysis of Candidates and SrGAP3 Transiently Transfected
into HEK293T
SrGAP3 served as bait and was cloned into the vector pEGFPC23C (Tab. 6.4,
p. 52). The full-length sequence of srGAP3 was chosen, since the protein di-
merises via its N-terminal F-BAR domain [163], which increases local binding
site concentration and could thus strengthen otherwise weak monomeric in-
teractions. Prey constructs (candidates, srGAP3, and GST) were cloned into
the vector pmCherryC23C resulting in N-terminally mCherry-tagged proteins
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Table 6.4.: Protein constructs for the analysis of srGAP3-binding in vivo. Candidate
and control proteins were N-terminally tagged with mCherry. SrGAP3 was pro-
duced as eGFP-fusion as well as mCherry-fusion protein.
Protein Name Speciesa MWa mCherry/eGFP- Conservation
Fusion MW % similarity/
[kDa] [kDa] % identitya
Microtubule-associtated transport
α-Centractin Hs 42.6 71.3 –
EB1 Hs 30.0 57.4 –
Drebrin Hs 71.4 99.6 –
Signal transduction
Grb2 Hs 25.2 53.6 –
Neurochondrin Hs 78.9 107.0 –
RNA transport/processing
Strap Hs 38.4 66.6 –
Phosphoregulation
14-3-3β Hs 28.1 56.1 –
14-3-3γ Rn 28.3 57.2 100 %
14-3-3 Rn 29.2 57.4 100 %
14-3-3ζ Hs 27.8 57.0 –
14-3-3η Hs 28.2 56.2 –
14-3-3θ/τ Hs 27.8 56.0 –
Endocytosis
Endophilin-A2 Hs 41.5 70.4 –
AP2α2 (701-938) Mm 27.0 55.1 98.7/96.2 %
Endophilin-A1 Hs 40.0 68.9 –
Amphiphysin Rn 74.9 103.8 88.9/86.4 %
Vesicle transport
α-Cop Mm 138.4 167.3 99.2/98.4 %
Vps26A Hs 38.2 67.5 –
Vps35 Hs 91.7 120.1 –
Controls/bait proteins
GST from 25.8 52.2 –
pGEX6P1a
srGAP3 Hs 124.5 154.1 –
eGFP from 30.3 – –
pEGFPC23Ca
a Hs, Homo sapiens; Rn, Rattus norvegicus; Mm, Mus musculus; pGEX6P1, vector (GE
Healthcare); pEGFPC23C, vector; MW, expected molecular weight; Amino acid sequence
conservation to human ortholog calculated from pairwise alignment with Needleman-
Wunsch algorithm: http://www.ebi.ac.uk/Tools/psa/emboss_needle/.
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(Tab. 6.4). In case of AP2α2, I only used the appendage domain (residues 701-
938), which carries the adaptor function [223].
For five constructs, we could only obtain DNA of either rat or mouse origin,
but sequence alignments revealed that the amino acid conservation was - apart
from Amphiphysin - close to 100 % (see Tab. 6.4, p. 52). However, the SH3
domain of Amphiphysin, which depicts a possible interaction region, shares
97.3 % sequence identity with its human ortholog (compare 6.4.1, p. 57). The
outcome of the experiments is therefore expected to be independent of the ge-
netic origin of these constructs.
Western blot analyses confirmed the expression of all proteins in full length
(Fig. 6.8). In accordance with reported data [237], the band of tagged Drebrin
appeared at 130 kDa instead of 100 kDa. Furthermore, almost all mCherry-
tagged proteins produced double bands, whose origin remained elusive. A
mass spectrometric analsis of the bands revealed that they both contained the
repective construct in full length, while post-translational modifications, such
as phosphorylation, acetylation, ubiquitilation, or SUMOylation were undetect-
able. Furthermore, all candidate constructs were co-expressed with eGFP or
eGFP-srGAP3 in 70 - 90 % of cells as assessed by fluorescence microscopy (ex-
emplary image in Fig. 6.9, p. 54). As srGAP3 was reported to be expressed
in kidney [161], I tested whether HEK293T cells contain endogenous srGAP3
using Western blotting. I was unable to detect this protein with conventional
antibodies (data not shown) and thus concluded that endogenous background
levels of srGAP3 are sufficiently low to exclude interference with my assay.
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Figure 6.8.: Prey and bait proteins are expressed in HEK293T cells. Constructs
of mCherry-tagged candidate proteins (“prey”), eGFP-tagged srGAP3 (“bait”), or
eGFP alone were transfected into HEK293T cells and the expression was analysed by
Western blots of cell lysates using anti-mCherry (upper panel) and anti-GFP (lower
panel) antibodies. The expected molecular weight of the fusion proteins are listed in
Tab. 6.4, p. 6.4. The additional band in the Drebrin-lane represents laterally diffused
Grb2 and is attributed to the high viscosity of whole cell lysates.
Figure 6.9.: Co-expression of eGFP-srGAP3 and mCherry-tagged candidates in
HEK293T cells. Shown is a representative HEK293T cell expressing eGFP-srGAP3
(A) and mCherry-EB1 (B). C: Composite image of both channels. The image was
aquired with a Zeiss LSM 510 Meta with a 63x oil objective and the images processed
with Fiji [204].
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6.3.2. Results of the Fluorescence-Based Co-IP Assay
In order to distinguish direct interaction partners of srGAP3 from those that
were indirectly pulled-down in the GST pull-down experiment, I carried out
the fluorescence-based Co-IP assay for the 19 candidate proteins and measured
the relative amount of bound mCherry-tagged candidate of co-immunoprecipi-
tations with eGFP-srGAP3 to co-immunoprecipitations with eGFP. MCherry-
srGAP3, which was expected to form heterodimers with eGFP-srGAP3 [163]
and for this reason included as a positive assay control, produced a strong bind-
ing signal (Fig. 6.10, p. 56). In contrast, the mCherry-fluorescence intensity of
the negative assay control, GST, differed only insignificantly between Co-IPs
with either eGFP-srGAP3 or eGFP (Fig. 6.10, p. 56). From these results, I con-
cluded that the assay captures true binding events.
Within the final data set of the 19 candidates, a significant increase in the
mCherry-fluorescence intensity compared to control precipitations was detec-
ted for α-Centractin, the 14-3-3 isoforms γ, ζ and θ/τ, and the SH3 domain-
containing proteins Grb2, Endophilin-A1, Endophilin-A2, and Amphiphysin
(Fig. 6.10, p. 56), indicating that these proteins can interact with full-length
srGAP3 in HEK293T cells. Therefore, I was able to validate approximately
42 % of the total set of candidate proteins. Endophilin-A2 was the only candid-
ate, for which mCherry-fluorescence intensities of the control experiments were
not close to background levels (marked by grey line in Fig. 6.10, p. 56), which
could have been caused by either unspecific binding of mCherry-Endophilin-
A2 to eGFP or precipitation of this construct during the assay. The amount of
mCherry-tagged protein bound by eGFP-srGAP3 varied between different con-
structs, but since the measured intensities represented relative values (compare
Discussion, 7.1, p. 77), it is impossible to interpret them in terms of binding af-
finities. Nevertheless, candidate proteins exhibiting weak mCherry-
fluorescence intensities in this assay (α-Centractin and 14-3-3ζ) were excluded
from further analyses for two reasons: Firstly, they possessed a higher prob-
ability to originate from indirect binding events and secondly, low affinities,
poor folding as well as low expression levels might have prevented binding
of the respective protein and might similarly complicate their analysis in vitro
(compare Discussion, 7.1, p. 76).
To show that complex formation with the remaining set of validated interaction
partners (Grb2, Endophilin-A1, Endophilin-A2, Amphiphysin, as well as the
14-3-3 isoforms γ and θ/τ) was in fact mediated by the C-terminal region of
srGAP3, I continued with the mapping of the binding sites in vitro and in vivo.
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Figure 6.10.: SrGAP3 interacts with SH3 domain-containing and 14-3-3 proteins
in vivo. MCherry-tagged candidate proteins and eGFP-tagged srGAP3 or eGFP
were co-transfected into HEK293T cells and the complex formation measured
with a fluorescence-based co-immunoprecipitation assay. The average mCherry-
fluorescence intensity (emission, Em, at 610 nm, in arbitrary units, AU) from co-
immunoprecipitations of each candidate with either eGFP-srGAP3 or eGFP is in-
dicated. For each sample, two (α-COP) to four independent replicates were meas-
ured (standard deviation of samples is indicated, when three to four replicates were
measured). Asterisks mark samples in which the difference between eGFP-srGAP3
and eGFP differs significantly (p < 0.05 in unpaired t-test). With the exception of α-
Centractin, positive candidates could be grouped into SH3-domain-containing pro-
teins (blue) and 14-3-3 (green). The grey line marks the average plate background
before incubation (31 ± 5 AU). SrGAP3, which dimerises [163], served as positive
control. GST was used as negative control. The statistical analysis was performed
with SigmaPlot (version 12.3, Systat Software Inc.).
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6.4. Confirmation of the Interaction of SrGAP3 with
SH3 Domain-Containing Proteins In Vitro
The SH3 domain is the shared feature of Endophilin-A1, Endophilin-A2,
Amphiphysin, and Grb2 (Fig. 6.11, p. 57) and potential SH3-binding motifs
reside in the C-terminal region of srGAP3 (Fig. 6.2, p. 42). Therefore, we hy-
pothesised that the SH3 domain constitutes the interaction surface for srGAP3-
CTR. For this reason, I measured the association of the isolated SH3 domains
with GST-srGAP3-CTR using ITC.
Figure 6.11.: Domain architecture of srGAP3 interaction partners containing SH3 do-
mains. N-BAR, Bin-Amphiphysin-Rvs domain with additional N-terminal helix;
SH3, Src-homology 3 domain; SH3N/SH3C, N-terminal and C-terminal SH3 do-
main, respectively; SH2, Src-homology 2 domain. The SH3 domain construct bound-
aries are indicated in blue. For sequence identifiers, see Tab. B.3, p. 167.
6.4.1. Production of SH3 Domains
Constructs of SH3 domains were expressed as GST-fusion proteins in E. coli
and purified to homogeneity as assessed by SDS-PAGE (Fig. 6.12, p. 58).
Amphiphysin was of rat origin, but its SH3 domain shares a high amino acid
sequence identity of 97.3 % with the human protein: only two positions at the
C-terminus differ (H681R, E683D), while the binding and specificity pocket are
fully conserved (data not shown). Consequently, the genetic origin of the SH3
domain was expected to be irrelevant to the outcome of the in vitro-binding
studies. In order to exclude that the absence of complex formation is related to
improperly folded proteins, I analysed the folding status of the SH3 domains
with CD spectroscopy. I found that all SH3 domains unfolded cooperatively
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Figure 6.12.: Purity controls of SH3
domains. SDS-PAGE of the final
protein pools from purifications
of SH3 domains from Endophilin-
A2 (residues 302-368, 8.3 kDa),
Endophilin-A1 (residues 290-349, 7.7
kDa), Amphiphysin (residues 610-683,
9.2 kDa), and Grb2 (N-terminal SH3
domain, SH3N: residues 1-56, 7.3
kDa; C-terminal SH3 domain, SH3C:
residues 156-217, 7.6 kDa).
Figure 6.13.: Purified SH3 domains unfold cooperatively. Melting curves of SH3
domains (0.2 mg/ml) were obtained from measurements of circular dichroism at
203 nm (largest difference between native and unfolded state, compare [238]) from
20 °C to 90 °C. The average melting temperature of two independent measurements
was calculated from the inflexion point of the curve with Spectra Manager II (Jasco):
Endophilin-A2 SH3: TM = 64.1 ± 0.6 °C; Endophilin-A1 SH3: TM = 68.7 ± 0.5 °C;
Amphiphysin SH3: TM = 43.6 ± 0.5 °C; Grb2 SH3N: TM = 55.1 ± 0.2 °C; Grb2 SH3C:
TM = 69.5 ± 1.1 °C.
with increasing temperature, which provided evidence for their folded nature
(Fig. 6.13, p. 58). Nevertheless, the SH3 domains failed to produce very dis-
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tinct CD spectra (data not shown). All SH3 domains were sufficiently stable
at 20 °C, which was chosen as measurement temperature in subsequent ex-
periments. Unfortunately, srGAP3-CTR degraded quickly after removal of the
GST-tag and could therefore only be used as GST-fusion protein, which also
precluded a structural analysis of this region.
6.4.2. The C-terminal Region of SrGAP3 Confers Binding to
SH3 Domains In Vitro
To confirm that the newly identified complexes between srGAP3 and the SH3
domain-containing proteins Endophilin-A1, Endophilin-A2, Amphiphysin, and
Grb2 were in fact mediated by the CTR of srGAP3, I conducted isothermal ti-
trations with the individual SH3 domains of these proteins and GST-tagged
srGAP3-CTR. These experiments revealed that the SH3 domains of the two En-
dophilins and the C-terminal SH3 domain of Grb2 (Grb2 SH3C) indeed directly
bound to GST-srGAP3-CTR (Fig. 6.14, p. 61). The affinity of the complexes of
Endophilin-A1 and -A2 (Kd = 17 µM and 24 µM, respectively, Tab. 6.5, p. 60)
was in the expected range for SH3-mediated interactions (Kd = 1-100 µM, [51]).
Grb2 SH3C produced ambiguous isotherms when used at the high concentra-
tions that were required to observe the interaction. At lower concentrations
the resulting binding isotherm could not be fitted reliably. For this reason, I
omitted the quantification of this titration even though a binding isotherm was
detected (Tab. 6.5, p. 60). GST-srGAP3-CTR also weakly interacted with the N-
terminal SH3 domain of Grb2 (Grb2 SH3N), but the signal was too weak to be
quantified reliably (Tab. 6.5, p. 60). On the contrary, binding to Amphiphysin
SH3 was undetectable with the employed experimental settings (Fig. 6.14, Tab.
6.5), which were dictated by the limited solubility of GST-srGAP3-CTR. For
this reason, I could not exclude that I failed to capture this interaction for tech-
nical reasons (compare 6.4.3, p. 61 for additional data). Taken together, these
results confirm that the C-terminal region of srGAP3 mediates binding to SH3
domains, presumably via yet to be identified linear motifs. Therefore, I invest-
igated these SH3-dependent interactions in the following set of experiments in
greater detail.
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Table 6.5.: Thermodynamic data from isothermal titrations of SH3 domains and vari-
ous srGAP3 fragments.
Syringe Component Conc. Cell Component Conc. Kd
a Na ∆Hobsa
[µM] [µM] [µM] [kcal/mol]
Endophilin-A1 SH3
Endophilin-A1 SH3 300 GST-srGAP3-CTRb 30 17 ± 1 1.1 ± 0.0 -9.8 ± 0.2
Endophilin-A1 SH3 1000 srGAP3 PxxP-fragmentb 100 17 ± 1 1.0 ± 0.0 -9.3 ± 0.1
Endophilin-A1 SH3 1000 srGAP3 AxxA-fragmentb 100 n. d.b n. d. n. d.
Endophilin-A2 SH3
Endophilin-A2 SH3 300 GST-srGAP3-CTR 30 24 ± 3 0.7 ± 0.1 -12.0 ± 1.3
Endophilin-A2 SH3 1000 srGAP3 PxxP-fragment 100 20 ± 1 1.1 ± 0.3 -8.5 ± 0.3
srGAP3 PxxP-fragment 1000 Endophilin-A2 SH3 100 23 ± 0 1.3 ± 0.1 -6.3 ± 1.0
Endophilin-A2 SH3 1000 srGAP3 AxxA-fragment 100 n. d. n. d. n. d.
Amphiphysin SH3
Amphiphysin SH3 300 GST-srGAP3-CTR 30 n. d. n. d. n. d.
Amphiphysin SH3 1000 srGAP3 PxxP-fragment 100 27 ± 6 1.2 ± 0.1 -1.4 ± 0.4
Amphiphysin SH3 1000 srGAP3 AxxA-fragment 100 n. d. n. d. n. d.
Grb2 SH3Nb
Grb2 SH3N 300 GST-srGAP3-CTR 30 NQb NQ NQ
Grb2 SH3N 500 srGAP3 PxxP-fragment 50 NQ NQ NQ
Grb2 SH3N 500 srGAP3 AxxA-fragment 50 NQ NQ NQ
Grb2 SH3Cb
Grb2 SH3C 300 GST-srGAP3-CTR 30 NQ NQ NQ
srGAP3 PxxP-fragment 300 Grb2 SH3C 30 15 ± 5 1.2 ± 0.1 -4.7 ± 1.8
srGAP3 AxxA-fragment 300 Grb2 SH3C 30 n. d. n. d. n. d.
a Analysis performed with single-site binding model; Kd = dissociation constant; N = stoichiometry (syringe
component to cell component); ∆H(obs) = observed binding enthalpy. Indicated is the standard deviation
between 2 to 3 independent experiments. Grb2 SH3N and Grb2 SH3C were measured only once due to
limited availability of GST-srGAP3-CTR.
b GST-srGAP3-CTR: srGAP3 (residues 810-1099) N-terminally tagged with GST; n. d., not detected; srGAP3
PxxP-fragment: residues 1047-1079; srGAP3 AxxA-fragment: residues 1047-1079 with mutation of P1056 and
P1059 to alanine. NQ, non-quanitfiable; SH3N: N-terminal SH3 domain; SH3C: C-terminal SH3 domain.
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Figure 6.14.: GST-srGAP3-CTR directly interacts with SH3 domains. Isothermal ti-
trations of 300 µM SH3 domain into 30 µM GST-srGAP3-CTR (C-terminal region,
residues 810-1099 of srGAP3) at 20 °C. The upper panel shows the raw heat signals
(separated by shifting of the baselines), whereas the lower panel contains the integ-
rated heat signal per injection corrected for the heat of dilution.
6.4.3. Characterisation of a Multi-Class SH3-Binding Motif in
SrGAP3
Linear motifs usually consist of stretches of 3 to 11 amino acids [45] and are
inherently more difficult to predict than globular domains due to their short-
ness as well as the resulting high number of false-positive results [45]. For this
reason, I used high stringency settings and the consensus prediction of the ELM
resource [188, 189] and Scansite [190, 191] as a basis to narrow down the list of
potential interacting motifs (compare alignment, Fig. 6.2, p. 42). Since SLiM-
Pred was reported to perform especially well in the prediction of polyproline
type II motifs compared to other de novo predictors [194], its results were in-
cluded in this analysis in order to prioritise potential binding regions. Interest-
ingly, only a single SH3-binding motif (residues 1053-1062) was predicted with
high confidence by all algorithms (compare Fig. 6.15A, p. 62): RPPPMRPVRP.
This motif is present in srGAP3 sequences with only three exceptions (Melea-
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Figure 6.15.: A multi-class SH3-binding motif is present in srGAP3. A: MUSCLE
alignment [179, 180] of srGAP1, 2, and 3 from H. sapiens of the SH3-binding motif
region. Conserved (light grey) and similar (bold) positions are highlighted. The
motif classes are indicated above (ELM resource classification, http://elm.eu.org/).
B: Amino acid sequence (+GPLGSCY from vector) of the purified srGAP3 fragment
and the mutant thereof (P1056A/ P1059A) as well as their location within the CTR.
CTR, C-terminal region; CC, predicted coiled-coil segment. The SH3-binding motif
is highlighted in yellow and the mutated proline residues are underlined. C: SDS-
PAGE purity control of the srGAP3 PxxP-fragment (4.1 kDa) and AxxA-fragment
(4.0 kDa).
gris gallopavo, Camelus ferus, and Poecilia formosa). These sequences originated
from predicted and unverified sequence annotations and, thus, it remains un-
clear whether they also harbour the motif. Nevertheless, this sequence analysis
implies that I have identified a potential SH3-binding motif that is universally
conserved among srGAP3 proteins.
A unique feature of this motif is its multi-class nature (Fig. 6.15A), which
could equip srGAP3 with a flexible interaction surface for recognition of dif-
ferent SH3 domains and hence depicted an ideal candidate to mediate bind-
ing to Endophilin-A1, Endophilin-A2, and Grb2. Moreover, the SH3 domain
of Amphiphysin was shown to specifically bind to a short linear motif in the
proline-rich region of Dynamin with the sequence PSRPNR [239]. As this motif
resembles the predicted SH3-binding motif in class II orientation (Fig. 6.15A),
whereby both conform to the consensus PxRPxR, Amphiphysin might likewise
engage this region in srGAP3 for complex formation. SrGAP1 and srGAP2,
on the contrary, lack a classical type I or type II polyproline consensus motif
at this position (Fig. 6.15A),which potentially renders it a characteristic that
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distinguishes srGAP3 from srGAP1 and srGAP2 (compare Discussion 7.2.1, p.
80).
Based on these bioinformatic predictions, I designed a shorter srGAP3 con-
struct comprising this linear motif (aa 1047-1079, "PxxP-fragment", Fig. 6.15B)
and tested, whether it exhibited binding to the SH3 domains in isothermal ti-
trations. In order to delineate interacting residues, I also prepared a mutated
fragment, in which the core proline residues P1056 and P1059 were replaced
by alanines ("AxxA-fragment", Fig. 6.15B). The two protein constructs were
expressed in E. coli and purified to homogeneity (Fig. 6.15C).
Analysis of the Interaction Between the SrGAP3 PxxP-Fragment and the
SH3 Domains of Endophilins
The ITC experiments revealed that this smaller srGAP3 PxxP-fragment con-
taining the predicted linear motif indeed interacted with the SH3 domains of
Endophilins in a 1:1 stoichiometry (Fig. 6.16A and B, p. 66). The affinities of the
complexes (Kd = 17 and 20 µM, Tab. 6.5, p. 60) were similar to the complexes
involving the full C-terminal region. Reverse titrations yielded similar ther-
modynamic parameters, which corroborated a single-site interaction model. In
order to demonstrate that binding to both Endophilins in fact depended on the
presence of the predicted SH3-binding motif, I conducted titrations with the
mutated srGAP3 fragment (AxxA-fragment, Fig. 6.15B, p. 62). This mutant
failed to bind either Endophilin-A1 SH3 or Endophilin-A2 SH3 (Fig. 6.16A
and B, p. 66) and these results, thus, indicated that the predicted multi-class
SH3-binding motif between residues 1053 and 1062 of srGAP3 mediated the
interaction.
Analysis of the Interaction Between the SrGAP3 PxxP-Fragment and the
SH3 Domains of Grb2
In the previous set of ITC experiments, I demonstrated that Grb2 assembled
with srGAP3-CTR in vitro and complex formation was governed by the C-
terminal SH3 domain of Grb2, while the N-terminal SH3 domain depicted a
potential low-affinity interaction site (see 6.4.2, p. 59). McDonald et al. [240]
reported that the two SH3 domains of Grb2 can recognise the same linear motif
in Sos1, yet bind it with different affinities. As the linear motif in the srGAP3
PxxP-fragment might behave similarly, I determined the binding characteristics
of both SH3 domains to this protein construct using ITC: The measured affin-
ities (Tab. 6.5, p. 60) suggested that binding sites for both domains might be
located within the PxxP-fragment, but that the affinity for Grb2 SH3C (Kd =
14 µM) is at least an order of magnitude higher than for Grb2 SH3N (affinity
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too low to be quantified reliably). Furthermore, the complex with Grb2 SH3C
exhibited a 1:1 stoichiometry and an affinity in the same range as complexes
between srGAP3 and the Endophilins (Tab. 6.5, p. 60). Reverse titrations yiel-
ded non-reproducible binding isotherms for unknown reasons and were there-
fore omitted in this analysis.
In order to test whether the predicted SH3-binding motif was likewise respons-
ible for complex formation with Grb2, I carried out isothermal titrations with
the srGAP3 AxxA-fragment. Indeed, titrations of Grb2 SH3C with this mutated
srGAP3 fragment revealed that this interaction also depended on this linear
motif (Fig. 6.16C, p. 66). In contrast, the two proline residues were not required
for the interaction with Grb2 SH3N: Although the measured signal of titrations
with the srGAP3 AxxA-fragment was too weak to be reliably quantified (Tab.
6.5, p. 60), it displayed a similar shape as the isotherms from titrations with
the wild-type fragment (data not shown). Therefore, it can be concluded that
the C-terminal SH3 domain of Grb2 directly bound to the proline-rich motif
within the srGAP3 PxxP-fragment, while the N-terminal SH3 domain either re-
cognised a different motif or non-specifically interacted with the srGAP3 PxxP-
fragment (compare Discussion 7.2.1, p. 80).
Analysis of the Interaction Between the SrGAP3 PxxP-Fragment and
Amphiphysin SH3
As outlined above, the predicted SH3-binding site contained a consensus se-
quence recognised by the Amphiphysin SH3 domain. Therefore, I explored the
binding behaviour of Amphiphysin SH3 to this smaller srGAP3 fragment, al-
though I failed to detect a direct interaction between Amphiphysin SH3 and
the full C-terminal region of srGAP3 in earlier experiments (see Tab. 6.5, p. 60
and Fig. 6.14, p. 61). Indeed, the srGAP3 PxxP-fragment bound the SH3 do-
main of Amphiphysin in a 1:1 stoichiometry (Fig. 6.16D, p. 66) and affinities
that were comparable to the data obtained from titrations with Endophilin-A1
and -A2 SH3 as well as Grb2 SH3C (Kd = 27 µM, Tab. 6.5, p. 60). The en-
thalpic contribution of these interactions was generally smaller (Tab. 6.5, p.
60), which explains, why binding was undetectable in titrations with the full
C-terminal region: Only at these higher protein concentrations the generated
heat of binding was large enough to surpass the detection limit at the employed
experimental settings. Reverse titrations of the SH3 domain with the srGAP3
fragment were accompanied by a large heat of dilution from titrating a highly
concentrated unfolded peptide into buffer, which masked the binding isotherm
(data not shown). For this reason, the data set lacks additional support for a
single-site binding mode from the reverse experiment.
Following up on these results, I analysed whether the binding event likewise
required the presence of the SH3-binding motif. I found that, similar to ex-
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periments with Endophilin-A2, Endophilin-A1, and Grb2, mutations in core
interacting residues within the motif abrogated binding (Fig. 6.16C). Taken
together, these results demonstrated an unexpected flexibility of a single SH3-
binding motif in srGAP3 in engaging in different SH3-dependent interactions.
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Figure 6.16.: A single SH3-binding motif in srGAP3 mediates binding to
Endophilin-A1 SH3, Endophilin-A2 SH3, Grb2 SH3C, and Amphiphysin SH3.
Interactions were measured with isothermal titration calorimetry at 20 °C. The up-
per panel shows the raw heat signal of titrations with the srGAP3 PxxP-fragment
(residues 1047-1079) only. The lower panel shows the integrated heat signal per
injection corrected for the heat of dilution for the srGAP3 PxxP-fragment and the
mutated AxxA-fragment (P1056A/ P1059A). Binding isotherms were analysed as-
suming a single-site binding model. A: 1000 µM Endophilin-A1 SH3 were ti-
trated into 100 µM srGAP3 PxxP-fragment or 100 µM srGAP3 AxxA-fragment. B:
1000 µM Endophilin-A2 SH3 were titrated into 100 µM srGAP3 PxxP-fragment or
100 µM srGAP3 AxxA-fragment. C: 300 µM srGAP3 PxxP-fragment or srGAP3
AxxA-fragment were titrated into 30 µM C-terminal SH3 domain of Grb2 (Grb2
SH3C) and D: 1000 µM Amphiphysin SH3 into 100 µM srGAP3 PxxP-fragment or
100 µM srGAP3 AxxA-fragment. In titrations with Grb2 SH3C syringe and cell com-
ponent were switched due to technical reasons.
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6.5. Characterisation of the 14-3-3/srGAP3-Complex
In Vivo
The second group of srGAP3-interaction partners validated in the in vivo-bin-
ding assay comprised the 14-3-3 proteins (see results of Co-IP assay, p. 55,
14-3-3γ and 14-3-3θ/τ). As mentioned earlier, the association between srGAP3
and this protein family has already been described by others [207, 241], but
these data sets lacked information on specific interaction motifs or the corres-
ponding 14-3-3 isoforms.
6.5.1. Phosphorylation Analysis of SrGAP3
14-3-3 proteins typically bind to linear motifs, which incorporate a phosphory-
lated serine or threonine [84], although non-phosphorylated motifs have also
been reported [213–216] (compare Bioinformatic Analysis for motif descrip-
tions 6.1.2, p. 38). Database searches revealed that proteomic studies had iden-
tified numerous phosphorylation sites within the C-terminal region of srGAP3
and some of these phosphorylation sites even colocalised with predicted 14-3-
3-binding motifs (Fig. 6.17, p. 69). But since phosphorylation depends on many
different factors such as tissue type or developmental stage [242, 243], we de-
cided to analyse the phosphorylation state of srGAP3 used in my experiments.
We determined the phosphorylation states of endogenous srGAP3 from rat
brain (stage P14) and of overexpressed human srGAP3 from HEK293T cells
with mass spectrometry. SrGAP3 was almost exclusively phosphorylated in
the C-terminal region (Fig. 6.17) with S759 being the only exception. The phos-
phorylation sites S837, S858, S874, S895, and S919 were conserved between rat
and human as well as different cell types and the residues S858 and S919 ad-
ditionally colocalised with or lay adjacent to predicted 14-3-3-binding sites. As
phosphorylation is often tissue-specific [242], we were not surprised to find
several cell type-specific phosphorylation sites and two of those were, at the
same time, positioned within or close to 14-3-3-binding motifs: S932 and S1070.
Moreover, we not only confirmed several phosphorylation sites identified in
other studies, but also found additional phosphorylated residues: T885,
S894/S895, S932, S1011, and T1082 (Fig. 6.17, p. 69).
On the one hand, the goal of this project consisted of the characterisation of
brain-specific srGAP3-complexes, while the methodology was, on the other
hand, restricted to the usage of HEK293T cells. For this reason, I solely con-
sidered those phosphorylation sites within or close to predicted 14-3-3-binding
sites in the following experiments that were present in both samples: S858 and
S919. As revealed by my sequence analysis, both motifs are not only present in
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human srGAP3, but invariably conserved within vertebrate srGAP3 proteins
(data not shown) suggesting that their function might even be conserved in
non-mammalian species and therefore over larger evolutionary distances.
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6.5.2. Do the Mutations S858A and S919A Affect Complex
Formation with the 14-3-3 Isoforms γ and θ/τ?
To test, whether phosphorylation of S858 and S919 affected binding to 14-3-3
proteins, I constructed phosphorylation-incompetent srGAP3 mutants by re-
placing S858 and S919 with alanines (see Fig. 6.17, Tab. 6.6) and determined
whether these mutations impaired binding of srGAP3 to the 14-3-3 isoforms
γ and θ/τ. The mutant S895A depicted a negative control, since this phos-
phorylation site was positioned outside of predicted 14-3-3-binding sites, but
at the same time conserved between different cell types (Fig. 6.17).
Table 6.6.: Constructs for 14-3-3 motif characterisation. 14-3-3 isoforms are were
tagged with mCherry and srGAP3 full-length and point mutants thereof with eGFP.
Protein Name Speciesa MWa mCherry/eGFP-
Fusion MW
[kDa] [kDa]
14-3-3γ Rn 28.3 57.2
14-3-3θ/τ Hs 27.8 56.0
srGAP3 Hs 124.5 154.1
srGAP3 S858A Hs 124.5 154.1
srGAP3 S919A Hs 124.5 154.1
srGAP3 S858A S919A Hs 124.5 154.1
srGAP3 S895A Hs 124.5 154.1
eGFP from 30.3 –
pEGFPC23Ca
a Rn, Rattus norvegicus; Hs, Homo sapiens; pEGFPC23C, vector; MW, molecular
weight.
I measured complex formation with the fluorescence-based Co-IP assay (com-
pare 6.3, p. 48) and could show that the mutations S858A and S919A affected
the interaction with either isoform (Fig. 6.18). In case of 14-3-3θ/τ, the mutation
of either S858 or S919 to alanine reduced binding to 58 % and
62 % compared to srGAP3 wild-type. The simultaneous presence of both muta-
tions compromised complex formation even further (bound fraction reduced
to 41 %, Fig. 6.18B). Interestingly, S919 lay adjacent to and not within the re-
spective linear motif, but still affected its binding capabilities (compare Fig.
6.17, p. 69), which demonstrates the complexity of phosphorylation-dependent
14-3-3-interactions (compare Discussion 7.2.2, p. 83).
In case of 14-3-3γ, on the other hand, I only observed significantly less binding
in Co-IPs with the srGAP3 double mutant (reduced to 68 % of wild-type, Fig.
6.18A). Nevertheless, the two point mutations failed to fully abrogate binding
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to 14-3-3s with the employed experimental settings,which points towards the
presence of additional binding sites.
In summary, multiple sites within the C-terminal region of srGAP3 seemed to
be involved in binding of 14-3-3s suggesting a complex mode of interaction.
Two of these sites, S858 and S919, could be validated in this project and were
involved in binding to the 14-3-3 isoforms γ and θ/τ in HEK293T cells. Since
their phosphorylation pattern was tissue-invariant, they are expected to hold
the same function in brain-specific srGAP3/14-3-3-complexes.
Figure 6.18.: Binding of 14-3-3γ and θ/τ to srGAP3 involves phosphorylation of S858
and S919. MCherry-tagged 14-3-3γ and θ/τ and eGFP-tagged srGAP3 were co-
expressed in HEK293T cells and the interaction analysed in a fluorescence-based
co-immunoprecipitation assay. The fraction of bound 14-3-3γ and 14-3-3θ/τ in
percent of co-immunoprecipitations with srGAP3, mutants thereof, or eGFP are
indicated. The average mCherry fluorescence intensity of three independent ex-
periments was corrected for the instrument background and normalised to the
wild-type sample (srGAP3 wt). Error bars correspond to the standard deviation
between replicates and asterisks mark samples that are significantly different from
co-immunoprecipitations with srGAP3 wild-type (p < 0.05 in unpaired t-test). EGFP
and srGAP3 S895A served as assay and negative control, respectively. The statistical
analysis was performed with SigmaPlot (version 12.3, Systat Software Inc.).
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7. DISCUSSION
The srGAP family of proteins has been implicated in various aspects of neur-
onal development [151, 152, 155–158, 244] and these findings were, on a mo-
lecular level, mainly substantiated through functional characterisations of the
N-terminal domains [127, 151, 154, 156, 163, 165], whereas less attention has
been given to the C-terminal region [207, 245]. The C-terminal region exhib-
its the highest divergence between paralogous srGAP proteins [151] and my
bioinformatic analysis predicted it to be natively disordered (Fig. 6.2, p. 42).
Since database searches revealed the presence of potential short linear motifs
for protein-protein interactions, I attempted to characterise protein complexes
formed by the C-terminal region of srGAP3. With a combination of different
biochemical and biophysical methods, I was able to show that srGAP3 uses
such linear motifs for binding of 14-3-3 proteins as well as the SH3 domain-
containing proteins Endophilin-A1, Endophilin-A2, Amphiphysin, and Grb2
(Fig. 7.1). In the following sections, I will discuss my methodology (7.1), spe-
cific characteristics of the identified interactions (7.2, 7.3), hypothetical func-
tions of the formed complexes (7.4), and I will finally try to answer the question,
whether the C-terminal region is natively unstructured (7.5).
7.1. Top-Down Approach for the Identification of
Direct Interaction Partners of SrGAP3-CTR
The identification of direct interaction partners for a specific protein or pro-
tein domain is not a trivial task. About 300 SH3 domains are, for example,
encoded in the human genome [50] and isolating the subset of SH3 domains
that directly binds to a protein of interest confronts the researcher with a dif-
ficult combinatorial problem that has to be solved in a reasonable amount of
time. In principle, two different starting points exist to dissect the cellular ma-
chinery associated with a specific protein without prior knowledge: The first
comprises multiplexed screening of binary interactions ("bottom-up"), which is
realised in library-based methods and is generally performed outside the nat-
ive environment of the protein [246, 247]. The second constitutes the isolation
of multi-protein complexes from the native tissue containing the target protein
("top-down"), which is the focus of pull-down or co-immunoprecipitation ex-
periments that are usually combined with mass spectrometry methods [233].
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Figure 7.1.: Protein interactions of the C-terminal region of srGAP3 and functional
implications. An interaction model of srGAP3-CTR with the relative positions
of the identified linear motifs and the respective binding partners is displayed.
Shown in blue is the multi-class SH3 domain-interaction motif and marked with
a cross is the approximate position of a predicted multi-class SH3-binding motif
in srGAP1 (see 7.2.1 for further discussion). The analysed 14-3-3-binding motifs
with the corresponding phosphorylation sites are marked in dark green, whereas
potential additional motifs are depicted in light green (see 7.2.2 for discussion).
Asterisks mark identified phosphorylation sites located within 14-3-3 motifs. The
amino acid sequences of the motifs, as well as functional associations derived from
Gene Ontology terms and literature data, and potential functional implications of
the identified complexes are displayed below. 14-3-3 functions were subsumed un-
der the category phosphoregulation/protein interaction, whereas Endophilins and
Amphiphysin belong to the endocytic machinery, and Grb2 is associated with re-
ceptor tyrosine kinase (RTK) signalling (see 7.4 for further discussion).
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In vivo-crosslinking (e.g. [248]) represents an intermediate approach, but is ir-
relevant to the following discussion paragraphs and therefore not explained in
greater detail.
In this project, I pursued a top-down strategy for the identification of binding
partners for srGAP3-CTR, in which the initial GST pull-down from rat brain
lysate was followed by a validation experiment relying on co-immunoprecipi-
tations from HEK293T cells and a subsequent analysis of interacting domains
and motifs. Ultimately, this led to the identification of six previously unknown
protein complexes (Fig. 7.1, p. 74). Why did this methodology yielded results
in contrast to the library-based approach from Haussmann [220] employing a
yeast-two-hybrid screen?
GST Pull-Down from Rat Brain Lysate
The main difference lies in the isolation of multi-protein complexes from nat-
ive tissue in the initial pull-down experiment, in which several linear motifs in
srGAP3-CTR could, for example, have acted in parallel to bind different mem-
bers of larger protein assemblies (compare 7.3, p. 89). Furthermore, the bait
protein GST-srGAP3-CTR was presented as an immobilised dimer through the
N-terminal GST-tag and within the framework of the resulting multiple attach-
ment sites, low affinity complexes - like the identified SH3 domain-interactions
- were potentially stabilised through cooperative effects [48, 233]. In contrast,
the detection limit of yeast-two-hybrid experiments, which only detects binary
interactions [246], is a Kd of approximately 1 µM [246]. This cut-off is smal-
ler than the measured affinities and might explain, why Haussmann [220] was
unable to detect these complexes.
Another advantage of GST pull-down experiments is their ability to detect
phosphorylation-dependent interactions, which cannot be captured by yeast-
two-hybrid screens due to a different phosphorylation pattern in yeast [249].
This aspect might be especially important in the light of the identified
14-3-3 interactions, which usually, but not always involve phosphorylation of
the binding motif in the ligand (Fig. 7.1, p. 74) [79, 84]. If phoshorylation of
GST-srGAP3-CTR had, however, been absolutely required for complex forma-
tion between srGAP3 and 14-3-3s, the bait protein would have had to be phos-
phorylated by kinases present in the lysate. And although we treated the lysate
with phosphatase inhibitors, which stabilise the phosphorylated states of pro-
teins, we omitted the parallel application of kinase activators or ATP, which
might be required for a quantitative phosphorylation of the bait protein in vitro
(compare [250]). It is therefore likely that phosphorylation of GST-srGAP3-CTR
was dispensable for complex formation with 14-3-3s in this experimental set-
up, although we did not analyse its phosphorylation state after incubation with
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the rat brain lysate. On the other hand, even if complex formation was inde-
pendent of phosphorylation of a bait protein, phosphorylation of binding part-
ners might have been necessary for the interaction and a comparative analysis
of GST pull-down experiments in presence and absence of phosphatase inhib-
itors should help to clarify this issue. Despite these caveats of our own res-
ults, GST pull-down experiments should perform superior to yeast-two-hybrid
screens in the analysis of 14-3-3-dependent interactions.
It is clear that the outcome of a pull-down experiment will directly depend on
the type and origin of the tested tissue. This becomes especially important, if
the bait protein - as in this case - is developmentally regulated [159, 160, 221],
which might similarly apply to expression patterns of binding partners mak-
ing them potentially exclusively detectable at certain developmental stages.
After postnatal day 14, srGAP3 mainly relocates from the cytosol to the nucleus
[159], which means that repeating the experiment with earlier developmental
stages might help to identify different or additional cytosolic binding partners
for srGAP3-CTR, whereas later stages would aim at the isolation of nuclear
srGAP3-containing complexes.
An obvious drawback of the pull-down approach is its high amount of false-
positive results originating from indirect interactions [251]. In order to improve
the signal-to-noise ratio, we utilised srGAP1-CTR in parallel to dissect binding
partners, that are potentially specific for either srGAP-family member. On the
other hand, we had expected that the CTRs bind their ligands mainly through
linear motifs, which typically engage in low-affinity interactions [45] and for
this reason we omitted extensive washing procedures to increase the detection
probability. The mass spectrometry results thus likely contained a consider-
able amount of background signal, which rendered the validation of the pull-
down results through an alternative method especially important. Therefore,
we selected a subset of 19 proteins, which was mainly specific for srGAP3-CTR,
and I subsequently analysed the interactions with srGAP3 in an orthogonal ap-
proach, which permitted the detection of direct protein-protein interactions.
Fluorescence-Based Co-IP Assay
The established Co-IP assay was based on an immobilised nanobody direc-
ted against GFP [196] and nanobodies feature special characteristics that might
have been advantageous in this particular experimental set-up: Due to their
small size, nanobodies achieve higher probe densities on solid supports com-
pared to conventional antibodies [252, 253]. In my assay, relatively high pro-
tein concentrations (upper limit of the plate supplier’s recommendations) were
necessary to saturate the plate surface with the GFP-nanobody, which maybe
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indicates such higher probe densities. Increased amounts of immobilised nano-
body were reported to positively affect the sensitivity of surface plasmon reson-
ance experiments [252, 253] and might have likewise improved the sensitivity
of my assay.
I utilised the GFP-nanobody to co-precipitate mCherry-tagged candidate pro-
teins through eGFP-tagged srGAP3 full-length and was able to confirm the in-
teraction of srGAP3 with eight of the 19 candidate proteins in vivo: α-Centractin,
Grb2, Endophilin-A1, Endophilin-A2, Amphiphysin, as well as the 14-3-3 iso-
forms γ, θ/τ, and ζ (Fig. 6.10, p. 56). These interactions were likely to be
direct, since overexpression and the resulting high protein concentrations of
both interaction partners in HEK293T cells rendered indirect binding events
improbable (compare Fig. 6.5, p. 48 for set-up). Of course, indirect interac-
tions cannot be formally excluded, which especially applies to cases, where the
binding signal was weak (such as α-Centractin and 14-3-3ζ).
These eight binding partners (Fig. 7.2, p. 78, displayed in green) have been im-
plicated in a subset of cellular networks, which also involved several candid-
ates, which I was unable to validate in the Co-IP assay (Fig. 7.2, p. 78). Indirect
interactions in larger protein assemblies presumably caused the occurrence of
these and other proteins in the initial pull-down experiment. However, it is
likewise conceivable that non-validated candidates either represented unspe-
cific background due to insufficient washing (see above, 76) or were unable to
bind srGAP3 in this specific experimental set-up, for example due to masking
of binding sites through phosphorylation (e.g. [254]).
The amount of bound mCherry-tagged binding partners varied considerably
between different srGAP3/candidate pairs in the fluorescence-based Co-IP as-
say (Fig. 6.10, p. 56), which might imply that they interacted with different
strength with srGAP3. Nevertheless, it is impossible to draw conclusions about
the affinity of the interactions for several reasons: Firstly, the nature of the in-
teraction (transient or stable) or the concentration of active protein inside the
cell might affect the amount of bound protein in a similar fashion. Secondly,
transient transfections for each srGAP3/candidate pair were optimised to max-
imise the expression of both constructs and the fluorescence levels solely nor-
malised to its own eGFP control, but not to other srGAP3/candidate combin-
ations. Therefore, the obtained mCherry-fluorescence intensities represent re-
lative values to the respective eGFP control and the overall amount of bound
protein in individual samples might have been influenced by the respective
expression levels. However, I decided to exclude candidates that weakly co-
precipitated with eGFP-srGAP3 (α-Centractin, 14-3-3ζ) from further analyses
due to the higher probability that they represented indirect binding events (see
above) or that specific protein features - such as low affinity-binding or poor
folding - could complicate a characterisation in vitro. The remaining set of val-
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Figure 7.2.: Functional networks involving srGAP3. Interaction data with exper-
imental support was retrieved from the STRING database (http://string-db.org/
[255]), from the literature, or identified in this project. Solid lines depict connections
with high confidence, whereas dashed lines illustrate weak experimental support.
Binding partners of srGAP3-CTR that were identified in this study are shown in
green (filled green box: interaction with CTR validated; encircled in green: interac-
tion with full-length srGAP3). Encircled in solid black are non-validated candidates
from the co-immunoprecipitation assay. Proteins that were identified in the mass
spectrometric analysis of the GST pull-down experiment, but not investigated fur-
ther, are marked with a dashed black line. Son of sevenless 1 (Sos1) was identified
in co-immunoprecipritations of endogenous srGAP3 from rat brain lysate (data not
shown). RTK: receptor tyrosine kinase. Functional associations were retrieved from
either the Gene Ontology database (http://geneontology.org/) or the literature.
idated interaction partners belonged to the SH3 domain-containing proteins
(Endophilin-A1, Endophilin-A2, Amphiphysin, Grb2) and 14-3-3s (isoform γ
and θ/τ).
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Characterisation of SH3 Domain-Complexes with ITC
Utilising ITC, I confirmed the direct interaction of the SH3 domains of Endo-
philin-A1, Endophilin-A2, Amphiphysin, and Grb2 with the full
C-terminal region as well as a shorter PxxP-fragment of srGAP3. The affinities
were low with Kd values in the micromolar range and specific characteristics
of the formed complexes are discussed in section 7.2.1. Through a mutational
analysis, I was able to delineate a single proline-rich motif in srGAP3-CTR that
conferred binding to at least three of these proteins (data for Endophilin-A1
only preliminary, Fig. 7.1, p. 74).
An obvious advantage of isothermal titration calorimetry is the potential to de-
termine all biophysical parameters (enthalpy, affinity, stoichiometry, and - de-
rived from that - the entropy) in a single experiment without the need to label
the components [256]. A drawback of this method is clearly the requirement
for large amounts of soluble protein to obtain meaningful data in the invest-
igation of such low affinity interactions [141]. In case of the SH3 domain of
Amphiphysin, I was for this reason unable to detect the direct interaction with
the full C-terminal region of srGAP3: At the employed protein concentration
and measurement temperature, the enthalpic change - which depends on these
settings [256] - was below the detection limit. In contrast, the interaction of
this SH3 domain with a smaller srGAP3 fragment, which was soluble at higher
protein concentrations, was successfully detected.
Mutational Analysis of 14-3-3-Dependent Interactions
In most cases, binding to 14-3-3 proteins requires phosphorylation of a serine
or threonine residue in the target motif [84, 85] and, for this reason, I focused
on the analysis of predicted 14-3-3-binding motifs in srGAP3-CTR that were
phosphorylated in our samples. I employed HEK293T cells to validate the in-
teraction of 14-3-3 proteins with srGAP3, but the phosphorylation pattern of
srGAP3 transiently expressed in this cell type only partially matched its phos-
phorylation pattern in rat brain (Fig. 6.17, p. 69). As the goal of this project
was the identification of brain-specific srGAP3-complexes, which is the tissue
srGAP3 is mainly expressed in [161], I took only those phosphorylation sites
into account that were shared between both cell types (S858 and S919). Con-
sequently, the identified residues within srGAP3 that are involved in complex
formation with 14-3-3s in HEK293T cells should carry out the same function in
the rat brain.
To investigate the binding behaviour of these predicted motifs, I initially at-
tempted to analyse their interaction with the 14-3-3 proteins in vitro using frag-
ments of srGAP3-CTR, which carried phosphomimetic mutations (phosphory-
lated positions mutated to aspartate). This approach was unsuccessful and,
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therefore, I performed a mutational analysis of full-length srGAP3, in which I
screened for loss of interactions with 14-3-3 proteins in the fluorescence-based
Co-IP assay. With this methodology, I was able to identify two of several posi-
tions within the C-terminal region of srGAP3 that are involved in the complex
formation with 14-3-3s (Fig. 7.1, p. 74), which will be discussed in detail in
section 7.2.2.
In summary, a top-down approach employing a panel of different in vivo and
in vitro methods uncovered six previously unknown direct interaction partners
of srGAP3, which bind to its C-terminal region: Amphiphysin, Endophilin-A2,
Endophilin-A1, Grb2, 14-3-3γ, 14-3-3θ/τ.
7.2. Protein-Peptide Interactions Mediated by
SrGAP3-CTR
Bioinformatical structure predictions revealed that the C-terminal region of
srGAP proteins likely lacks secondary structure elements that can be combined
to produce a classically folded tertiary structure and, therefore, this region is
possibly intrinsically disordered (see section 7.5 for further discussion). The
functions attributed to unstructured segments are diverse and can range from
chaperone activity or flexible connections of folded domains to assembly of
protein complexes or scavenging of small molecules [37]. Protein-protein inter-
actions of disordered regions are often mediated by linear motifs [37], which
usually bind to globular domains [46] and represent versatile interaction mod-
ules that can be combined in numerous ways in a single polypeptide chain [45].
Employing database searches, I detected such linear motifs in the C-terminal re-
gion of srGAP3 for binding to 14-3-3 proteins and SH3 domains, which I was
able to validate experimentally. In the following subsections, I will discuss spe-
cific features of the identified motifs and how they might have contributed to
the selective binding of the respective proteins.
7.2.1. SH3 Domain-Dependent Interactions
In the canonical binding mode, SH3 domains recognise proline-rich sequen-
ces, which form a type II polyproline helix and contain a PxxP core motif [55,
212]. Positively charged amino acid preceding (class I: [RK]xxPxxP) or follow-
ing (class II: PxxPx[KR]) the PxxP core are accommodated by an acidic spe-
cificity pocket, which determines the binding orientation of the ligand peptide
[57–59, 257]. Additional residues within or close to the motif as well as vari-
able loop regions in the SH3 domain that contribute to the specificity pocket
not only affect the affinity of the interaction, but are also instrumental to the
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diverse specificity landscape of SH3-mediated interactions, which can range
from exclusive to promiscuous [257, 258].
Using the outlined experimental set-up (compare section 7.1, p. 73), I was able
to show that the SH3 domains of the Endophilins, Amphiphysin, and the C-
terminal SH3 domain of Grb2 share the ability to bind to a single proline-rich
motif in the C-terminal region of srGAP3 with a Kd of 14 - 27 µM. Weak in-
teractions like these are typical for SH3-mediated complexes (Kd = 1-100 µM
[51]) and can partially be attributed to the relatively small buried surface area
in domain-peptide interactions (200-500 A˚ [259]) compared to complexes in-
volving two structured domains (2000 A˚ [260]). The linear motif in srGAP3
with the sequence RPPPMRPVRP is positioned at the end of the C-terminal re-
gion (residues 1053-1062, Fig. 7.1, p. 74) and carries properties of class I and
class II peptides, which we assumed to be important in binding of SH3 domains
with differing class preferences. Nevertheless, the motif must contain addi-
tional sequence features that allowed it to selectively bind the above-mentioned
SH3 domains, but not all SH3 domains tested, such as the SH3 domain of the
Abelson interactor 1 (data not shown) or the N-terminal SH3 domain of Grb2
(see results on Grb2 SH3N, 6.4.3, p. 63).
The SH3 domain of Amphiphysin was, for example, reported to specifically re-
cognise class II motifs containing two arginines [239] that are accommodated by
a negatively charged patch covering its binding surface [261]. Dynamin1 and
Synaptojanin associate with the SH3 domain of Amphiphysin through such
motifs (PSRPNR and PIRPSR, respectively [262]) and the resulting consensus
sequence PxRPxR is also incorporated in the srGAP3 sequence (RPPPMRPVRP).
Therefore, it is not surprising that Amphiphysin SH3 interacted with this multi-
class SH3-binding motif in srGAP3. The affinity of this interaction is three times
higher than the previously reported affinity of the Amphiphysin-Dynamin com-
plex [263], rendering it to my knowledge the strongest interaction for this SH3
domain described so far.
The binding specificity of the SH3 domains of Endophilins was reported to
be more complex [54, 262], with certain preference for class I motifs with an
additional arginine in position +2 relative to the first proline in the PxxP core
[54, 264]. This consensus is likewise present in the identified motif in srGAP3
(RPPPMRPVRP). The more extensively studied Endophilin-A1 can also recog-
nise the Amphiphysin-binding class II motif in Dynamin1 (PSRPNR [262]) and,
thus, might either recognise the same class II consensus sequence in srGAP3 as
Amphiphysin or select the class I orientation. Interactions of Endophilin-A1
and Endophilin-A2 thermodynamically resembled each other (Tab. 6.5, p. 60),
which might reflect similar complex interfaces. This might even be expected,
as the two domains share a high degree of sequence identity (80 %) and the
residues lining the canonical SH3 domain binding pocket are almost fully con-
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served [265]. However, NMR-based binding studies would be required to fully
understand the complex formation with the SH3 domains of Endophilins.
The interaction of Grb2 was mediated by its C-terminal SH3 domain, while
the N-terminal SH3 domain might constitute a secondary interaction site that
is able to recognise the same region, yet interacts with a different motif. Al-
though I detected a weak binding signal in titrations of Grb2 SH3N and the
PxxP-fragment, I obtained a similar signal with the mutated AxxA-fragment
(compare Tab. 6.5, p. 60). These findings indicate either that the interaction
was independent of the two mutated prolines or that the observed enthalpic
change in titrations with Grb2 SH3N represented an unspecific signal. In the
following paragraph, I will therefore discuss both possibilities, but mainly fo-
cus on the interactions mediated by Grb2 SH3C.
SrGAP3 has the ability to dimerise [163] and simultaneous binding of SH3N
and SH3C to one srGAP3 dimer would somewhat be reminiscent of the Grb2/
Sos1 complex, which is conversely governed by the N-terminal SH3 domain of
Grb2 [266]. In this complex, Grb2 SH3N can bind to each of four motifs in Sos1
with high affinity, whereas SH3C only engages with the first motif in a low-
affinity interaction [240]. Although one might expect that SH3N out-competes
SH3C, simultaneous binding of both SH3 domains of Grb2 to Sos1 was found to
be crucial for efficient activation of Ras signalling [240, 267–269]. Consequently,
this model illustrates, how the secondary interaction site Grb2 SH3N in the
Grb2-srGAP3 complex could become important in a specific functional context.
Similar to srGAP3, Grb2 possesses the ability to form dimers [163, 270, 271] and,
thus, two Grb2 SH3C domains could bind to one srGAP3 dimer, which would
resemble the Grb2/Gab1 complex [60, 272]. In this complex, Grb2 SH3C was
shown to interact with two RxxKP motifs in Gab1 [60, 272], in which the RxxK
core is crucial for binding [273]. This consensus is similar to the RxxRP motif
contained in the srGAP3 sequence RPPPMRPVRP, in which the lysine is substi-
tuted by arginine. This amino acid exchange and the preference of Grb2 SH3C
against prolines in position +1 relative to the first arginine [273] might explain,
why this SH3 domain interacted with srGAP3 with a fivefold lower affinity
than with Gab1, which contains the RxxK consensus (compare [273]). On the
other hand, mutation of two proline residues (RPPPMRPVRP) instead of the
two arginines abrogated binding in my experimental set-up, which suggests an
entirely different interaction mechanism that is independent of the RxxR core.
Again, additional experiments, such as mutational analyses or a structure de-
termination of the complex, would be required to reveal the underlying mode
of interaction.
The identified motif was - with only three exceptions - conserved among
srGAP3 sequences, which suggests a general importance for the function of
srGAP3 and might support the idea that the identified complexes universally
occur in vertebrates (compare Results 6.4.3, p. 61). Noteworthy, srGAP1 also
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contains a predicted multi-class SH3-binding motif at a different position within
the CTR (relative position indicated in Fig. 7.1, p. 74). The motif with the se-
quence RGEPPPPVRRP is likewise conserved with only a few exceptions, but
whether it indeed confers binding to SH3 domains remains to be demonstrated.
Interestingly, two of the six srGAP1 sequences that lacked the motif at the con-
served position (Poecilia formosa and Danio rerio), shared a multi-class motif with
srGAP3 proteins at the end of the C-terminal region (compare Fig. 7.1, p. 74).
Therefore, the precise location of SH3-binding motifs within the C-termini of
srGAP1 and srGAP3 might, in addition to their amino acid sequence, be im-
portant for effective complex formation with SH3 domain-containing proteins.
Apart from these two exceptions, srGAP1 and srGAP2 sequences are at this
position devoid of typical class I and class II SH3-binding motifs or specific
consensus sequences for Endophilins, Amphiphysin, or Grb2, which renders
the interactions potentially specific for srGAP3. As linear motifs are often lost
in paralogous sequences [45, 274], this finding might even be expected, but it
is, of course, possible that srGAP1 and srGAP2 likewise employ this region for
SH3 domain-dependent interactions via non-canonical proline-rich motifs.
Additional predicted proline-rich motifs with similar consensus sequences are
absent from srGAP3, but whether the identified motif constitutes the only bind-
ing site within srGAP3 for these interaction partners awaits experimental de-
monstration. The associated question, whether the motif is also essential for
the interaction in the context of full-length proteins, could be answered with
the fluorescence-based Co-IP assay employing a mutated version of full-length
srGAP3, in which the core proline residues of the motif are replaced by alanine.
In summary, I found a single SH3 domain-binding motif in the C-terminal
region of srGAP3 that displayed a surprising flexibility in engaging in dif-
ferent SH3 domain-dependent interactions. The versatile, yet specific recog-
nition of this motif by the SH3 domains of Endophilin-A1, Endophilin-A2,
Amphiphysin, Grb2, and was potentially attributed to its multi-class nature
as well as the presence of an additional arginine residue in the +2 position rel-
ative to the first proline in the PxxP core. Therefore, these results may provide
an example how additional amino acids in conjunction with the canonical PxxP
motif can contribute to the specificity in SH3 domain-mediated interactions.
7.2.2. 14-3-3-Dependent Interactions
The family of 14-3-3 proteins comprises seven isoforms in mammals (β, γ, ,
η, σ, θ/τ, and ζ), which share high sequence similarities [79] and bind to their
targets as rigid, saddle-shaped dimers (reviewed in [81]). The C-terminal re-
gions of srGAP1, srGAP2, and srGAP3 contain multiple linear motifs that are
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predicted to confer binding to 14-3-3s and the association between these pro-
tein families in HEK293T cells has already been noticed by others [86, 207]. In
contrast, ARHGAP4 proteins seem to have lost the ability to bind 14-3-3 pro-
teins [207] and are devoid of predicted 14-3-3-binding motifs. In this project,
I was able to show that srGAP3 also forms complexes with this protein fam-
ily in the developing rat brain and could confirm the interaction in HEK293T
cells. Moreover, I demonstrated that srGAP3 selectively bound the 14-3-3 iso-
forms γ and θ/τ in the latter cell type. In murine embryonic brain, srGAP3 was
reported to represent a substrate for 14-3-3  [241], whereas it was unable to as-
sociate with this isoform in HEK293T cells. Therefore, 14-3-3-binding seems to
be a general function of srGAP proteins and is conserved in different organ-
isms and cell types, yet might depend on distinct 14-3-3 isoforms in different
tissues, which is potentially related to tissue-specific phosphorylation patterns
and binding sites (Fig. 7.1, p. 74) [242, 243].
Another level of complexity is added through the ability of 14-3-3 proteins to
form homo- or heterodimers (Fig. 7.2, p. 78, reviewed in [79]). 14-3-3 γ, for
example, prefers to bind targets in a homodimeric fashion, whereas 14-3-3 
usually heterodimerises [275]. The formation of unfavourable and less stable
homodimers of 14-3-3  [79] could thus also have prevented complex formation
with srGAP3 in my assay.
From the work of Ivan Blasutig [207], it was known that the C-terminal re-
gion of srGAP3 is necessary for the interaction with 14-3-3s, but specific lin-
ear motifs remained undefined. In the majority of complexes, 14-3-3s bind to
linear motifs featuring a phosphorylated serine or threonine residue [84, 85];
although all 14-3-3 isoforms were reported to recognise the canonical sequen-
ces RSx[pS]xP (mode I) and Rx[F/Y]x[pS]xP (mode II) [80], identified motifs of
in vivo-ligands, like srGAP3, often diverge from this consensus (reviewed in
[79]). In fact, numerous 14-3-3-binding motifs were predicted in the C-terminal
region of srGAP3, but all belonged to the motif class with the divergent con-
sensus [RHK][STALV]x([ST])x[PESRDFTQ] (class 3, Fig. 6.17, p. 69), which
underlines the difficulty in predicting true 14-3-3-binding sites. Because of the
high complexity of this interaction system with numerous predicted motifs,
multiple 14-3-3 isoforms, and tissue-specific phosphorylation sites (see Discus-
sion, 7.1), I restricted the analysis to predicted 14-3-3-interaction motifs that
were phosphorylated in HEK293T cells as well as in the rat brain (compare Fig.
7.1, p. 74).
Employing the Co-IP assay in HEK293T cells, I found that phosphorylation of
S858 and S919 in the C-terminal region of srGAP3 promoted complex forma-
tion with 14-3-3 γ and θ/τ (Fig. 7.1, p. 74). These residues are embedded in or
lie adjacent to predicted 14-3-3-binding motifs and the respective motifs might
therefore directly participate in the interaction. My bioinformatical analysis
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further revealed that these motifs are universally conserved in srGAP3 sequen-
ces, which clearly argues for their importance. Nevertheless, mutation of these
serine residues to alanine only reduced, but failed to fully abrogate binding,
which points towards the presence of additional 14-3-3-binding sites and sug-
gests a complex mode of interaction between srGAP3 and 14-3-3s. This would
be in accordance with the findings of Blasutig [207], who noticed a gradual
loss of 14-3-3-binding in co-immunoprecipitations with srGAP3 constructs that
were stepwise truncated from the C-terminus.
Nevertheless, the two mutations S858A and S919A might physiologically affect
the srGAP3/14-3-3 complex in vivo, since simultaneous binding of two motifs
of one ligand molecule to a 14-3-3 dimer can be instrumental to the function
of the respective protein complex (reviewed in [87]). The Bcl2-associated ag-
onist of cell death (BAD) protein, for example, stably interacts through either
of two motifs with 14-3-3s, but only if both motifs engage in the interaction at
the same time, binding of BAD to BCL-XL and therefore apoptosis is efficiently
prevented [276]. This means that, although the two point mutations in srGAP3
were insufficient to abolish the interaction with 14-3-3 proteins due to the pres-
ence of additional motifs, either one of them could - in analogy to the BAD/
14-3-3 complex - be important in a specific functional context (see 7.4.2 for fur-
ther discussion of functional implications).
With truncated srGAP3 constructs, Blasutig [207] further mapped the binding
region of 14-3-3 proteins to the residues 883 to 954 and the potential binding
motif surrounding S858, which I identified in this project, lies N-terminal to that
region. This finding demonstrates either the requirement of multiple attach-
ment sites for stable complex formation [80] or a dependence of phosphoryla-
tion at S858 on sites located further downstream (see below, [85]). Mutation of
S919 to alanine also resulted in impaired binding of 14-3-3 proteins to srGAP3,
although this residue is positioned adjacent to, but not within a predicted
14-3-3-interaction site. These findings illustrate the difficulty of identifying true
14-3-3-binding sites in vivo through mutation of phosphorylation sites or trun-
cated constructs (compare [85]). Although it is, of course, possible that the
neighbouring motif of S919 forms direct contacts with 14-3-3s and is affected
by this phosphorylation event, it is likewise conceivable that phosphorylation
of S919 is part of a hierarchical phosphorylation system, in which phosphoryla-
tion of this primary site triggers phosphorylation of the actual 14-3-3-binding
motif and therefore complex formation [85]. The forkhead in rhabdomyosar-
coma (FKHR) protein, for example, is phosphorylated by protein kinase B (PKB)
at S256, which in turn leads to phosphorylation at Thr24 and binding of
14-3-3 at this secondary site [277]. In order to unambiguously show that the
motifs surrounding S858 and S919 represent bona fide 14-3-3-interaction sites,
the complex formation with 14-3-3 proteins would have to be analysed in vitro
employing phospho-peptides or in vitro-phosphorylated srGAP3-CTR.
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This obviously poses the question which kinase(s) phosphorylate these sites in
vivo. Usually, the amino acid sequence of the target motif determines the kinase
specificity [278, 279] and 14-3-3 proteins typically recognise linear motifs that
are phosphorylated on serine and threonine residues by basophilic kinases, for
example PKA or PKB [78, 86]. Indeed, NetPhosK (http://www.cbs.dtu.dk/
services/NetPhosK/) [280] predicts a preference for PKB and PKA at S858, but
no phosphorylation at S919. Blasutig [207], on the other hand, reported that
the complex formation between srGAP proteins and 14-3-3s depends on phos-
phorylation by protein kinase C, which is likewise known to phosphorylate
14-3-3 motifs [281]. As outlined above, it is again possible that hierarchical
phosphorylation events come into play and, thus, it might be difficult to find
the respective kinase, which directly phosphorylated the 14-3-3-binding mo-
tifs. How could this question be tackled experimentally? First of all, neuron-
derived cell lines (e.g. Neuro2A) might depict model systems that are better
suited to study brain-specific 14-3-3-interactions. If the phosphorylation pat-
tern of srGAP3 in these cells matches its pattern in the rat brain, specific kinase
inhibitors could be applied in the fluorescence-based Co-IP assay to obtain a set
of relevant kinases, which could subsequently be tested in in vitro phosphoryla-
tion assays.
From the presented experimental results, it is clear that the C-terminal region
of srGAP3 must contain additional 14-3-3-binding motifs, which might, for ex-
ample, involve tissue-specific phosphorylation and binding sites, such as the
predicted motif surrounding the HEK293T-specific phosphorylation site S932
or the brain-specific S1070 (Fig. 7.1, p. 74). This latter motif is especially inter-
esting, since it is positioned close to the identified SH3 domain-binding motif
and 14-3-3-binding at this site could either positively or negatively regulate
SH3-dependent interactions through masking of the proline-rich motif or al-
losteric effects (compare [81] and section 7.4.2).
Alternatively, srGAP3 could engage unconventional binding motifs for the in-
teraction with 14-3-3 proteins. Although phosphorylation of the ligand peptide
is required in most 14-3-3-dependent interactions [85], exceptions to that rule
have been reported [213–215]. The respective motifs either follow the canonical
consensus sequence, but remain unphosphorylated [214, 282], or are entirely
different and enriched in hydrophobic residues (e.g. GLLDALDLAS [215]).
With respect to non-phosphorylated canonical consensus sequences, one mo-
tif in the C-terminal regions of srGAP proteins stands out: Only at a single site,
srGAP1, srGAP2 as well as srGAP3 share the prediction for a 14-3-3-binding
motif (S1030, Fig. 6.17, p. 69). The respective motif in srGAP3 follows the
sequence RSSSSS (residues 1027-1032, Fig. 7.1, p. 74) and lacked any detect-
able phosphorylation in either HEK293T cells or rat brain. Since mass spectro-
metry can only provide a snapshot of the native phoshorylation state and the
obtained sequence coverage will depend on a variety of factors, such as sample
processing and the specific spectrometry method [283] or the origin, quality, or
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type of protein to be analysed [242, 283], we might have simply failed to cap-
ture its phosphorylation. But even if this motif was unphosphorylated under
native conditions, it would still depict a prime candidate for complex formation
with 14-3-3s: Given the low sequence and positional conservation on the level
of predicted binding motifs between the different srGAP paralogs, it would be
truly surprising if this motif would have been kept intact without experiencing
any evolutionary constraints related to its assumed function in 14-3-3-binding
or would have been acquired by chance at exactly this position in all three para-
logs. Whether the motif depicts a true 14-3-3-binding site, is certainly contro-
versial and its location outside the predicted 14-3-3-binding region (see above,
compare Blasutig [207]) argues against it. Other 14-3-3-binding motifs that are
present upstream of this motif could, however, have acted as alternative bind-
ing sites in the absence of this motif in C-terminally truncated srGAP3, which
might explain why it remained undetected in the experimental set-up of Ivan
Blasutig [207] (Fig. 7.1, p. 74).
In summary, multiple motifs present in the C-terminal region of srGAP3 con-
fer binding to 14-3-3 proteins, which might not only ensure a robust interac-
tion even in the absence of single binding sites, but could also open up the
possibility to dynamically modulate the interaction surface of srGAP3 through
phospho-regulation of individual motifs through different kinases [284].
7.2.3. The Specificity Issue
Low affinities measured in vitro are always associated with the question, how
the respective complexes can be specific or occur at all given the lower protein
concentrations inside the cell and the high probability that a short motif will
appear by chance in unrelated proteins [285]. The answer is that the cell can
make use of a number of different mechanisms to facilitate their formation in
the native context. First of all, through multimerisation, which is the shared
feature of all interaction partners described in this work [95, 163, 270, 286,
287], initially weak monomeric interactions can be stabilised and therefore be-
come relevant in the cell. In the same line of reasoning, the presence of several
14-3-3-binding sites in srGAP3-CTR might likewise positively affect the affin-
ity of 14-3-3-involving complexes either through cooperative effects, when two
motifs simultaneously bind to a 14-3-3 dimer [80], or local increase in binding
site concentration in an avidity-guided fashion [288, 289].
Secondly, the proteins srGAP3, Endophilin-A1, Endophilin-A2, and
Amphiphysin contain BAR domains, which represent membrane-interaction
modules (see introduction on BAR domains, 1.1.3, p. 6) [95, 163], and mem-
brane confinement is believed to facilitate the recognition of binding partners
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through reduction of dimensions in a “matricity-driven” process [289]. An-
other important contribution to specificity comes from flanking regions of the
motif, which not only help to improve the affinity through additional contacts,
but can also prevent non-native interactions through steric hindrance [65]. This
intimate connection between linear motifs and their flanking regions is addi-
tionally underlined by the finding that they evolve in a concerted fashion [290].
Although these mechanisms might guide the selective association of srGAP3
with the identified binding partners, it is still unclear, how srGAP3 could dis-
criminate between three different SH3 domain-containing proteins, which bind
to a single motif with similar affinities. It is, of course, possible that simul-
taneous binding of at least two interaction partners could be realised through
multimerisation of srGAP3 [163]. Furthermore, the regulated and directional
assembly of multi-protein complexes, in which the identified SH3-mediated
interactions are expected to occur (see section 7.3, p. 89 for further discussion),
might either promote or prevent individual interactions in the context of co-
operative binding and ordered complex assembly [48].
Another important factor might be differences in local protein concentration
[48], which can be regulated through a variety of mechanisms: Firstly, the loc-
alisation of signalling proteins rather seems to depend on active processes than
mere diffusion [48]. Through active transport [291], restricted localisation via
interaction partners (as for example through binding of srGAP3 to 14-3-3s, see
7.4.2, p. 93 for further discussion), or localised translation, which is especially
important in neurons [292], the cell might impose a spatio-temporal regula-
tion pattern onto individual srGAP3-containing complexes. Secondly, multi-
valent protein-peptide interactions have been reported to promote phase sep-
aration inside the cell [293], which has also been suggested for Grb2-involving
protein complexes [294, 295]. Such phase separations via multivalent bind-
ing events have recently been shown to cluster surface receptors into micro-
domains thereby creating locally organised signalling zones [296]. These trans-
itions will generate sharp and dynamic concentration gradients in a local envir-
onment and will probably affect binding affinities as well as binding kinetics of
associated protein complexes [293].
Where and when the identified srGAP3-containing complexes occur inside the
cell and whether they are mutually exclusive, remains to be elucidated, but they
will likely depend on a complex panel of different regulatory mechanisms.
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7.3. Transient Protein-Protein Interactions in Signal
Transduction
Transient protein-protein interactions play crucial roles in cellular signalling
pathways [36, 297] and are often mediated by adaptor modules, such as SH3
domains or 14-3-3s, which recognise short linear motifs with moderate affinity
and variable specificity [32, 45, 285]. SrGAP3 was implicated in Slit-Robo sig-
nalling [151] through binding of its SH3 domain to a proline-rich region in the
intracellular domain of Robo receptors [151] and its affinity for a Robo1-derived
peptide was determined at a Kd of 5.6 µM [166]. In this project, I furthermore
found that srGAP3 engages its C-terminal region and the linear motifs therein
for interactions with SH3 domains that are characterised by similar weak af-
finities. Are there possibly reasons, why low affinities could be beneficial for
signalling processes in general?
Protein-peptide interactions are entropically disfavoured due to the ordering
of unstructured residues in an unfolded peptide [34, 50], which often results
in low affinities and fast association/dissociation rates [34, 298–300]. This is a
prerequisite for the formation of reversible and highly dynamic signalling com-
plexes [34]. Additionally, such transient complexes mediated by linear motifs
usually do not occur in isolation, but are part of large protein assemblies (com-
pare 7.2.3, p. 87 and Fig. 7.2, p. 78), in which several low affinity interactions
become stabilised through cooperative effects [45, 48] and thereby allow signal
integration from different pathways for highly combinatorial and discrete de-
cision making [45, 48, 49]. Cooperativity will also provide the basis for robust
signalling systems [48] and robustness might also have been the underlying
driving force for the stable association between 14-3-3s and srGAP3 even in the
absence of individual binding motifs.
The question whether initially weak and promiscuous protein-peptide inter-
actions could in principle be evolved into high affinity-complexes has been
exemplarily answered with SH2 domains [301], which bind phosphorylated
motifs with mediocre affinities [302]: Three mutations in the Fyn SH2 domain
were sufficient to create a superbinder SH2 domain, which bound its ligands
with about 340x higher affinity than its wild-type version [301]. This combina-
tion of mutations also efficiently turned other SH2 domains into superbinders,
but, however, never occurs in this subcluss of SH2 domains in nature [301].
Could evolution have even selected against strong motif-mediated interactions
[303]? As linear motifs can be acquired by chance in unrelated proteins [285] or
be easily hijacked by pathogens [304], they might generally represent untrust-
worthy binding surfaces [303, 304]. Consequently, the low affinity could serve
to protect the cell from deleterious off-target binding [303]. Therefore, it is pos-
sible that srGAP3 preferentially associates with several, but not all of the newly
identified binding partners under native conditions. First evidence that some
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of these complexes indeed occur in vivo, stemmed from the isolation of native
srGAP3-containing complexes from rat brain lysate, in which we were able to
identify Grb2 as well as 14-3-3 proteins (data not shown).
On the other hand, the described evolutionary flexibility of linear motifs, which
is also reflected by the apparent lack in conservation between different srGAP
paralogs, imparts evolutionary plasticity onto networks [303, 305] and leads to
rewiring and tuning of the respective pathways [306]. Therefore, the poten-
tial ability of the C-terminal regions of paralogous srGAPs in binding different
proteins might account - in addition to temporal and spatial regulation patterns
[159] - for the functional diversity observed within this protein family [151–153,
155–157, 218].
Although direct evidence is still missing, we have good reasons to believe that
the identified complexes also exist in vivo, since the identified transient protein-
protein interactions mediated by linear motifs in the C-terminal region or by the
SH3 domain of srGAP3 are in good agreement with the established principles
of signal transduction in eukaryotes.
7.4. Functional Implications of the Identified
Complexes
Correct neural development is required for normal brain function and regu-
lated, among other signalling networks (reviewed in [307]), by the Slit-Robo
pathway [148, 150, 307]. SrGAP proteins act downstream of Robo receptors
[151] and a more general role at the intersection of signal transmission, actin
cytoskeleton regulation, and membrane deformation during different steps of
vertebrate neural development has been established (compare introduction on
the function of srGAP3, p. 25) [127, 153–157, 161, 163–165, 308].
Using sensitive homology detection methods, I identified a remote srGAP or-
tholog in the genomes of the choanoflagellate Salpingoeca rosetta and the filas-
terean Capsaspora owczarzaki. These phyla of unicellular organisms represent
the closest relatives to metazoans and possess the ability to form colonies as
well as different cell types [206, 309]. They are, thus, at the boundary of mul-
ticellularity [310] and evidence is increasing that the processes driving cellular
differentiation in these organisms are governed by homologous proteins par-
ticipating in vertebrate signalling pathways and establishing the tissue archi-
tecture [310–315]. This finding would put srGAPs already at the onset of meta-
zoan evolution, in which they might have been part of a set of proteins that was
essential to establish and subfunctionalise inter-cellular networks, and further
suggests a general importance of srGAPs in cellular differentiation.
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Finally, my bioinformatic analysis furthermore revealed that paralogous srGAP
sequences (srGAP1, 2, and 3, ARHGAP4) emerged in vertebrates. Although
the paralogs share a role in neural development [151, 155, 161, 163, 316], they
were found to be important for different steps of these processes [155, 157, 158,
163, 218]. This functional divergence partially arises from differential spatio-
temporal regulation patterns [159, 160, 219], but might likewise depend on
structural differences in protein domains that can, for example, result in un-
equal ligand-recognition specificities [127, 151, 308]. The presented results pro-
vide first examples on how srGAP3 could employ its C-terminal region in pro-
tein-protein interactions that are potentially specific for this paralogous sub-
group. As a functional characterisation of these complexes was beyond the
scope of this project, I will, in the following sections, develop working hypo-
theses for future projects that are mainly guided by known functions of the
identified interaction partners.
7.4.1. Potential Functions of SH3 Domain-Mediated
Complexes
As outlined above, srGAP3 associated in HEK293T cells and in vitro with the
SH3 domain-containing proteins Endophilin-A1, Endophilin-A2, Amphiphysin,
and Grb2 (compare Fig. 7.1, p. 74).
With respect to cellular functions, Endophilins and Amphiphysin belong to
the clathrin-dependent endocytic machinery (compare introduction, Fig. 1.4,
p. 12): Amphiphysin is the major binding partner of Dynamin in nerve ter-
minals [317] and engages its SH3 domain for this interaction [239, 261, 262].
Overexpression of its SH3 domain was furthermore found to block receptor-
mediated endocytosis by interfering with Dynamin recruitment [318]. Endo-
philins are likewise enriched in nerve terminals [264], where they bind Dynamin
[264] and also Synaptojanin [262]. All of these srGAP3-binding partners have
been implicated in synaptic vesicle endocytosis [317, 319, 320], whereas only
Endophilin-A2 and Amphiphysin were additionally reported to regulate
AMPA receptor trafficking at postsynaptic sites [321, 322].
Grb2 is implicated in growth factor receptor signalling, where it binds activ-
ated receptor tyrosine kinases and links them to Ras signalling through simul-
taneous binding of the Ras guanine-nucleotide exchange factor Sos1 [268, 269,
323–327]. Grb2 was also found to be involved in associated receptor-uptake
mechanisms [328–330] and its general importance in developmental processes
is underlined by its constant expression levels throughout neural development
[331] and the severe phenotype of Grb2 knockout mice, which die after em-
bryonic day 7.5 [332].
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The common theme present in the functional repertoire of these binding part-
ners thus seems to be their involvment in endocytic processes. Endocytosis is
not only important at presynaptic sites to balance synaptic vesicle release [333],
but also affects the position and the amount of neuronal receptors at the en-
tire cell surface [3]. Receptor-uptake can serve to adjust the responsiveness of
a neuron to guidance cues [13, 16, 17] and has been found to be essential for
signal transduction itself in certain cases (e.g. TGFβ [18, 334] or G-protein-
coupled receptors [335]). Therefore, I would speculate that srGAP3 recruits the
endocytic machinery through its association with Endophilins, Amphiphysin,
or Grb2 to activated receptors to trigger their uptake and downstream sig-
nalling, for example via Ras. Another possibility is the recruitment of Endo-
philins and Amphiphysin at presynaptic sites for the regulation of synaptic ves-
icle endocytosis. In fact, recruitment of endocytic factors by GAP proteins has
already been described: Oligophrenin-1, which is a BAR domain-containing
RhoGAP protein of the GRAF family [336], was reported to recruit Endophil-
ins at pre- and postsynaptic sites, thereby controlling synaptic vesicle endocyt-
osis and AMPA receptor uptake [337, 338]. Similar to srGAP3, Oligophrenin-1
employs a single proline-rich motif, which contains internal and flanking pos-
itively charged amino acids (aa 739 - 750, RPPVRPPDPPCR) and is located at
the end of a putatively disordered C-terminal region, for binding the SH3 do-
mains of these proteins [337, 338]. Therefore, these findings not only support
the relevance of my identified srGAP3 complexes in vivo, but also suggest a
more general mechanism, by which certain GAP proteins can recruit endocytic
factors through C-terminal SH3 domain-binding motifs.
It will, undoubtedly, be difficult to identify the respective receptors, but the
Robo family surely constitute prime candidates, as srGAP3 was reported to
bind via its SH3 domain to the intracellular domains of Robo1 and Robo2 [152].
The Slit/Robo pathway regulates midline crossing of axons [148, 149, 339, 340]
and srGAP3 has been implicated in the positioning of post crossing axons in
the ventrolateral funiculus through a functional interplay with Robo receptors,
although the precise mode of action remained unclear [152]. Robo receptors are
also endocytosed [341], but so far nothing is known about the uptake mechan-
ism and its impact on Robo signalling.
Another potential target for srGAP3-mediated receptor uptake could be the
gamma-amminobutyric acid A (GABAA-)receptor, since srGAP3 was found to
be important for its clustering at inhibitory synapses in the CA1 region of the
Hippocampus (specifically in the stratum radiatum) through an interaction of
srGAP3’s SH3 domain with Gephyrin [248]. The regulation of surface levels
of the GABAA-receptor through endocytosis and recycling is required for its
function [342], but the uptake mechanism and involved downstream factors
are unknown. Importantly, Endophilin-A2 is also expressed in this brain re-
gion [264] and it could be possible that srGAP3 might not only regulate clus-
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tering, but also endocytosis of the GABAA-receptor through the recruitment of
Endophilin-A2.
How could a general hypothesis of uptake be tested? It would be possible to
compare surface receptor levels of neuronal cells (e.g. Neuro2A, [153]) that
overexpress srGAP3 wild-type to those carrying a mutated srGAP3-construct,
in which the two core proline residues are exchanged to alanines (see Fig. 6.15B,
p. 62). Since probably all neuronal cells will contain endogenous srGAP3
(compare [145, 153, 160]), a parallel knockdown of the endogenous srGAP3
wild-type might be required. Moreover, endocytosis and subsequent recyc-
ling might be restricted to activated receptors and, thus, it could be necessary
to treat the cells with activating factors, such as the Slit protein (compare intro-
duction on the Slit-Robo pathway, p. 25) [151, 343]. Evidence for complex form-
ation between srGAP3 and the identified endocytic proteins could furthermore
stem from co-localisation experiments before and after treatment with activat-
ing factors or in presence or absence of the interfering srGAP3 PxxP-fragment.
As the expression level and pattern of srGAP3 is developmentally regulated
[157, 159, 160, 344], a comprehensive co-localisation study from different neur-
onal stages and regions would additionally be required to track these com-
plexes in vivo.
On the basis of the presented results, it is therefore possible to deduce clear
working hypotheses regarding functional implications of the identified com-
plexes, which might argue for their existence in vivo. In summary, my results
not only revealed a link between srGAP3 and the endocytic machinery as well
as the Ras signalling pathway, but also provided evidence that the C-terminal
region carries an adaptor function to connect srGAP3 with different cellular
networks.
7.4.2. Potential Functions of 14-3-3-Mediated Complexes
14-3-3 proteins are expressed in all eukaryotic cells and involved in numer-
ous cellular pathways, such as apoptosis, metabolism, cell cycle progression,
or transcription, in which they regulate the activity of their binding partners
through various mechanisms (reviewed in [78]). How could they specifically
affect the function of srGAP3?
Firstly, the relatively rigid 14-3-3 dimer (compare introduction, Fig. 1.2, p. 7)
[84] is believed to impose its structure onto ligands upon binding [81] and could
thereby lock the flexible C-terminal region of srGAP3 in a specific conformation
[345]. The resulting disorder-to-order transition [87, 345–347] could either af-
fect srGAP’s affinity for other binding partners via allosteric effects [345] or in-
crease its half-life through shielding of disordered residues [348], which might
otherwise accelerate its degradation [349].
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Secondly, 14-3-3s could orchestrate the interactions of srGAP3 with other pro-
teins through exposing or masking of binding sites in response to different in-
coming signals [276, 350, 351]. As outlined above (see 7.2.2, p. 83), this aspect
might be especially relevant to the predicted binding site S1070 (see Fig. 7.1, p.
74), which is located adjacent to the identified SH3-binding motif. Moreover,
the subcellular localisation of srGAP3 changes from cytoplasmic to nuclear in
older cell stages [159, 221] and 14-3-3 proteins could assist in establishing this
distribution pattern, for example through masking of nuclear localisation sig-
nals [352], which were proposed to reside in the C-terminal region [221].
Thirdly, dimeric 14-3-3 proteins might act as bridging adaptors [79, 81] by teth-
ering otherwise non-interacting proteins to srGAP3. Although this function
of 14-3-3s is only weakly supported by experimental data compared to other
assigned functions [80, 81, 353–355], it potentially explains the occurrence of
certain false-positive candidates in the initial pull-down experiment that might
have been pulled down indirectly through a 14-3-3 dimer (e.g. EB1, see Fig. 7.2,
p. 78).
How could these hypotheses be analysed experimentally? A relatively simple
approach would involve the overexpression of the inhibiting R18 peptide that
was found to interfere with all 14-3-3 interactions inside the cell [86, 356, 357].
Although the system would be completely dysregulated and validation ex-
periments would be required to demonstrate direct effects on the interaction
between 14-3-3s and srGAP3, this approach might nonetheless provide first in-
side into the functional repertoire of these protein complexes. It would, for ex-
ample, be possible to analyse changes in the subcellular localisation of srGAP3
or to measure its stability over time in different cell types. Whether 14-3-3s also
affect the ability of srGAP3-CTR to bind SH3 domains, could be tested with
co-immunoprecipitation or co-localisation experiments in presence or absence
of the R18 peptide.
In any case, a functional analysis of srGAP3/14-3-3 complexes will either sup-
port a role of the C-terminal region in establishing the spatio-temporal reg-
ulation pattern of srGAP3 [221] or provide a solution to the question how
the availability of linear motifs and therefore complex formation through the
C-terminal region could be finely tuned for specific cellular functions.
7.5. Is the C-Terminal Region of SrGAP3 Natively
Unstructured?
Intrinsic disorder describes a set of very different conformational states of poly-
peptide chains, which can range from the absence of any recognisable structure
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over partially folded elements to molten or collapsed globules, which are reas-
onably stable [37]. Despite of this diversity, they all share the lack of a classically
folded tertiary structure with a hydrophobic core [37].
My bioinformatic analysis demonstrated that none of the investigated C-termi-
nal sequences of srGAP proteins contain - apart from short helical or coiled-coil
segments - predicted secondary structure elements that are likely to be com-
bined in a fixed 3D-structure. Conversely, disorder was reliably predicted over
the full CTR with exception of regions that might harbour secondary struc-
ture elements. Furthermore, sequences of C-terminal regions clustered accord-
ing to the phylogenetic relationship, which would be expected from sequences
experiencing few evolutionary constraints in sequence space. This character-
istic is often, but not necessarily a trait of disordered regions [358] and might
be restricted to exposed residues that are located outside of interfaces [359–
361] or “functional hot spots” [362]. Linear motifs represent such “functional
hot spots”, are enriched in disordered segments [217], and database searches
revealed that they are likewise enriched in the C-terminal region of human
srGAP3. Moreover, I was able to validate at least two of the predicted motifs
experimentally. Taken together, the bioinformatical analysis strongly supports
the hypothesis that the C-terminal region of srGAP3 and srGAP proteins in
general is intrinsically disordered.
Nevertheless, it was impossible to prove this hypothesis experimentally, since
the instability of srGAP3-CTR precluded a structural analysis (compare Results
6.4.1, p. 57). At the same time, this finding also argues for its disordered state,
whereby its high flexibility might have made it amenable to protease cleavage
[363–365]. Such faster degradation kinetics of unstructured regions [349] are
used inside the cell as a means to regulate the abundance of intrinsically dis-
ordered proteins [366]. The analysis of intrinsic disorder is experimentally chal-
lenging, but accessible through NMR or CD spectroscopy in conjunction with
functional studies [40]. In more recent examples, single-molecule Förster res-
onance energy transfer (smFRET) has been applied to specifically investigate
conformational ensembles of intrinsically disordered regions [367] or folding
upon binding [368]. Due to the instability of the full CTR, I mainly employed
smaller fragments for in vitro-experiments that covered the full length of the
CTR with the exception of the predicted coiled-coil segment. All of these frag-
ments were highly soluble and exhibited considerable heat stability (data for
residues 904-954, 810-910, 995-1079 not shown), which is a general character-
istic of natively disordered regions due to the lack of extensive secondary and
tertiary contacts [37].
Furthermore, disordered segments have been reported to be enriched in phos-
phorylation sites (reviewed in [37]). As part of our interaction studies with
14-3-3 proteins, we analysed the phosphorylation pattern of endogenous
srGAP3 from rat brain and found that it was almost exclusively phosphorylated
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in the C-terminal region. Although conclusive experimental evidence is still
missing, it can be concluded from all of this evidence that the C-terminal re-
gion of srGAP3 likely depicts a natively unstructured region.
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Part II.
Regulation of Syndapin1 by EHD1

8. INTRODUCTION
Vesicle trafficking relies on a complex machinery of membrane-interacting and
-bending proteins as well as factors involved in actin cytoskeletal dynamics
and microtubular transport [23, 27]. F-BAR proteins, such as Syndapins (for
synaptic Dynamin-associated protein [369]), have been suggested to intercon-
nect these processes in vivo [370, 371]. The proteins of the Syndapin family,
which are also termed PACSINs (for Protein Kinase C and Casein Kinase 2 sub-
strate in neurons [372]), are conserved in metazoa [373] and comprise the para-
logs Syndapin1, Syndapin2, and Syndapin3 in mammals [369, 372–376], which
have differential expression patterns: Syndapin1 constitutes the brain-specific
isoform, whereas Syndapin2 is ubiquitously expressed and Syndapin3 is found
in heart, lung, and muscle [376]. They share a conserved domain architecture
with an N-terminal F-BAR domain followed by a variable linker region and a
C-terminal SH3 domain (Fig. 8.1E, p. 101) [369, 372].
Via the SH3 domain, all Syndapin isoforms were found to bind the endocytic
proteins Dynamin and Synaptojanin as well as the Arp2/3-complex activator
N-WASP (neuronal Wiskott-Aldrich syndrome protein), which promotes actin
polymerisation [369, 375, 376] (compare introduction on endocytosis 1.2.1,
p. 10, and actin polymerisation, section 1.2.2, p. 11). For this reason, Synda-
pins were suggested to function at the intersection of endocytic processes and
actin dynamics [371, 375, 377]. Although Syndapins share a role in membrane
trafficking, individual isoforms have been implicated in different endocytic
pathways (reviewed in [378]). Syndapin1, in particular, participates in activity-
dependent bulk endocytosis, which is launched upon repetitive neuronal stim-
ulation (compare general introduction, p. 1) [379].
Targeting of Syndapin1 to membranes depends on its F-BAR domain (see in-
troduction on lipid binding domains, section 1.1.3, p. 6) [99–101, 130]. Like
conventional F-BAR domains, the F-BAR domain of Syndapin1 forms an elong-
ated dimer (compare Fig. 1.3, p. 9), but due to strongly kinked tips it possesses
a unique tilde shape (Fig. 8.1A, p. 101) [92, 99]. In contrast to conventional
F-BAR architectures, this results in a doubly bent membrane binding surface
(Fig. 8.1D, p. 101), which enables stabilisation of various curvature types [99,
130, 131]. A hydrophobic wedge loop (Fig. 8.1A, p. 101), which is believed
to insert into one leaflet of the bilayer, acts in concert with the curved surface
to drive Syndapin1-dependent membrane deformations (see introduction on
deformation mechanisms, p. 8) [99].
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Artificial liposomes often serve as a model system to study BAR domain-medi-
ated membrane-bending in vitro. The F-BAR domain of Syndapin1 has been
shown to deform such liposomes into tubules (Fig. 8.1F, p. 101) [99, 100, 130],
but this activity is downregulated in the full-length protein through an autoin-
hibitory clamp between the SH3 and F-BAR domain (Fig. 8.1A-E, p. 101) [130].
The autoinhibition can be released through binding of ligands to the SH3 do-
main, which leads to prominent tubulation of liposomes [130]. Since the bind-
ing surface for the F-BAR domain overlaps with the canonical SH3-binding
pocket, SH3 domain ligands probably activate Syndapin1 through a displace-
ment mechanism (Fig. 8.1C, p. 101) [130].
A flexible linker connects the F-BAR domain with the SH3 domain and this re-
gion is, compared to the globular domains, most divergent between different
Syndapin isoforms [129]: The linker does not only vary in length and amino
acid sequence, but also in the number of contained Asn-Pro-Phe (NPF) motifs,
which can range from zero in Syndapin3 to three in Syndapin2 (Fig. 8.2, p.
102). NPF motifs mediate binding to EH domains [72] and - in case of Synda-
pins - to the EH domains of the EHD (for EH domain-containing [380]) family
of proteins [129, 381] (compare introduction on EH domains, subsection 1.1.2,
p. 5). Moreover, both NPF motifs of Syndapin1 were found to be required for a
stable association with EHD1 [129].
In mammals, the EHD family of proteins consists of four paralogs (EHD1-4)
[380, 382–384], which have been implicated in various types of membrane traf-
ficking at the plasma membrane and endosomal compartments (compare in-
troduction, Fig. 1.1, p. 3 for description of the endosomal system) [22, 384].
EHD1, in particular, was found to be important for recycling of cargo from the
endocytic recycling compartment (ERC) back to the plasma membrane [385–
388]. However, it might possess a divergent function in neurons, as it mainly
labelled early endosomes in this cell type and was required for cargo-specific
endocytosis [18, 388, 389]. EHD proteins are composed of a G-domain, which
structurally resembles the GTPase-domain of Dynamins, yet is specific for ATP,
followed by a helical domain, and a C-terminal EH domain (Fig. 8.3A, p. 103)
[390]. Furthermore, EHD proteins can form homo- and heterodimers [384, 390–
392] via their G-domain and the EH domain-binding pocket is occupied by an
internal Gly-Pro-Phe (GPF) motif located in a linker connecting the helical do-
main with the EH domain (Fig. 8.3B, p. 103) [390]. The structural and biophys-
ical characterisation of the isoform EHD2 suggests that EHD proteins assemble
in ring-like fashion around membrane tubes and promote curvature generation
by inserting the tips of their helical domain in a wedging mechanism into the
lipid bilayer (Fig. 8.3B-D, p. 103) [390, 393]. Moreover, membrane-binding re-
leased the ATPase-activity of EHD2, but the hydrolysis rate was 600x slower
than the GTP-hydrolysis rate of Dynamin [386, 390]. Despite this low activity,
EHD proteins have been suggested to act as “pinchases” at endosomal com-
partments in analogy to Dynamins in endocytic processes (see introduction on
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Figure 8.1.: The F-BAR domain of Syndapin1 is autoinhibited by an interaction with
the SH3 domain. The structure of full-length Syndapin1 is shown (PDB ID 2X3W
and 2X3X). A: Syndapin1 in secondary-structure representation. The F-BAR domain
monomers are depicted in gold and purple, respectively, whereas the SH3 domain
is shown in green. The N and C termini as well as the secondary-structure assign-
ment, and the wedge loop are only marked on one chain. B: Close-up of the interface
between the F-BAR domain and the SH3 domain. The β-strands of the SH3 domain
are labelled according to the conventional nomenclature (see introduction on SH3
domains, 1.1.2, p. 5). Residues involved in binding are represented as sticks and po-
lar contacts as red dashed lines. C: The peptide (blue) derived from the proline-rich
region of Dynamin1 is modelled into the expected PxxP-binding groove of the SH3
domain. D: Coloring of the protein surface according to the electrostatic potential:
red (negative) through white (neutral) to blue (positive). The lower panel depicts
an open-up view of the interface. Important residues that were mutated in func-
tional assays are labelled. Note, that the interface is mainly composed of positively
charged residues in the F-BAR and negatively charged residues in the SH3 domain.
E: Domain architecture of mouse Syndapin1 (GI: 557948024). F: Electron micro-
graph of phosphatidylserine-liposomes incubated with Syndapin1 F-BAR. F-BAR,
Fes-Cip4-homology-BAR (Bin-Amphiphysin-Rvs) domain; SH3, Src-homology 3 do-
main; NPF, peptide motif composed of Asn-Pro-Phe. The domain boundaries are
indicated. Panel A-D and F as well as the figure legend were adopted from Rao et al.
[130].
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Syndapin1  NATGAVEST--SQAGD----------------------------------- (337) 
Syndapin2  GINQTGDQSGQNKPGSNLSVPSNPAQSTQLQSSYNPFEDEDDTGSSISEKE (378) 
Syndapin3  SIVPTRDGT--APPPQ----------------------------------- (337) 
 
Syndapin1  ---RGSVSSYDRGQTYATEWSDDESGNPFGGNEANGGANPFEDD---AKG (384) 
Syndapin2  DIKAKNVSSYEKTQTYPTDWSDDESNNPFSSTDANGDSNPFDEDTTSGTE (428) 
Syndapin3  -----SPSSPGSGQ--DEDWSDEESPRK---------------V---ATG (365) 
Figure 8.2.: The linker region of mouse Syndapin1 and Syndapin2, but not
Syndapin3 contain NPF motifs. MSAProbs [178] alignment of mouse Syndapin
sequences (Syndapin1, GI: 557948024; Syndapin2, GI: 226958422; Syndapin3, GI:
576067844). Conserved positions are highlighted in grey and similar residues are
printed in bold. NPF motifs are displayed in red. The full variable region of mouse
Syndapins is shown.
endocytosis, p. 10) [390, 394] and ATP hydrolysis was indeed found to be ne-
cessary for EHD-mediated vesiculation of membranes in vivo [390] and in vitro
[394, 395], although direct experimental evidence is still missing.
Complex formation of EHD1 with either Syndapin1 or Syndapin2 is necessary
for membrane trafficking and receptor recycling, as overexpression of either
Syndapin’s variable linker region or the EH domain, which both interfere with
the interaction, impaired transferrin receptor uptake [129]. The complex la-
bels tubular and vesicular structures in HeLa cells and co-distributes at post-
synaptic sites in primary hippocampal neurons [129]. Further evidence for
a function in recycling stems from studies in Caenorhabditis elegans, in which
Syndapin1 and EHD1 colocalise on recycling endosomes [396]. However, the
specific role of the Syndapin1-EHD1 complex in neurons as well as molecular
mechanisms associated with its function remain to be elucidated.
In order to gain further insight into membrane rearrangements of Syndapin1 in
presence of its binding partner EHD1, we reconstituted this complex on artifi-
cial membranes in vitro.
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Figure 8.3.: Structural model of EHD2. A: Domain architecture of EHD proteins. G
domain, GTPase domain (ATP-specific in EHD proteins [390]); Helical, helical do-
main; EH, Eps15-homology domain. The location of the Gly-Pro-Phe (GPF) motif,
which occupies the EH domain-binding pocket, is marked. B: Structure of the EHD2
dimer in the presence of the nonhydrolyzable ATP analog AMPPNP (PDB ID: 2QPT)
C: Electron micrograph of phosphatidylserine-liposomes incubated with EHD2. D:
Structural model of an oligomeric ring of EHD2 on lipid tubes derived from the
crystal structure. Panel C and D were adopted from Daumke et al. [390].
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9. MATERIALS AND METHODS
9.1. Cloning Strategies and DNA Constructs
The Syndapin1 clone was obtained from BioCat Gmbh (Heidelberg). For ex-
pression in E. coli, mouse Syndapin1 (residues 1-441) was cloned into pGEX6P1
and pGEX4T1 (GE Healthcare). The construct for the Syndapin1 F-BAR domain
was obtained by introduction of a stop codon after aa 326 of Syndapin1 by site-
directed mutagenesis of pGEX4T1-Syndapin1. Syndapin1 ∆SH3 (aa 1-384) and
the linker region between the F-BAR domain and the SH3 domain (aa 327-384)
were cloned into pGEX4T1. The NPF motifs in Syndapin1 were mutated to
AAA by two consecutive rounds of site-directed mutagenesis. The clone for hu-
man EHD1 was obtained from BioCat Gmbh (Heidelberg). Full-length EHD1
(residues 1-534) was cloned into the pET_Trx_1b vector (provided by Gunter
Stier, Heidelberg), which contained a N-terminal thioredoxin-tag followed by
a His6-tag. The mutant EHD1 W485A, in which the conserved tryptophan in
the EH domain-binding pocket was replaced by alanine, was obtained by site-
directed mutagenesis. The EH domain of mouse EHD1 (residues 438-534) was
cloned into pGEX6P1. An overview of all constructs and primers can be found
in the appendix (Tab. C.1, p. 170).
9.2. Protein Expression and Purification
Syndapin1 full-length, Syndapin1 mNPF and EHD1 EH were expressed as
GST-fusion proteins in E. coli BL21 Gold (DE3) cells. Protein expression was
induced with 0.5 mM IPTG and the cells were harvested after 5 h at 28 °C.
The cells were lysed in 50 mM Tris/HCl (pH 8.0), 300 mM NaCl, 4 mM DTE,
4 mM Benzamidine, 2 mM EDTA, as well as cOmplete Protease Inhibitor Cock-
tail (Roche) and the cleared lysate was applied to a Glutathione Sepharose 4B
column (GE Healthcare). After washing with a high salt buffer (1 M NaCl),
bound protein was eluted in a linear GSH gradient and the free protein pro-
duced by incubation with PreScission protease (GE Healthcare). GST was re-
moved with a second affinity column and the flow-through, which contained
the target protein, subjected to size exclusion chromatography (Superdex 200
for Syndapin1 full-length, Superdex 75 for EHD1 EH) in 50 mM Tris/HCl
(pH 8.0), 150 mM NaCl, 2 mM DTE, and - in case of EHD1 EH - 2 mM CaCl2.
105
9. MATERIALS AND METHODS
Syndapin1 full-length, Syndapin1 mNPF and EHD1 EH were concentrated to
24 mg/ml, 9 mg/ml, and 32 mg/ml, respectively.
The Syndapin1 Linker, Syndapin1 F-BAR, and Syndapin1 ∆SH3 constructs
were also expressed as GST-fusion proteins in E. coli BL21 Gold (DE3) cells
with the same protocol as employed for full-length Syndapin1. The crude ex-
tracts were applied to a Glutathione Sepharose 4B column in 50 mM Tris/HCl
(pH 8.0), 300 mM NaCl, 4 mM DTE, 4 mM Benzamidine, 2 mM EDTA, and
cOmplete Protease Inhibitor Cocktail, washed with a high salt buffer (1 M
NaCl), and eluted in a linear GSH gradient. DnaK, which often co-purifies
with unfolded peptides, was removed from Syndapin1 Linker protein pools
according to Thain et al. [199]. The GST-tag was cleaved off with Thrombin
(Sigma) during dialysis in 50 mM Tris/HCl (pH 8.0), 50 mM NaCl, 2 mM DTT,
and 2 mM CaCl2 and removed with a second affinity column. Subsequently,
the protein was bound to an anion exchange column (Source Q, GE Health-
care) and eluted in a linear salt gradient. The eluates were subjected to size ex-
clusion chromatography (Superdex 75 for Syndapin1 Linker, Superdex 200 for
Syndapin1 F-BAR and ∆SH3) in 50 mM Tris/HCl (pH 8.0), 300 mM NaCl, and
2 mM DTT. The final protein pools of Syndapin1 Linker, Syndapin1 F-BAR, and
Syndapin1 ∆SH3 were concentrated to 29 mg/ml, 23 mg/ml, and 11 mg/ml,
respectively.
EHD1 and EHD1 W485A were expressed in E. coli Rosetta 2 (DE3) cells. Protein
expression was induced with 0.5 mM IPTG and the cells harvested after 16 h
at 22 °C. The bacteria were lysed in 20 mM Hepes (pH 8.0), 400 mM NaCl,
1 mM MgCl2, 2.5 mM β-Mercaptoethanol, 1 % NP-40, as well as cOmplete
Protease Inhibitor Cocktail and the cleared lysate applied to a Ni Sepharose
(GE Healthcare) column. After washing with high salt buffer (1 M NaCl), the
fusion protein was eluted in a linear imidazole gradient. The thioredoxin- and
His6-tags were removed by incubation with Tobacco Etch Virus protease during
dialysis against 50 mM Tris/HCl (pH 8.0), 50 mM NaCl, and 2 mM DTE. Since
the protein precipitated at 4 °C, the dialysis as well as all subsequent steps were
carried out at 23 °C. The free protein was further purified with anion exchange
chromatography and eluted in a linear salt gradient. The fractions containing
the target protein were applied to a Superdex 200 column in 50 mM Tris/HCl
(pH 8.0), 300 mM NaCl, and 2.5 mM β-Mercaptoethanol and EHD1 and EHD1
W485A concentrated to 35 mg/ml and 11 mg/ml, respectively.
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9.3. Lipid Biochemistry Methods
9.3.1. Liposome Preparation
Total lipid extract from bovine brain (Folch I fraction) from Avanti (131101)
and Sigma (B1502) were mixed 1:1 in chloroform and supplemented with 1 %
(w/w) PtdIns(4,5)P2 (Sigma, P9763) as well as 1 % (w/w) Rhodamine-labelled
phosphatidylethanolamine (PE, Avanti, 810150) (modified lipid mix from [397]).
The Endomix (protocol provided by Felix Wieland, Universität Heidelberg)
was prepared with 35 mol% Cholesterol (Avanti, 700000), 10 mol% sphingomy-
elin (Avanti, 860062), 10 mol% PE (Avanti, 840026), 10 mol% phosphatidylser-
ine (PS, from Avanti, 840032), 5 mol% phosphatidylinositol (Avanti, 840042), 25
mol% phosphatidylcholine (PC, from Avanti, 840055), and 5 mol% PtdIns(4,5)P2
(Sigma, P9763). Lipids were dried at 37 °C under a N2-stream and residual
solvent removed in a vacuum manifold for 16 h. The dried lipid film was hy-
drated for 3 h at 37 °C in 20 mM Hepes (pH 7.5), 140 mM KCl, 10 mM NaCl, 1
mM MgCl2 to yield a final lipid concentration of 5 mg/ml for Folch I liposomes
and 4 mM for Endomix liposomes. Multi-lamellar liposomes were produced
by nine freeze-thaw cycles with liquid nitrogen and a water bath at 37 °C [398,
399] and the liposome solution was stored at -80 °C until further usage. For
co-pelleting and tubulation assays, small unilamellar vesicles were produced
by sonication for 3 min [97, 131], which yielded a clear solution.
9.3.2. Liposome Co-Pelleting Assay
The liposome co-pelleting assay was performed as described by Goh et al. [131].
In particular, 0.5 mg/ml sonicated Folch I liposomes were mixed with 5 to
100 µM of protein in 20 mM Hepes (pH 7.5), 140 mM KCl, 10 mM NaCl,
1 mM MgCl2 and incubated for 15 min at 25 °C. Liposomes were pelleted
by centrifugation at 87000 rpm for 15 min at 20 °C and the supernatant and
pellet fractions analysed by SDS-PAGE. Quantification of protein bands was
performed with the FusionCapt Advance software (Vilber Lourmat). For this
purpose, the amount of protein in supernatant or pellet was calculated as per-
centile of the summed intensities of both fractions (100 %).
9.3.3. Liposome Tubulation Assay
For investigation of the tubule formation potential of individual proteins and
protein complexes, 0.25 mg/ml sonicated Folch I liposomes or 200 µM sonic-
ated Endomix liposomes were incubated with 10 to 1000 µM protein in
20 mM Hepes (pH 7.5), 140 mM KCl, 10 mM NaCl, 1 mM MgCl2 for 20 min
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at 25 °C, spotted onto glow-discharged carbon-coated copper grids with pi-
coloform film, and incubated for additional 10 min. The solution was removed
by blotting, the grid washed once with buffer, and the specimen was stained by
incubation with 1 % filtered uranyl acetate solution for 45 sec. Excessive liquid
was removed by blotting and the samples were imaged with a TECNAI Spirit
transmission electron microscope (FEI). Tubule diameters were quantified with
Fiji [204] and statistically analysed with SigmaPlot (version 12.3, Systat Soft-
ware Inc.).
9.4. Isothermal Titration Calorimetry
All measurements were carried out at 20 °C and the ligand was titrated under
constant stirring at 300 rpm into the cell (cell volume 1.4295 ml) in 28 steps of
10 µl, and a spacing between titration steps of 240 sec. 180 to 300 µM ligand
were titrated into 18 to 30 µM protein solution. Prior to measurements, all
proteins were extensively dialysed against 50 mM Tris/HCl (pH 8.0), 150 mM
NaCl, and 0.5 mM tris(2-carboxyethyl)phosphine.
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Syndapin1 is an accessory protein in dynamin-dependent endocytosis [371,
375, 400] and has - via its association with EHD1 - also been implicated in en-
docytic receptor recycling [129]. How the latter protein complex carries out its
function on a molecular level is not understood and, therefore, we specifically
wanted to investigate how binding of EHD1 affects the membrane sculpting
potential of Syndapin1 by reconstituting this protein complex on artificial lipo-
somes.
10.1. Production of Proteins
We purified mouse Syndapin1, human EHD1, as well as different fragments
thereof (Fig. 10.1) from bacteria expressing these proteins. Since mouse and
human EHD1 have an amino acid sequence identity of over 99 % and, we ex-
pected that the results of our experiments would not be influenced by the hu-
Figure 10.1.: Domain architecture of EHD1 and Syndapin1. Protein constructs of
EHD1 and Syndapin1 used in this study. Mutations are indicated in italics. G do-
main, GTPase domain (ATP-specific in EHD1 proteins [390]); Helical, helical do-
main that composes the membrane interaction surface [390]; EH, Eps15-homology
domain; F-BAR, Fes-Cip4-homology-BAR (Bin-Amphiphysin-Rvs) domain; SH3,
Src-homology 3 domain; NPF, peptide motif composed of Asn-Pro-Phe. The do-
main boundaries of human EHD1 and mouse Syndapin1 are shown in black and the
construct boundaries in red.
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Figure 10.2.: Purification controls EHD1
and Syndapin1. SDS-PAGE of fi-
nal protein pools from purifications
of EHD1 (residues 1-534, 60.7 kDa),
EHD1 EH (residues 438-534, 11.3
kDa), EHD1 W485A (residues 1-534,
60.6 kDa), Syndapin1 (residues 1-441,
50.0 kDa), Syndapin1 F-BAR (residues
1-326, 38.4 kDa), Syndapin1 ∆SH3
(residues 1-384, 44.3 kDa), Syndapin1
Linker (residues 327-384, 6.0 kDa),
Syndapin1 mNPF (residues 1-441, 50.7
kDa). Syndapin1 Linker appears
at higher molecular weigths, which
is probably related to reduced SDS-
binding of an unfolded peptide in
conventional Tris-glycine SDS-PAGE
[401].
man origin of the EHD1 constructs. Our EHD1 full-length construct contained,
however, the mutation F2V (Fig. 10.1), which resides in a conserved region that
was recently found to be functionally important in the related isoform EHD2
[393] (see 11.2.2, p. 125 for further discussion). The final protein pools were
mainly homogeneous as assessed by SDS-PAGE (Fig. 10.2).
10.2. Syndapin1 and EHD1 Affect Membrane Shape
In Vitro
EGFP-tagged Syndapin1 overexpressed in COS7 cells was reported to be mainly
distributed in the cytoplasm, while the isolated F-BAR domain was located at
the membrane [130]. In a less complex in vitro-environment, Syndapin1 full-
length and the F-BAR domain can, however, both interact with liposomes [99–
101, 130]. It was hypothesised that this labile interaction of Syndapin1 full-
length with membranes is caused by its inability to form stabilising higher-
order oligomers in the closed conformation [130]. Nevertheless, it is also pos-
sible that phosphorylation of Syndapin1 is involved in its membrane targeting
in vivo [397, 402] and its assembly in specific oligomers [243] (see 11.1, p. 121
for discussion). The binding partner EHD1 was likewise reported to bind mem-
branes in vivo and in vitro [387, 391, 395].
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Figure 10.3.: Syndapin1 and EHD1 bind Folch I vesicles. SDS-PAGE of fractions from
liposome co-pelleting assay. 0.5 mg/ml sonicated Folch I liposomes (see Materi-
als and Methods 9.3.1, p. 107 for composition) were incubated with either 5 µM
Syndapin1 full-length (left), Syndapin1 F-BAR (middle), or EHD1 (right) and pel-
leted by centrifugation. SN: supernatant, Pe: pellet. The fraction in percent of pro-
tein in the pellet is indicated (100 % = SN% + Pe%), which was calculated from
duplicates.
As we intended to study the effect of the complex formation between these pro-
teins on artificial membranes, we carried out a control experiment in which we
tested binding of the individual proteins to our Folch I liposomes using a lipo-
some co-pelleting assay. We incorporated 1 % PtdIns(4,5)P2 in the Folch I lipid
mix, as this component was reported to be part of EHD1-containing tubules in
the endocytic recycling compartment [19, 403, 404]. Furthermore, PtdIns(4,5)P2
has been shown to increase Syndapin1-binding to PS in PC- and PE-containing
liposomes [101], which are all contained in the Folch I mix according to the
supplier’s analysis. As expected, the results demonstrated that Syndapin1 as
well as EHD1 were enriched in liposome-containing fractions (Fig. 10.3), in-
dicating that they also interacted with Folch I liposomes in our experimental
set-up. Additional experiments with the isolated F-BAR domain furthermore
revealed that the amount of membrane-associated Syndapin1 full-length and
the F-BAR domain differ by only 9 % (40 % compared to 49 %, Fig. 10.3), which
corroborated the results from Wang et al. [99] and Rao et al. [130].
The F-BAR domain of Syndapin1 can deform native and artificial membranes
into tubules [99, 100], but this activity is inhibited in the full-length protein [99,
130]. EHD proteins are ATPases [390, 405] and the isoform EHD2 was also
found to tubulate vesicles in vitro with increased efficiency in the presence of
ATP or ADP [390]. Whether EHD1 shares the ability to deform membranes
in vitro has not been studied in detail (see [395] for primary experiments), but
from cell-based experiments EHD1 is known to be important for the generation
of tubular recycling endosomes [387, 406] and their vesiculation [394, 395] in an
ATP-dependent manner [395]. To analyse the effect of Syndapin1 in conjunc-
tion with EHD1 on the shape of artificial membranes, we imaged Folch I lipo-
somes incubated with these proteins with transmission electron microscopy.
The microscopic analysis of the Folch I liposomes revealed that sonication pro-
duced liposomes with a broad range of sizes and therefore curvatures (Fig.
10.4A), which is consistent with data from Goh et al. [131]. To test our assay,
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Figure 10.4.: Syndapin1 is autoinhibited and tubule formation depends on release of
the F-BAR domain. Syndapin1 was reported to be autoinhibited [99, 130] through
binding of its SH3 domain to the F-BAR domain [130]. Deletion of the SH3 domain
and the linker promotes tubule formation. Representative transmission electron mi-
crographs of A: sonicated Folch I liposomes incubated with B: 10 µM Syndapin1, C:
10 µM Syndapin1 ∆SH3, and D: Syndapin1 F-BAR. Scale bar corresponds to 200 nm.
Samples were negatively stained with uranyl acetate.
we incubated the Folch I liposomes with full-length Syndapin1, which should
be autoinhibited [99], as well as truncated constructs thereof, which had been
reported to deform membranes in vitro [99, 130]. As expected, tubules were ab-
sent from samples that contained full-length Syndapin1 (Fig 10.4B), whereas we
observed tubule formation in samples with either Syndapin1∆SH3 (Fig. 10.4C)
or the isolated F-BAR domain (Fig. 10.4D). These findings are in line with the
autoinhibition model of Wang et al. [99] and Rao et al. [130] and demonstrated
that we successfully established the tubulation assay.
We next tested EHD1 in our assays and found that, similar to Syndapin1, EHD1
was unable to deform Folch I liposomes on its own (Fig. 10.5A and B, p. 113).
EHD1, however, strongly aggregated vesicles for unknown reasons. When we
incubated Folch I liposomes with both proteins at the same time, we observed
- in contrast to samples with the individual proteins - numerous tubules (Fig.
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Figure 10.5.: The Syndapin1-EHD1 complex tubulates liposomes in vitro. Represent-
ative transmission electron micrographs of sonicated Folch I liposomes incubated
with A: 10 µM Syndapin1, B: 10 µM EHD1 or C: both proteins. Scale bar corres-
ponds to 200 nm. Samples were negatively stained with uranyl acetate.
10.5C). Since this effect could also have been caused by the membrane inter-
action of the individual proteins independent of complex formation, we then
determined, whether the generation of tubules required binding of Syndapin1
to EHD1.
10.3. Influence of the Interaction Between
Syndapin1 and EHD1 on Tubule Formation
Using co-immunoprecipitation and pull-down experiments, Braun et al. [129]
had shown that the EH domain of EHD1 and the linker region of Syndapin1
containing the NPF motifs are necessary and sufficient for complex formation
between these proteins. Furthermore, mutation of either or both NPF motifs to
NPV abrogated binding to EHD1 in GST pull-downs [129].
In order to confirm that Syndapin1 and EHD1 used in our experiments indeed
form a direct complex, we carried out isothermal titrations with the purified
proteins. Our results demonstrated that Syndapin1 bound EHD1 with a Kd
of 18 µM (Tab. 10.1), which is in the same range as the published affinity of
the cognate Syndapin2-EHD2 complex (Kd = 37 µM [407]). A precise determ-
ination of the affinity and the stoichiometry of the Syndapin1-EHD1 complex
was, however, hampered by the fact that both proteins precipitated in each
other’s presence at the required high concentrations. With additional titrations
employing either a single EH domain of EHD1 or the NPF-containing linker
region of Syndapin1 (EHD1 EH and Syndapin1 Linker, Fig. 10.1, p. 109), we
could confirm that these regions are sufficient for complex formation (Tab. 10.1,
compare [129]). The determination of the stoichiometry of these complexes
yielded inconsistent results and ranged between 1:2 (one Syndapin1 molecule
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Table 10.1.: Thermodynamic data from isothermal titrations of Syndapin1 and
EHD1.
Syringe Component Conc. Cell Component Conc. Kd
a Na ∆Hobsa
[µM] [µM] [µM] [kcal/mol]
Syndapin1 180 EHD1 18 21c 0.23c -22
Syndapin1 Linkerb 300 EHD1 30 15 ± 4 0.6 ± 0.0 -4.5 ± 1.5
EHD1 EHb 300 Syndapin1 30 35 1.1 -7.7
EHD1 EH Syndapin1 mNPFb n. d.b n. d. n. d. n. d.
Syndapin1 Linker EHD1 W485A n. d. n. d. n. d. n. d.
a Analysis performed with single-site binding model; Kd = dissociation constant; N = stoichiometry
(syringe component to cell component); ∆H(obs) = observed binding enthalpy. Indicated is the
standard deviation between two independent experiments. This data set is preliminary and at the
time of writing several complexes had only been measured once.
b Syndapin1 Linker, residues 327-384, which contain NPF motifs; EH, Eps15-homology domain
(residues 438-534 of EHD1); Syndapin1 mNPF, full-length Syndapin1 with both NPF motifs
mutated to AAA; n. d., non detectable.
c Complex of full-length proteins precipitates and, for this reason, the parameters probably contain
considerable errors.
with two NPF motifs per EHD1 dimer) to 1:1 (one Syndapin1 per single EH
domain, Tab. 10.1). Titrations with mutated constructs, in which we either
replaced the NPF motifs by alanines (Syndapin1 mNPF, Fig. 10.1, p. 109) or
exchanged the conserved tryptophan in the EH domain-binding pocket with
alanine (EHD1 W485A, Fig. 10.1, p. 109, compare [72, 76]), revealed that the in-
teraction depended on a functional EH domain and the NPF motifs (Tab. 10.1).
We then asked whether tubule formation depended on the interaction between
EHD1 and Syndapin1 and, therefore, we repeated the electron microscopy as-
say with different binding-deficient mutants: First, we tested Syndapin1 mNPF
and found that, in contrast to wild-type Syndapin1, it occasionally deformed
Folch I liposomes into tubules (Fig. 10.6B, p. 116). This finding was probably
related to partial degradation of the construct (compare purification controls in
Fig. 10.2, p. 110), which partially released the autoinhibition of the F-BAR do-
main. Folch I liposomes incubated with Syndapin1 mNPF and wild-type EHD1
were significantly less tubulated (Fig. 10.6C, p. 116) compared to samples con-
taining both wild-type proteins (Fig. 10.6A, p. 116), and occasional tubules
likely originated from the activity of Syndapin1 mNPF alone. Therefore, tubule
formation by Syndapin1 in conjunction with EHD1 depended on the presence
of the NPF motifs.
In a second experiment, we tested the mutant EHD1 W485A and found that,
like wild-type EHD1, it was unable to form tubules (Fig. 10.6D, p. 116). More-
over, tubulation was significantly impaired, when EHD1 W485A was applied
together with wild-type Syndapin1 to liposomes (Fig. 10.6E, p. 116). From
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these experiments we concluded that a functional EH domain was required for
reshaping of the liposomes.
To confirm that the inability to generate tubules was indeed caused by the
absence of the protein-protein interaction and not simply by improperly fol-
ded mutant proteins, we carried out competition experiments employing the
Syndapin1 Linker, which was reported to interfere with the interaction of
Syndapin1 and EHD1 [129]. The Syndapin1 Linker itself was unable to induce
tubules in the electron microscopic assay (Fig. 10.6F, p. 116) and considerably
decreased the tubulating potential of the Syndapin1-EHD1 complex (Fig. 10.6A
and G, p. 116). Moreover, this linker region had to be applied in excess in or-
der to outcompete full-length Syndapin1, which suggested that Syndapin1 and
EHD1 stably interact with each other.
In summary, complex formation via the EH domain of EHD1 and the NPF mo-
tifs of Syndapin1 was required for the formation of tubules in our assays. Inter-
fering with this interaction by either mutating both NPF motifs to AAA or by
mutating the EH domain binding pocket efficiently blocked reshaping of the
vesicles.
10.4. Effect of a Single EH Domain of EHD1 on
Tubule Formation
In the previous experiments, we had employed full-length constructs of
Syndapin1 as well as EHD1 and both proteins interacted with our vesicles (see
above). Since we wanted to focus on the investigation of the morphogenic po-
tential of Syndapin1, but not EHD1, on artificial membranes, we needed to rule
out an influence of membrane-tethering through EHD1 on tubule formation.
Therefore, we restricted subsequent assays to the single EH domain and asked,
whether it was sufficient to drive the observed membrane rearrangements to-
gether with Syndapin1.
However, the EH domain of EHD1 has been reported to interact with phos-
phorylated phosphatidylinositols and phosphatidic acid [403, 408]. Folch I ex-
tracts indeed contain phosphatidylinositol phosphates [409], mainly
PtdIns(4,5)P2 [410], and also phosphatidic acid (according to supplier’s ana-
lysis). Therefore, we tested whether the EH domain of EHD1 also binds to
our Folch I vesicles. Employing the liposome co-pelleting assay, we could
demonstrate that the isolated EHD1 EH domain was not enriched in liposome-
containing fractions (Fig. 10.7, p. 117) and, thus, unable to bind to Folch I
vesicles in the employed concentration range. For this reason, membrane re-
shaping in subsequent assays should presumably have originated from the in-
teraction of Syndapin1 with the liposomes.
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Figure 10.6.: The interaction between Syndapin1 and EHD1 is required for tu-
bule formation in vitro. Representative transmission electron micrographs of
Folch liposomes incubated with A: 10 µM Syndapin1 and 10 µM EHD1, B: 10 µM
Syndapin1 mNPF (NPF motifs mutated to AAA), C: 10 µM Syndapin1 mNPF and
10 µM EHD1, D: 10 µM EHD1 W485A (inactivated EH domain), E: 10 µM Syndapin1
and 10 µM EHD1 W485A, F: 1000 µM Syndapin1 Linker (region containing NPF mo-
tifs), G: 10 µM Syndapin1, 10 µM EHD1, and 1000 µM Syndapin1 Linker. Scale bar
corresponds to 200 nm. Samples were negatively stained with uranyl acetate.
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Figure 10.7.: The EH domain of EHD1 is unable
to bind Folch I vesicles. SDS-PAGE of fractions
from liposome co-pelleting assay. 0.5 mg/ml sonic-
ated Folch I liposomes were incubated with 100 µM
EHD1 EH domain and pelleted by centrifugation.
SN: supernatant, Pe: pellet. The fraction in percent
of protein in the pellet is indicated (100 % = SN% +
Pe%), which was calculated from duplicates.
We then incubated Folch I liposomes with Syndapin1 and the EH domain of
EHD1 and found that tubules were present, similar to samples with the full-
length proteins (Fig. 10.8B, p. 118). On the contrary, the EH domain alone
was unable to deform the vesicles (Fig. 10.8A, p. 118). Therefore, it can be
concluded that a single EH domain of EHD1 in complex with Syndapin1 is
sufficient for tubulation. The EH domain was, however, less effective than full-
length EHD1 (see 11.2.2, p. 125 for discussion). Employing the liposome co-
pelleting assay, we could show that the amount of Syndapin1 in the liposome-
containing fraction increased only by 3 % in presence of the EH domain (data
not shown), indicating that tubule formation was not caused by increased mem-
brane-targeting of Syndapin1.
Since Folch I lipids are natural extracts with a large batch-to-batch variability,
we wanted to confirm our results with a synthetic lipid mixture of known com-
position resembling internal membranes (Endomix, compare methods section
9.3.1, p. 107, composition determined by the lab of Felix Wieland, Heidelberg).
Syndapin1 and EHD1 similarly interacted with the Endomix liposomes (data
not shown) and we then carried out the tubulation assay with these vesicles.
We found that, similar to our results with Folch I liposomes, tubules were ab-
sent from incubations with Syndapin1 full-length (Fig. 10.9B, p. 119), while the
F-BAR domain produced numerous tubules (Fig. 10.9C, p. 119). In contrast to
our results with Folch I vesicles, we observed additional membrane topologies
in samples with Endomix liposomes and the isolated F-BAR domain: striated
tubules (Fig. 10.9C, p. 119, inset) and small vesicles with a diameter of 36 nm
(quantification not shown).
We next tested, whether the EH domain of EHD1 was also able to induce tubule
formation by Syndapin1 full-length with Endomix liposomes. The EH domain
of EHD1 alone had no effect on the shape of Endomix vesicles at these higher
concentrations (data not shown). Employing a series of EH domain concen-
trations, we showed that the Syndapin1-EHD1 EH complex likewise tubulated
our synthetic liposomes and that tubule abundance was positively correlated
with the concentration of the EH domain (Fig. 10.9D-E, p. 119). A reasonable
explanation for this finding is that increasing amounts of Syndapin1 are found
in complex with the EH domain. Due to the low affinity of the interaction, the
EH domain had to be applied in excess (compare ITC data, Tab. 10.1, p. 114).
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Figure 10.8.: A single EH domain of EHD1 in complex with Syndapin1 is sufficient
for tubule formation in vitro. Representative transmission electron micrographs of
sonicated Folch I liposomes incubated with A: 300 µM EHD1 EH domain and B:
10 µM Syndapin1 and 300 µM EHD1 EH domain. Scale bar corresponds to 200 nm.
Samples were negatively stained with uranyl acetate.
Furthermore, a quantification of Endomix tubule diameters revealed that the
tubules formed by the complex of Syndapin1 and EHD1 EH were wider than
the tubules formed by the F-BAR domain alone (130 nm compared to 112 nm,
respectively, p < 0.001 in Mann-Whitney Rank Sum Test, Fig. 10.10, p. 119). On
Folch I liposomes, the F-BAR domain generated tubules with a similar diameter
(99 nm, data not shown).
From these results, we concluded that binding of the EH domain of EHD1 to
the NPF motifs of Syndapin1 likely opens up the autoinhibitory conformation
and that this alternative route for the activation of Syndapin1 is independent of
ligand-binding to the SH3 domain (compare [130]).
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Figure 10.9.: Tubule abundance is positively correlated with the concentration of
EHD1 EH. Representative transmission electron micrographs of A: sonicated Endo-
mix liposomes, incubated with B: 10 µM Syndapin1, C: 10 µM Syndapin1 F-BAR (the
inset shows a close-up of a striated tubule), D-E: 10 µM Syndapin1 and 100/400/
800 µM EHD1 EH domain. Scale bar corresponds to 200 nm. Samples were negat-
ively stained with uranyl acetate.
Figure 10.10.: Quantification of tubule diameters generated by different Syndapin1
constructs. Diameters of tubules formed by Syndapin1 F-BAR (left) as well as
Syndapin1 full-length in complex with EHD1 EH (right) on Endomix liposomes and
imaged with transmission electron microscopy were measured with Fiji [204] and
statistically analysed with SigmaPlot (version 12.3, Systat Software Inc.). The red
line denotes the median and the blue line the 75%ile.
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The membrane system of eukaryotic cells undergoes constant remodelling to
realise a certain cellular morphology, to exchange material with the environ-
ment and between different cellular compartments, or to transmit signals bet-
ween or within cells [27]. For these purposes, membranes need to be bent, for
example, into tubular structures, separated by vesiculation, or interconnected
through fusion events [27]. Membrane reshaping is considered to be an active
process driven by a finely tuned interplay between membrane-interacting pro-
teins, the lipid composition, and the actin cytoskeleton [29, 30]. The BAR do-
main superfamily of proteins depict such membrane-interacting scaffolds that
can stabilise and/or induce curvature [92] and that have been implicated in
various aspects of membrane rearrangements [30].
All BAR domains share the ability to form rigid dimers with an intrinsically
curved membrane-interaction surface that is positively charged and enables
binding to negatively charged phospholipid-headgroups via electrostatic inter-
actions [30, 95, 98, 99, 103]. It is generally believed that they induce or stabilise
different membrane shapes by a scaffolding mechanism, in which the degree
of membrane bending corresponds to the overall topology of their intrinsic
curvature (compare introduction on BAR domains, 1.1.3, p. 6) [27, 95].
11.1. Tubule Formation by the F-BAR Domain of
Syndapin1
From a structural perspective, the F-BAR domains of Syndapins represent a
unique subgroup within the BAR domain superfamily, since the tips are strong-
ly bent away from the central helical bundle, thereby realising an S-shape (Fig.
8.1, p. 101), which is in principle able to support two types of curvatures [92,
99]. The wedge loop, which is an additional membrane-interacting feature and
believed to insert into one leaflet of the bilayer, acts in concert with the concave
surface to drive membrane rearrangements (see introduction, Fig. 8.1, p. 101)
[99]. This structural model was substantiated by the versatile deformation po-
tential that the F-BAR domain of Syndapin1 displays on artificial liposomes: It
was found to form tubules with different diameters (98 nm and 17 nm), as well
as small vesicles with a diameter of 31 nm [99, 131]. Disrupting the membrane
association by introducing mutations into either the curved interaction surface
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or the wedge loop abrogated tubulation as well as vesiculation [99]. In our
experiments, the isolated F-BAR domain of Syndapin1 produced only wide tu-
bules on Folch I liposomes (99 nm) and wide tubules (112 nm) as well as small
vesicles (36 nm) with our synthetic lipid mix (Fig. 10.4, p. 112 and Fig. 10.9,
p. 119).
Why did we observe different membrane morphologies dependend on the em-
ployed lipid mix and compared to published results? It was reported that
the composition and curvature of the liposomes as well as the precise exper-
imental conditions can influence the ability of the F-BAR domain to support
different membrane shapes [99, 131], which likely explains these heterogen-
eous results. Folch lipids are, for example, natural extracts with a large batch-
to-batch variability and differences in lipid compositions will alter the mechan-
ical properties of the artificial membrane [30, 131]. This, in turn, will influence
Syndapin1’s membrane-bending ability [30, 131] and might explain why Wang
et al. [99] observed different morphologies with Folch I liposomes. Further-
more, it is known that the initial size and lamellarity and, thus, the elasticity
of the liposomal membrane can affect the outcome of tubulation assays with
Syndapin1 [131]: Usage of smaller vesicles (50 to 200 nm) as starting material
was, for example, found to support vesiculation through the F-BAR domain,
whereas larger vesicles promoted the formation of wide tubules [99]. Therefore,
differences in the size distribution and lamellarity of the vesicles between our
and published assays [99], which are difficult to control in different sonication
set-ups, could also have contributed to the variability in produced curvatures.
Furthermore, F-BAR domains bind to the membrane mainly through electro-
static contacts, which renders their deformation activity highly salt dependent
[130, 131]. The higher ionic strength of our assay buffer compared to Wang
et al. [99] and Goh et al. [131] (150 mM NaCl and 50 mM NaCl, respectively)
could likewise account for the observed differences. Therefore, in vitro tubu-
lation should be tested under several conditions in order to be able to elimin-
ate effects originating from a specific experimental set-up. However, despite
these shortcomings, in vitro assays employing artificial membranes together
with structural analyses have proven to be valuable tools in the investigation
of BAR domain-mediated membrane sculpting.
In addition to the unique geometry of Syndapin1’s F-BAR domain with its two
inherent curvatures, the bending angle of the F-BAR homodimer can be mod-
ulated by phosphorylation [243], which brings another level of complexity to
Syndapin’s ability to support different membrane shapes in vivo. Although our
construct expressed in E. coli was not phosphorylated (assessed by mass spec-
trometry, data not shown), we cannot exclude the possibility that phosphoryla-
tion of the F-BAR domain in published assays [99, 131] caused the observed
differences. Moreover, phosphorylation of the F-BAR domain was suggested to
regulate lateral inter-dimer contacts [243], and arrangement into specific higher
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order oligomers, such as spirals, sheets, or chains, on the membrane is gen-
erally believed to drive BAR domain-mediated membrane deformation [30,
97, 130, 131]. Indeed, in cryo-electron microscopy-based reconstructions the
F-BAR domains of Cip4 and FBP17 [97, 109], as well as the N-BAR domain of
Endophilin-A1 [110], were arranged in spiral-like lattices on tubules [30]. Im-
portantly, under certain experimental conditions we and others have observed
striated tubules with the F-BAR domain of Syndapin1 (Fig. 10.9C, inset, p. 119)
[99], which indicate such ordered arrangements [97, 109, 110].
Finally, such higher order structures can be stabilised by lateral and tip-to-tip
contacts between adjacent dimers, as demonstrated for the F-BAR domain of
Cip4 [97]. Tip-to-tip interactions have also been suggested to be important
for the oligomerisation of the Syndapin2 F-BAR domain [411] and its tubula-
tion activity [412]. Although direct evidence for similar inter-dimer contacts in
Syndapin1 is still missing, it is clear that many Syndapin1 dimers need to act in
concert to induce or stabilise a certain membrane curvature [92]. Whether the
F-BAR domain of Syndapin1 actively generates curvature in vivo or is simply
required to stabilise curved membrane topologies formed by other proteins, is
still an open question, but its tight regulation through the SH3 domain (see
subsequent section) and phosphorylation might argue for an active contribu-
tion [30].
11.2. The Extended Autoinhibition Model of
Syndapin1
11.2.1. Binding to the SH3 Domain
Many BAR domain proteins involved in endocytic processes harbour an SH3
domain for the interaction with or the recruitment of other endocytic coat com-
ponents [27], but so far only the SH3 domain of Syndapin1 has been shown to
serve additional autoregulatory purposes [30, 99, 130]. In the closed state, the
SH3 domain folds back onto the F-BAR domain, thereby inhibiting its mem-
brane sculpting activity [130] (Fig. 11.1, p. 124). This model is consistent with
our finding that Syndapin1 full-length is unable to deform vesicles, whereas
the isolated F-BAR domain and a truncated construct lacking the SH3 domain
potently induce tubulation (Fig. 10.4, p. 112). This autoinhibitory clamp was
shown to be released by binding of the proline-rich region of Dynamin1 to the
SH3 domain, thereby probably displacing it from the F-BAR domain (Fig. 11.1,
p. 124) [130, 131].
How the activity is released upon displacement of the SH3 domain is not imme-
diately clear from the available data [131]. In the closed conformation,
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Figure 11.1.: Extended model for the release of the autoinhibition of Syndapin1. The
membrane deforming potential of the F-BAR domain of Syndapin1 is released either
upon binding of ligands to the SH3 domain, e. g. Dynamin1 (via its PRD, proline-
rich domain) [130] or binding of EHD1 (via its EH domain) to the NPF motifs.
Whether the SH3 domain is displaced in the Syndapin1-EHD1 complex is unclear
and therefore two possible positions are indicated. Figure adapted from Rao et al.
[130].
Syndapin1 is likewise able to associate with artificial membranes, as demon-
strated by our and published liposome binding assays [99, 101, 130, 131]. In-
stead, it was hypothesised that displacing the SH3 domain releases conform-
ational restraints [130] and triggers the formation of the aforementioned func-
tional higher order assemblies [30, 130, 131]. In fact, SH3 domain-mediated reg-
ulation of BAR modules might be more widespread than initially anticipated:
Recent data on the N-BAR proteins Endophilin and Amphiphysin suggest that
their ability to associate with membranes is inhibited in the full-length context,
but released upon binding of Dynamin’s proline-rich region to the SH3 domain
(compare introduction on endocytosis, Fig. 1.4, p. 12) [119]. Moreover, binding
of N-WASP to the SH3 domain of SNX9 was also proposed to open an autoin-
hibtory clamp [27, 413].
11.2.2. Binding to the NPF Motifs
In this project, we investigated the effect of complex formation between
Syndapin1 and EHD1 on the membrane-deforming activity of Syndapin1.
EHD1 possesses an EH domain, which was reported to interact with both NPF
motifs of Syndapin1 in pull-down experiments [129] and these motifs are loc-
ated in the flexible linker connecting the F-BAR domain and the SH3 domain
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(Fig. 11.1). Through isothermal titrations, we were able to show that this inter-
action is indeed direct and dependent on the EH/NPF modules. The affinity
of the interaction between Syndapin1 and EHD1 (Kd = 15-35 µM) was similar
to the published affinity of a related complex between Syndapin2 and EHD2
(Kd = 37 µM, [407]). Although the interaction is in the expected low affinity
range of EH domain-mediated complexes (our unpublished data and reviewed
in [69]), the complex might become stabilised under native conditions through
membrane tethering of both proteins [131, 289], which could in turn also lead
to mutual enhanced membrane binding. However, whether the two proteins
reciprocally recruit each other could not be tested with our co-pelleting assay,
since the complex precipitated in the absence of membranes. Floatation of lipo-
somes in sucrose gradients [101] constitutes an alternative approach to measure
enhancement, but giant unilamellar vesicles, which can be observed with con-
ventional fluorescence microscopy, should provide the optimal platform to ana-
lyse the time-dependent recruitment of the two proteins to membranes [119].
With our electron microscopic assay, we showed that binding of the EH domain
of EHD1 to the NPF motifs is sufficient and required to unlock Syndapin1’s tu-
bulation activity on Folch I as well as Endomix vesicles (Fig. 11.1, p. 124).
The generated curvatures likely originated from an interaction of Syndapin1
with the vesicles, since the EH domain failed to associate with the Folch I or
Endomix liposomes on its own. However, the EH domain of EHD1 was repor-
ted to bind membranes [403, 408] and the Folch I extract should (according to
the supplier’s analysis) contain lipids recognised by this domain, specifically
phosphatidic acid [408]. The concentration of these lipids might have been in-
sufficient to allow recruitment of the EH domain. Since the presence of the EH
domain did not increase membrane recruitment of Syndapin1 (compare res-
ults, p. 117), we can furthermore exclude that tubule formation resulted from
protein crowding on our vesicles, which has been shown to cause tubulation in
vitro (compare [414]).
Although the EH domain was sufficient for tubulation, a complex between the
two full-length proteins was much more potent in generating tubules com-
pared to the Syndapin1-EH complex. This might have been related to more
efficient membrane-targeting of Syndapin1 through the interaction of EHD1
with the vesicles (Fig. 10.3, p. 111). The isoform EHD2 was proposed to as-
semble in ring-like fashion around membrane tubes, thereby promoting tubule
formation (compare introduction, Fig. 8.3, p. 103) [390, 393], but whether EHD1
shares this ability is unclear. However, although EHD1 failed to produce tu-
bules on its own, it is possible that - through a structured assembly guided by
Syndapin1 - the two proteins acted in concert to drive membrane deformation.
Furthermore, EHD proteins are ATPases and were suggested to promote ves-
icle scission similar to Dynamins (compare introduction on endocytosis, Fig.
1.4, p. 12) [390]. In particular, EHD1 has been implicated in the exit of recycling
vesicles from endosomal compartments (compare introduction on endosomal
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recycling, Fig. 1.1, p. 3) [394, 395] and this function might depend on its ATPase
activity [395]. Therefore, nucleotide addition in our assays might not only alter
the morphogenic potential of EHD1 itself, but also that of the Syndapin1-EHD1
complex.
Unfortunately, we could not exclude the possibility that our results were influ-
enced by the mutation F2V at the N-terminus of our EHD1 construct, which
might be of functional importance: In EHD2, this residue is part of a conserved
stretch of amino acids, which constitutes a secondary membrane interaction site
and promotes a highly ordered arrangement of the EHD2 coat on membranes,
yet is not required for EHD2-mediated tubulation in general [393]. However,
whether this region also regulates the oligomeric assembly of EHD1 remains to
be shown.
How could binding of the EH domain to the linker activate the tubulation activ-
ity of the Syndapin1 F-BAR domain? Our results of the isothermal titrations
suggested that the NPF motifs were accessible in the full-length context, since
the affinities of Syndapin1 full-length and Syndapin1 Linker for EHD1 were
comparable (Tab. 10.1, p. 114). Furthermore, the linker was invisible in the
crystal structure also implying that it is rather flexible [130]. Therefore, it is not
obvious why ligand binding to the NPF motifs would release the autoinhibitory
clamp. As the second NPF motif is positioned close to the SH3 domain bound-
ary, one possibility would be a displacement mechanism via steric hindrance.
Since the buried surface area between the F-BAR domain and the SH3 domain
is small (460 A˚, [130]) and, thus, the interaction expected to be weak [130, 131],
binding to the NPF motifs - especially in the context of a stabilised protein com-
plex on the membrane - might be sufficient to displace the SH3 domain. An-
other possibility is that the linker becomes structured upon EH-domain bind-
ing, thereby adopting a conformation that is incompatible with autoinhibition
[415].
Another open question is the precise function of the NPF-containing linker
region in the autoinhibition. It has been reported that Syndapin1 ∆SH3 is
not as potent in deforming vesicles as the isolated F-BAR domain [130, 131].
Moreover, the different human Syndapin isoforms exhibit varying degrees of
autoinhibition in the full-length context [131]: Whereas Syndapin1 is inhib-
ited and Syndapin2 shows impaired activity compared to its isolated F-BAR
domain, Syndapin3 is fully active. It was hypothesised that not only struc-
tural differences between the F-BAR domains, but also the variability in the
amino acid sequence and length of the linker regions could contribute to the
observed differences between Syndapin isoforms [131]. Hence, the variable
region might be required to establish the full autoregulatory conformation of
Syndapin1, possibly binding to the F-BAR domain itself. Binding of the EH do-
main could then trigger a conformational change in the linker, thereby allowing
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Syndapin1 to form functional assemblies. Indeed, our initial experiments sup-
port this hypothesis, as Syndapin1 ∆SH3 was less potent in deforming vesicles,
which is consistent with reported data [99, 131], but exhibited increasing activ-
ity when incubated with increasing concentrations of the EH domain (data not
shown). Moreover, initial NMR-based studies also revealed a potential direct
interaction between the linker region and the F-BAR domain, which could be
outcompeted by the addition of the EH domain (data not shown). Additional
experiments are required to confirm these results.
In summary, we have identified an alternative path to release the autoinhibit-
ory conformation of Syndapin1 by binding of EHD1 to the NPF motifs in the
variable linker region. This route of Syndapin1 activation is independent of
ligand-binding to the SH3 domain and, although the underlying mechanisms
remains unclear, we have uncovered an unexpected function of the NPF motifs
in regulating membrane scaffolding by the F-BAR domain.
11.2.3. Membrane Deformation by Activated Syndapin1
The membrane sculpting potential of activated Syndapin1 was reported to be
as diverse as that of the isolated F-BAR domain [131]: Binding of a small pep-
tide derived from the proline-rich region of Dynamin1 to the SH3 domain pro-
moted the formation of tubules [130], whereas binding of its full proline-rich
region led to prominent vesiculation [131]. It was suggested that these dispar-
ate results originated from an additional membrane contact provided by the
full proline-rich region of Dynamin1 itself, which interacted with liposomes
through a polybasic stretch [131]. On the other hand, we found that binding
of the EHD1 EH domain to the NPF motifs leads to the formation of tubules
with a wider diameter than those formed by the F-BAR domain alone (130 nm
compared to 112 nm, respectively; Fig. 10.10, p. 119). Therefore, it is likely that
opening of the autoinhibitory clamp of Syndapin1 results in the formation of
a number of different lattices and their architecture might depend on inherent
features of the F-BAR domain as well as modulation through binding partners,
the lipid composition of the membrane, or phosphorylation [30, 131, 243]. Reg-
ulation of the F-BAR coat geometry through binding partners would also en-
sure the formation of context-specific lattices and, hence, membrane topologies
that are tailored to specific steps in the respective cellular process.
Under in vitro conditions, activated Syndapin1 seems to support tubules with
wide, as well as narrow diameters down to the point where spontaneous vesi-
culation occurs, which is indicated by the formation of small vesicles [131].
This is in line with the current model of membrane invagination, neck constric-
tion and subsequent vesicle fission in endocytic processes (compare introduc-
tion on endocytosis, 1.2.1, p. 10) [27, 92]. Although we only observed wide
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tubules in our assays, nucleotide addition and a concerted action of EHD1
might allow the assembly of different lattices and thereby promote constric-
tion. However, it is questionable whether under more physiological conditions
a complex between Syndapin1 and EHD1 is sufficient to drive membrane de-
formation or even vesiculation of endosomal membranes. This energetically
expensive process might instead require the recruitment of additional factors,
such as N-WASP, which triggers actin polymerisation [124, 416] and interacts
with Syndapin1 (see introductory section 8 on functions of Syndapin1, p. 99)
[369, 375]. In fact, Syndapin1 is known to interconnect the endocytic machinery
with the actin cytoskeleton [371, 400] and, although the precise function of the
Syndapin1-EHD1 complex in neurons remains unclear, Syndapin1 might serve
similar functions in EHD1-mediated membrane rearrangements.
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In this thesis, I have presented two projects on F-BAR domain-containing pro-
teins, of which the starting points were, admittedly, rather different: The first
project aimed at the identification of binding partners for a previously unchar-
acterised variable region, while the second project aimed at elucidating the
functional implication of a known complex mediated by linear motifs in a flex-
ible linker:
In the first part, I have provided evidence that the C-terminal region of srGAP
proteins is likely to be intrinsically disordered and acts as a versatile bind-
ing platform through contained linear motifs. Via the identified interactions,
srGAP3 is not only linked to the endocytic machinery as well as the Ras sig-
nalling cascade, but might also connect with yet to be identified pathways via
14-3-3 proteins. Furthermore, I have shown that this region is highly phos-
phorylated and that phosphorylation modulates the association with 14-3-3
proteins. In this sense, the C-terminal region of srGAP3 exhibits a broader
binding spectrum than classical adaptor domains and presents typical features
of intrinsically disordered segments of signalling proteins: the potential for sig-
nal integration and cross-talk between different pathways as well as mutability
through phosphoregulation [36, 37].
In the second part, I have shown that the autoinhibition of the F-BAR domain
of Syndapin1 can not only be released through binding of ligands to the SH3
domain, but also via binding of the EH domain of EHD1 to the NPF motifs.
Furthermore, I have found an additional type of curvature supported by ac-
tivated Syndapin1, which provides yet another example of its versatile mem-
brane deforming ability. From these results, we can draw the conclusion that,
although the underlying mechanism of membrane rearrangements driven by
the Syndapin1-EHD1 complex are still unclear, the activation of Syndapin1’s
membrane sculpting activity upon binding of EHD1 likely constitutes an im-
portant step.
At first sight, the presented results seem unrelated to each other, but we might
reduce them to the following common denominators: In both projects, the iden-
tified linear motifs seem to hold functions in the recruitment and/or scaffold-
ing of other proteins. SrGAP3 could recruit endocytic factors or the Ras sig-
nalling proteins, but might also be required for interconnecting upstream re-
ceptors with these machineries. The same applies to Syndapin1, which might
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not only arrange EHD1 in specific oligomers, but could also recruit this pro-
tein to specific membranes similar to the function of Syndapin2 in recruiting
EHD1 to the tubular recycling endosome [406]. Moreover, the NPF motifs of
Syndapin1 carry an implicit role in regulating the activity of the N-terminal
F-BAR domain through binding to EHD1. Similarly, the 14-3-3-binding sites in
the C-terminal region of srGAP3 could serve indirect regulatory purposes re-
garding the availability of binding sites, the stability, or the localisation of the
protein, which are typical functional outputs of 14-3-3 interactions [81]. All of
these linear motifs are located in intrinsically disordered regions and this aspect
might be important for their ability to establish certain regulatory states, as un-
structured segments are especially tailored to enable switch-like behaviour [49,
415].
Finally, I have provided the first example for an association between N-BAR
domain proteins (Endophilins and Amphiphysin), which promote membrane
invaginations [95, 96], with a specific subgroup of F-BAR proteins, which are
implicated in the formation of protrusions [154, 156]. If srGAP3 indeed recruits
the endocytic machinery for receptor internalisation, how could we envision
the formation of the endocytic pit mechanistically? On the one hand, this pro-
cess might require a temporary inhibition of the F-BAR’s counteracting activity.
On the other hand, it could be possible that the F-BAR domain of srGAP3 car-
ries an unexpected flexibility in stabilising different membrane shapes similar
to the diverse effects of Syndapins. In fact, the F-BAR domain of srGAP pro-
teins has been suggested to be autoregulated through regions located down-
stream [156, 417] and regulation of F-BAR domains through interdomain-con-
tacts could be another unifying principle underlying the functions of Syndapin1
and srGAP3.
130
Bibliography
[1] T. Jessell and E. R. Kandel. “Synaptic transmission: a bidirectional and
self-modifiable form of cell-cell communication”. In: Cell (1993), pp. 1–
30.
[2] Y.-N. Jan and L. Y. Jan. “Branching out: mechanisms of dendritic arbor-
ization”. In: Nat. Rev. Neurosci. (2010), pp. 316–328.
[3] B. Winckler and I. Mellman. “Trafficking guidance receptors.” In: Cold
Spring Harbor Perspec. Biol. (2010), a001826.
[4] J. Del Castillo and B. Katz. “Quantal components of the end-plate po-
tential”. In: J. Physiol. (1954), pp. 560–573.
[5] J. Del Castillo and B. Katz. “Biophysical aspects of neuro-muscular
transmission.” In: Prog. Biophys. Biop. Ch. (1955), pp. 121–170.
[6] V. Whittaker and M. Sheridan. “The morphology and acetylcholine con-
tent of isolated cerebral cortical synaptic vesicles”. In: J. Neurochem.
(1965), pp. 363–372.
[7] V. Whittaker, I. Michaelson and R. J. A. Kirkland. “The separation of
synaptic vesicles from nerve-ending particles (synaptosomes’)”. In: Bio-
chem. J. (1964), p. 293.
[8] K. Takei et al. “The synaptic vesicle cycle: a single vesicle budding step
involving clathrin and dynamin.” In: J. Cell Biol. (1996), pp. 1237–1250.
[9] Q. Zhang, Y. Li and R. W. Tsien. “The dynamic control of kiss-and-run
and vesicular reuse probed with single nanoparticles”. In: Science (2009),
pp. 1448–1453.
[10] E. L. Clayton, G. J. Evans and M. A. Cousin. “Bulk synaptic vesicle en-
docytosis is rapidly triggered during strong stimulation”. In: J. Neurosci.
(2008), pp. 6627–6632.
[11] P. Hoopmann et al. “Endosomal sorting of readily releasable synaptic
vesicles”. In: Proc. Natl. Acad. Sci. U. S. A. (2010), pp. 19055–19060.
[12] S. Watanabe et al. “Ultrafast endocytosis at mouse hippocampal syn-
apses.” In: Nature (2013), pp. 242–7.
[13] J. Allen and J. K. Chilton. “The specific targeting of guidance receptors
within neurons: who directs the directors?” In: Dev. Biol. (2009), pp. 4–
11.
131
Bibliography
[14] M.-P. Fache et al. “Endocytotic elimination and domain-selective tether-
ing constitute a potential mechanism of protein segregation at the ax-
onal initial segment”. In: J. Cell Biol. (2004), pp. 571–578.
[15] J. J. Garrido et al. “Dynamic compartmentalization of the voltage-gated
sodium channels in axons”. In: Biol. Cell (2003), pp. 437–445.
[16] M. Piper et al. “Endocytosis-dependent desensitization and protein
synthesis–dependent resensitization in retinal growth cone adaptation”.
In: Nat. Neurosci. (2005), pp. 179–186.
[17] G. J. Bashaw and R. Klein. “Signaling from axon guidance receptors.”
In: Cold Spring Harbor Perspec. Biol. (2010), a001941.
[18] C. C. Yap and B. Winckler. “Harnessing the power of the endosome to
regulate neural development.” In: Neuron (2012), pp. 1–12.
[19] B. D. Grant and J. G. Donaldson. “Pathways and mechanisms of endo-
cytic recycling”. In: Nat. Rev. Mol. Cell Biol. (2009), pp. 597–608.
[20] C. D’Souza-Schorey and P. Chavrier. “ARF proteins: roles in membrane
traffic and beyond”. In: Nat. Rev. Mol. Cell Biol. (2006), pp. 347–358.
[21] I. Jordens et al. “Rab proteins, connecting transport and vesicle fusion”.
In: Traffic (2005), pp. 1070–1077.
[22] J. Zhang, N. Naslavsky and S. Caplan. “Rabs and EHDs: alternate modes
for traffic control”. In: Bioscience reports (2012), pp. 17–23.
[23] F. R. Maxfield and T. E. McGraw. “Endocytic recycling”. In: Nat. Rev.
Mol. Cell Biol. (2004), pp. 121–132.
[24] J. Gruenberg and H. Stenmark. “The biogenesis of multivesicular endo-
somes”. In: Nat. Rev. Mol. Cell Biol. (2004), pp. 317–323.
[25] M. J. Kennedy and M. D. Ehlers. “Organelles and trafficking machinery
for postsynaptic plasticity”. In: Annu. Rev. Neurosci. (2006), p. 325.
[26] V. W. Hsu, M. Bai and J. Li. “Getting active: protein sorting in endocytic
recycling”. In: Nat. Rev. Mol. Cell Biol. (2012), pp. 323–328.
[27] O. Daumke, A. Roux and V. Haucke. “BAR Domain Scaffolds in
Dynamin-Mediated Membrane Fission.” In: Cell (2014), pp. 882–892.
[28] M. M. Kozlov, H. T. McMahon and L. V. Chernomordik. “Protein-driven
membrane stresses in fusion and fission.” In: Trends Biochem. Sci. (2010),
pp. 1–8.
[29] H. T. McMahon and J. L. Gallop. “Membrane curvature and mechanisms
of dynamic cell membrane remodelling.” In: Nature (2005), pp. 590–6.
[30] S. Suetsugu, S. Kurisu and T. Takenawa. “Dynamic Shaping of Cellular
Membranes by Phospholipids and Membrane-Deforming Proteins”. In:
Physiol. Rev. (2014), pp. 1219–1248.
132
Bibliography
[31] H. Wu. “Higher-order assemblies in a new paradigm of signal transduc-
tion.” In: Cell (2013), pp. 287–92.
[32] T. Pawson and P. Nash. “Assembly of cell regulatory systems through
protein interaction domains.” In: Science (2003), pp. 445–52.
[33] T. Pawson and P. Nash. “Protein-protein interactions define specificity
in signal transduction.” In: Genes Dev. (2000), pp. 1027–47.
[34] H. J. Dyson and P. E. Wright. “Intrinsically unstructured proteins and
their functions”. In: Nat. Rev. Mol. Cell Biol. (2005), pp. 197–208.
[35] L. M. Iakoucheva et al. “Intrinsic disorder in cell-signaling and cancer-
associated proteins.” In: J. Mol. Biol. (2002), pp. 573–84.
[36] J. R. Perkins et al. “Transient protein-protein interactions: structural,
functional, and network properties.” In: Structure (2010), pp. 1–11.
[37] R. van der Lee et al. “Classification of Intrinsically Disordered Regions
and Proteins.” In: Chem. Rev. (2014), pp. 6589–6631.
[38] W. Bode, P. Schwager and R. Huber. “The transition of bovine trypsino-
gen to a trypsin-like state upon strong ligand binding: The refined
crystal structures of the bovine trypsinogen-pancreatic trypsin inhibitor
complex and of its ternary complex with Ile-Val at 1.9 Å resolution”. In:
J. Mol. Biol. (1978), pp. 99–112.
[39] A. Bloomer et al. “Protein disk of tobacco mosaic virus at 2.8 Å resolu-
tion showing the interactions within and between subunits”. In: Nature
(1978), pp. 362–368.
[40] A. K. Dunker et al. “Intrinsically disordered protein”. In: J. Mol. Graph.
Model. (2001), pp. 26–59.
[41] P. Romero et al. “Identifying disordered regions in proteins from amino
acid sequence”. In: Int. Conference Neural Networks, 1997. IEEE. 1997,
pp. 90–95.
[42] V. N. Uversky, J. R. Gillespie and A. L. Fink. “Why are “natively unfol-
ded” proteins unstructured under physiologic conditions?” In: Proteins:
Struct., Funct., Bioinf. (2000), pp. 415–427.
[43] V. N. Uversky and A. K. Dunker. “The case for intrinsically disordered
proteins playing contributory roles in molecular recognition without a
stable 3D structure”. In: F1000 Biol. Rep. (2013).
[44] V. N. Uversky and A. K. Dunker. “Understanding protein non-folding”.
In: Biochim. Biophys. Acta, Proteins Proteomics (2010), pp. 1231–1264.
[45] F. Diella et al. “Understanding eukaryotic linear motifs and their role in
cell signaling and regulation.” In: Front. Biosci. (2008), pp. 6580–603.
[46] R. J. Weatheritt and T. J. Gibson. “Linear motifs: lost in (pre)translation.”
In: Trends Biochem. Sci. (2012), pp. 333–41.
133
Bibliography
[47] N. E. Davey et al. “Attributes of short linear motifs.” In: Mol. Biosyst.
(2012), pp. 268–81.
[48] T. J. Gibson. “Cell regulation: determined to signal discrete coopera-
tion.” In: Trends Biochem. Sci. (2009), pp. 471–82.
[49] K. Van Roey, T. J. Gibson and N. E. Davey. “Motif switches: decision-
making in cell regulation”. In: Curr. Opin. Struct. Biol. (2012), pp. 378–
385.
[50] A. Stein et al. “Dynamic interactions of proteins in complex networks: a
more structured view”. In: FEBS J. (2009), pp. 5390–5405.
[51] S. Li. “Specificity and versatility of SH3 and other proline-recognition
domains: structural basis and implications for cellular signal transduc-
tion”. In: Biochem. J. (2005), pp. 641–653.
[52] H. Yu et al. “Solution structure of the SH3 domain of Src and identifica-
tion of its ligand-binding site”. In: Science (1992), pp. 1665–1668.
[53] M. Noble et al. “Crystal structure of the SH3 domain in human Fyn; com-
parison of the three-dimensional structures of SH3 domains in tyrosine
kinases and spectrin.” In: EMBO J. (1993), p. 2617.
[54] M. Carducci et al. “The protein interaction network mediated by human
SH3 domains”. In: Biotechnol. Adv. (2012), pp. 4–15.
[55] W. A. Lim, F. M. Richards and R. O. Fox. “Structural determinants
of peptide-binding orientation and of sequence specificity in SH3 do-
mains.” In: Nature (1994), pp. 375–9.
[56] A. Musacchio et al. “Crystal structure of a Src-homology 3 (SH3) do-
main”. In: Nature (1992).
[57] J. K. Chen et al. “Biased combinatorial libraries: novel ligands for the
SH3 domain of phosphatidylinositol 3-kinase”. In: J. Am. Chem. Soc.
(1993), pp. 12591–12592.
[58] S. Feng et al. “Two binding orientations for peptides to the Src SH3 do-
main: development of a general model for SH3-ligand interactions”. In:
Science (1994), pp. 1241–1247.
[59] S. Feng et al. “Specific interactions outside the proline-rich core of two
classes of Src homology 3 ligands.” In: Proc. Natl. Acad. Sci. U. S. A.
(1995), pp. 12408–15.
[60] M. Lewitzky et al. “The C-terminal SH3 domain of the adapter protein
Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which
lack the SH3-typical PxxP core motif.” In: Oncogene (2001), pp. 1052–
1062.
[61] J.-F. Trempe et al. “SH3 domains from a subset of BAR proteins define a
Ubl-binding domain and implicate parkin in synaptic ubiquitination.”
In: Mol. Cell (2009), pp. 1–14.
134
Bibliography
[62] K. Murayama et al. “Crystal structure of the rac activator, Asef, reveals
its autoinhibitory mechanism”. In: J. Biol. Chem. (2007), pp. 4238–4242.
[63] K. Saksela and P. Permi. “SH3 domain ligand binding: What’s the con-
sensus and where’s the specificity?” In: FEBS Lett. (2012), pp. 2609–14.
[64] K. Kami et al. “Diverse recognition of non-PxxP peptide ligands by the
SH3 domains from p67phox, Grb2 and Pex13p”. In: EMBO J. (2002),
pp. 4268–4276.
[65] A. Stein and P. Aloy. “Contextual specificity in peptide-mediated pro-
tein interactions.” In: PLoS One (2008), e2524–10.
[66] Y. Groemping et al. “Molecular basis of phosphorylation-induced activ-
ation of the NADPH oxidase.” In: Cell (2003), pp. 343–55.
[67] F. Fazioli et al. “Eps15, a novel tyrosine kinase substrate, exhibits trans-
forming activity.” In: Mol. Cell. Biol. (1993), pp. 5814–5828.
[68] W. T. Wong et al. “A protein-binding domain, EH, identified in the re-
ceptor tyrosine kinase substrate Eps15 and conserved in evolution”. In:
Proc. Natl. Acad. Sci. U. S. A. (1995), pp. 9530–9534.
[69] S. Confalonieri and P. P. Di Fiore. “The Eps15 homology (EH) domain”.
In: FEBS Lett. (2002), pp. 24–29.
[70] A. E. Salcini et al. “Binding specificity and in vivo targets of the EH do-
main, a novel protein–protein interaction module”. In: Genes Dev. (1997),
pp. 2239–2249.
[71] E. Santolini et al. “The EH network”. In: Exp. Cell Res. (1999), pp. 186–
209.
[72] T. de Beer et al. “Molecular mechanism of NPF recognition by EH do-
mains”. In: Nat. Struct. Mol. Biol. (2000), pp. 1018–1022.
[73] R. H. Kretsinger et al. “The EF-hand, homologs and analogs”. In: Novel
calcium-binding proteins. Springer, 1991, pp. 17–37.
[74] S. Paoluzi et al. “Recognition specificity of individual EH domains of
mammals and yeast”. In: EMBO J. (1998), pp. 6541–6550.
[75] S. Kim et al. “Solution structure of the Reps1 EH domain and character-
ization of its binding to NPF target sequences”. In: Biochemistry (2001),
pp. 6776–6785.
[76] F. Kieken et al. “Mechanism for the selective interaction of C-terminal
Eps15 homology domain proteins with specific Asn-Pro-Phe-containing
partners.” In: J. Biol. Chem. (2010), pp. 1–8.
[77] J. Rumpf et al. “1H, 13C, and 15N chemical shift assignments for the
Eps15-EH2-stonin 2 complex.” In: Biomol. NMR Assignments (2008),
pp. 55–8.
135
Bibliography
[78] H. Fu, R. R. Subramanian and S. C. Masters. “14-3-3 proteins: struc-
ture, function, and regulation.” In: Annu. Rev. Pharmacol. Toxicol. (2000),
pp. 617–47.
[79] A. K. Gardino, S. J. Smerdon and M. B. Yaffe. “Structural determinants
of 14-3-3 binding specificities and regulation of subcellular localization
of 14-3-3-ligand complexes: a comparison of the X-ray crystal structures
of all human 14-3-3 isoforms.” In: Semin. Cancer Biol. (2006), pp. 173–82.
[80] M. B. Yaffe et al. “The structural basis for 14-3-3: phosphopeptide bind-
ing specificity”. In: Cell (1997), pp. 961–971.
[81] C. Mackintosh. “Dynamic interactions between 14-3-3 proteins and
phosphoproteins regulate diverse cellular processes”. In: Biochem. J.
(2004).
[82] N. Fukuhara et al. “SMG7 is a 14-3-3-like adaptor in the nonsense-
mediated mRNA decay pathway”. In: Mol. Cell (2005), pp. 537–547.
[83] A. J. Muslin et al. “Interaction of 14-3-3 with signaling proteins is medi-
ated by the recognition of phosphoserine”. In: Cell (1996), pp. 889–897.
[84] K. Rittinger et al. “Structural analysis of 14-3-3 phosphopeptide com-
plexes identifies a dual role for the nuclear export signal of 14-3-3 in
ligand binding”. In: Mol. Cell (1999), pp. 153–166.
[85] C. Johnson et al. “Bioinformatic and experimental survey of 14-3-3-
binding sites”. In: Biochem. J. (2010), pp. 69–78.
[86] J. Jin et al. “Proteomic, functional, and domain-based analysis of in vivo
14-3-3 binding proteins involved in cytoskeletal regulation and cellular
organization.” In: Curr. Biol. (2004), pp. 1436–50.
[87] M. B. Yaffe. “How do 14-3-3 proteins work?–Gatekeeper phosphoryla-
tion and the molecular anvil hypothesis”. In: FEBS Lett. (2002), pp. 53–
57.
[88] J. M. Janz, T. P. Sakmar and K. C. Min. “A novel interaction between
atrophin-interacting protein 4 and β-p21-activated kinase-interactive
exchange factor is mediated by an SH3 domain”. In: J. Biol. Chem. (2007),
pp. 28893–28903.
[89] J. E. Harlan et al. “Pleckstrin homology domains bind to
phosphatidylinositol-4, 5-bisphosphate.” In: Nature (1994), pp. 168–170.
[90] M. L. Cheever et al. “Phox domain interaction with PtdIns (3) P targets
the Vam7 t-SNARE to vacuole membranes”. In: Nature Cell Biol. (2001),
pp. 613–618.
[91] C. David, M. Solimena and P. De Camilli. “Autoimmunity in stiff-Man
syndrome with breast cancer is targeted to the C-terminal region of hu-
man amphiphysin, a protein similar to the yeast proteins, Rvs167 and
Rvs161”. In: FEBS Lett. (1994), pp. 73–79.
136
Bibliography
[92] B. Qualmann, D. Koch and M. M. Kessels. “Let’s go bananas: revisiting
the endocytic BAR code.” In: EMBO J. (2011), pp. 3501–15.
[93] A. Frost, V. M. Unger and P. De Camilli. “The BAR domain superfamily:
membrane-molding macromolecules”. In: Cell (2009), pp. 191–196.
[94] M. Masuda et al. “Endophilin BAR domain drives membrane curvature
by two newly identified structure-based mechanisms”. In: EMBO J.
(2006), pp. 2889–2897.
[95] B. J. Peter et al. “BAR domains as sensors of membrane curvature: the
amphiphysin BAR structure.” In: Science (2004), pp. 495–9.
[96] J. L. Gallop et al. “Mechanism of endophilin N-BAR domain-mediated
membrane curvature”. In: EMBO J. (2006), pp. 2898–2910.
[97] A. Frost et al. “Structural basis of membrane invagination by F-BAR do-
mains.” In: Cell (2008), pp. 807–17.
[98] W. M. Henne et al. “Structure and analysis of FCHo2 F-BAR domain: a
dimerizing and membrane recruitment module that effects membrane
curvature.” In: Structure (2007), pp. 1–14.
[99] Q. Wang et al. “Molecular mechanism of membrane constriction and
tubulation mediated by the F-BAR protein Pacsin/Syndapin.” In: Proc.
Natl. Acad. Sci. U. S. A. (2009), pp. 12700–5.
[100] T. Itoh et al. “Dynamin and the actin cytoskeleton cooperatively regulate
plasma membrane invagination by BAR and F-BAR proteins.” In: Dev.
Cell (2005), pp. 791–804.
[101] E. Dharmalingam et al. “F-BAR proteins of the syndapin family shape
the plasma membrane and are crucial for neuromorphogenesis.” In: J.
Neurosci. (2009), pp. 13315–27.
[102] A. Pykäläinen et al. “Pinkbar is an epithelial-specific BAR domain pro-
tein that generates planar membrane structures.” In: Nat. Struct. Mol.
Biol. (2011), pp. 902–7.
[103] T. H. Millard et al. “Structural basis of filopodia formation induced by
the IRSp53/MIM homology domain of human IRSp53”. In: EMBO J.
(2005), pp. 240–250.
[104] S. H. Lee et al. “Structural basis for the actin-binding function of missing-
in-metastasis”. In: Structure (2007), pp. 145–155.
[105] O. Pylypenko et al. “The PX-BAR membrane-remodeling unit of sorting
nexin 9”. In: EMBO J. (2007), pp. 4788–4800.
[106] J. Li et al. “Crystal structures of the BAR-PH and PTB domains of human
APPL1”. In: Structure (2007), pp. 525–533.
[107] M. M. Kozlov et al. “Mechanisms shaping cell membranes.” In: Curr.
Opin. Cell Biol. (2014), pp. 53–60.
137
Bibliography
[108] P. Janmey and P. Kinnunen. “Biophysical properties of lipids and dy-
namic membranes”. In: Trends Cell Biol. (2006), pp. 538–546.
[109] A. Shimada et al. “Curved EFC/F-BAR-domain dimers are joined end to
end into a filament for membrane invagination in endocytosis.” In: Cell
(2007), pp. 761–72.
[110] C. Mim et al. “Structural basis of membrane bending by the N-BAR pro-
tein endophilin.” In: Cell (2012), pp. 1–9.
[111] E. Boucrot et al. “Membrane fission is promoted by insertion of am-
phipathic helices and is restricted by crescent BAR domains.” In: Cell
(2012), pp. 124–36.
[112] M. R. Ambroso, B. G. Hegde and R. Langen. “Endophilin A1 induces
different membrane shapes using a conformational switch that is reg-
ulated by phosphorylation”. In: Proc. Natl. Acad. Sci. U. S. A. (2014),
pp. 6982–6987.
[113] S. Suetsugu et al. “The RAC binding domain/IRSp53-MIM homology
domain of IRSp53 induces RAC-dependent membrane deformation”.
In: J. Biol. Chem. (2006), pp. 35347–35358.
[114] W. M. Henne et al. “FCHo proteins are nucleators of clathrin-mediated
endocytosis.” In: Science (2010), pp. 1281–4.
[115] G. Di Paolo and P. De Camilli. “Phosphoinositides in cell regulation and
membrane dynamics”. In: Nature (2006), pp. 651–657.
[116] M. J. Taylor, D. Perrais and C. J. Merrifield. “A high precision survey of
the molecular dynamics of mammalian clathrin-mediated endocytosis”.
In: PLoS Biol. (2011), e1000604.
[117] I. Milosevic et al. “Recruitment of endophilin to clathrin-coated pit necks
is required for efficient vesicle uncoating after fission.” In: Neuron (2011),
pp. 587–601.
[118] Y. Posor et al. “Spatiotemporal control of endocytosis by
phosphatidylinositol-3,4-bisphosphate.” In: Nature (2013), pp. 233–
7.
[119] M. Meinecke et al. “Cooperative Recruitment of Dynamin and
BIN/Amphiphysin/Rvs (BAR) Domain-containing Proteins Leads to
GTP-dependent Membrane Scission.” In: J. Biol. Chem. (2013), pp. 6651–
61.
[120] S. J. Heasman and A. J. Ridley. “Mammalian Rho GTPases: new insights
into their functions from in vivo studies.” In: Nat. Rev. Mol. Cell Biol.
(2008), pp. 690–701.
[121] P. Ji, S. R. Jayapal and H. F. Lodish. “Enucleation of cultured mouse fetal
erythroblasts requires Rac GTPases and mDia2”. In: Nature Cell Biol.
(2008), pp. 314–321.
138
Bibliography
[122] K. Kobayashi et al. “p140Sra-1 (specifically Rac1-associated protein) is
a novel specific target for Rac1 small GTPase.” In: J. Biol. Chem. (1998),
pp. 291–5.
[123] S. Eden et al. “Mechanism of regulation of WAVE1-induced actin nucle-
ation by Rac1 and Nck”. In: Nature (2002), pp. 790–793.
[124] L. M. Machesky and R. H. Insall. “Scar1 and the related Wiskott–Aldrich
syndrome protein, WASP, regulate the actin cytoskeleton through the
Arp2/3 complex”. In: Curr. Biol. (1998), pp. 1347–1356.
[125] L. Blanchoin et al. “Direct observation of dendritic actin filament net-
works nucleated by Arp2/3 complex and WASP/Scar proteins”. In:
Nature (2000), pp. 1007–1011.
[126] L. A. Colgan and R. Yasuda. “Plasticity of dendritic spines: subcompart-
mentalization of signaling”. In: Annu. Rev. Physiol. (2014), pp. 365–385.
[127] S. H. Soderling et al. “The WRP component of the WAVE-1 complex at-
tenuates Rac-mediated signalling.” In: Nat. Cell Biol. (2002), pp. 970–5.
[128] D. C. Edwards et al. “Activation of LIM-kinase by Pak1 couples
Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics”. In:
Nature Cell Biol. (1999), pp. 253–259.
[129] A. Braun et al. “EHD proteins associate with syndapin I and II and such
interactions play a crucial role in endosomal recycling.” In: Mol. Biol.
Cell (2005), pp. 3642–58.
[130] Y. Rao et al. “Molecular basis for SH3 domain regulation of F-BAR-
mediated membrane deformation.” In: Proc. Natl. Acad. Sci. U. S. A.
(2010), pp. 8213–8.
[131] S. L. Goh et al. “Versatile membrane deformation potential of activated
pacsin.” In: PLoS One (2012), e51628–18.
[132] R. K. Saiki et al. “Primer-directed enzymatic amplification of DNA with
a thermostable DNA polymerase”. In: Science (1988), pp. 487–491.
[133] R. Don et al. “’Touchdown’PCR to circumvent spurious priming during
gene amplification.” In: Nucleic Acids Res. (1991), p. 4008.
[134] O. Edelheit, A. Hanukoglu and I. Hanukoglu. “Simple and efficient site-
directed mutagenesis using two single-primer reactions in parallel to
generate mutants for protein structure-function studies.” In: BMC Bio-
technol. (2009), p. 61.
[135] C. E. Seidman et al. “Introduction of plasmid DNA into cells”. In: Curr.
Protoc. Mol. Biol. (1997), pp. 1–8.
[136] R. B. DuBridge et al. “Analysis of mutation in human cells by using an
Epstein-Barr virus shuttle system.” In: Mol. Cell. Biol. (1987), pp. 379–
387.
139
Bibliography
[137] O. Boussif et al. “A versatile vector for gene and oligonucleotide transfer
into cells in culture and in vivo: polyethylenimine.” In: Proc. Natl. Acad.
Sci. U. S. A. (1995), pp. 7297–301.
[138] C. Ehrhardt et al. “Polyethylenimine, a cost-effective transfection re-
agent”. In: Signal Transduction (2006), pp. 179–184.
[139] U. K. Laemmli. “Cleavage of structural proteins during the assembly of
the head of bacteriophage T4.” In: Nature (1970), pp. 680–685.
[140] S. M. Kelly, T. J. Jess and N. C. Price. “How to study proteins by circular
dichroism.” In: Biochim. Biophys. Acta (2005), pp. 119–39.
[141] T. Wiseman et al. “Rapid measurement of binding constants and heats
of binding using a new titration calorimeter”. In: Anal. Biochem. (1989),
pp. 131–137.
[142] M. J. Todd and J. Gomez. “Enzyme kinetics determined using calori-
metry: a general assay for enzyme activity?” In: Anal. Biochem. (2001),
pp. 179–187.
[143] I. Jelesarov and H. R. Bosshard. “Isothermal titration calorimetry and
differential scanning calorimetry as complementary tools to investigate
the energetics of biomolecular recognition”. In: J. Mol. Recognit. (1999),
pp. 3–18.
[144] A. R. Ypsilanti, Y. Zagar and A. Chédotal. “Moving away from the
midline: new developments for Slit and Robo”. In: Development (2010),
pp. 1939–1952.
[145] C. Bacon, V. Endris and G. A. Rappold. “The cellular function of srGAP3
and its role in neuronal morphogenesis.” In: Mech. Dev. (2013), pp. 391–
5.
[146] M. Seeger et al. “Mutations affecting growth cone guidance in Droso-
phila: genes necessary for guidance toward or away from the midline”.
In: Neuron (1993), pp. 409–426.
[147] J. M. Rothberg et al. “Slit: an extracellular protein necessary for devel-
opment of midline glia and commissural axon pathways contains both
EGF and LRR domains.” In: Genes Dev. (1990), pp. 2169–2187.
[148] K. Brose et al. “Slit proteins bind Robo receptors and have an evolution-
arily conserved role in repulsive axon guidance”. In: Cell (1999), pp. 795–
806.
[149] T. Kidd, K. S. Bland and C. S. Goodman. “Slit Is the Midline Repellent
for the Robo Receptor in Drosophila”. In: Cell (1999), pp. 785–794.
[150] T. Ringstedt et al. “Slit inhibition of retinal axon growth and its role in
retinal axon pathfinding and innervation patterns in the diencephalon”.
In: J. Neurosci. (2000), pp. 4983–4991.
140
Bibliography
[151] K. Wong et al. “Signal transduction in neuronal migration: roles of GT-
Pase activating proteins and the small GTPase Cdc42 in the Slit-Robo
pathway.” In: Cell (2001), pp. 209–21.
[152] C. Bacon et al. “Evidence for a role of srGAP3 in the positioning of com-
missural axons within the ventrolateral funiculus of the mouse spinal
cord.” In: PLoS One (2011), e19887.
[153] Y. Ma et al. “The inverse F-BAR domain protein srGAP2 acts through
srGAP3 to modulate neuronal differentiation and neurite outgrowth of
mouse neuroblastoma cells.” In: PLoS One (2013), e57865.
[154] J. Coutinho-Budd et al. “The F-BAR domains from srGAP1, srGAP2, and
srGAP3 differentially regulate membrane deformation.” In: J. Cell Sci.
(2012), pp. 3390–3401.
[155] C. Charrier et al. “Inhibition of SRGAP2 function by its human-specific
paralogs induces neoteny during spine maturation.” In: Cell (2012),
pp. 923–35.
[156] S. Guerrier et al. “The F-BAR domain of srGAP2 induces membrane pro-
trusions required for neuronal migration and morphogenesis.” In: Cell
(2009), pp. 990–1004.
[157] H. il Kim et al. “Disruption of Wave Associated Rac-GAP (Wrp) Leads to
Abnormal Adult Neural Progenitor Migration Associated with Hydro-
cephalus.” In: J. Biol. Chem. (2012), pp. 39263–39274.
[158] D. L. Vogt et al. “ARHGAP4 is a novel RhoGAP that mediates inhibi-
tion of cell motility and axon outgrowth.” In: Mol. Cell. Neurosci. (2007),
pp. 1–11.
[159] Q. Yao et al. “Regulated shuttling of Slit-Robo-GTPase activating pro-
teins between nucleus and cytoplasm during brain development.” In:
Cell. Mol. Neurobiol. (2008), pp. 205–21.
[160] C. Bacon, V. Endris and G. Rappold. “Dynamic expression of the Slit-
Robo GTPase activating protein genes during development of the mur-
ine nervous system.” In: J. Comp. Neurol. (2009), pp. 224–36.
[161] V. Endris et al. “The novel Rho-GTPase activating gene MEGAP/
srGAP3 has a putative role in severe mental retardation.” In: Proc. Natl.
Acad. Sci. U. S. A. (2002), pp. 11754–9.
[162] R. Waltereit et al. “Srgap3-/- mice present a neurodevelopmental dis-
order with schizophrenia-related intermediate phenotypes.” In: FASEB
J. (2012), pp. 1–11.
[163] B. R. Carlson et al. “WRP/srGAP3 facilitates the initiation of spine de-
velopment by an inverse F-BAR domain, and its loss impairs long-term
memory.” In: J. Neurosci. (2011), pp. 2447–60.
141
Bibliography
[164] Y. Yang et al. “MEGAP impedes cell migration via regulating actin and
microtubule dynamics and focal complex formation.” In: Exp. Cell Res.
(2006), pp. 2379–93.
[165] V. Endris et al. “SrGAP3 interacts with lamellipodin at the cell mem-
brane and regulates Rac-dependent cellular protrusions.” In: J. Cell Sci.
(2011), pp. 3941–55.
[166] X. Li et al. “Structural basis of Robo proline-rich motif recognition by the
srGAP1 Src homology 3 domain in the Slit-Robo signaling pathway.” In:
J. Biol. Chem. (2006), pp. 28430–7.
[167] S. F. Altschul et al. “Gapped BLAST and PSI-BLAST: a new genera-
tion of protein database search programs”. In: Nucleic Acids Res. (1997),
pp. 3389–3402.
[168] J. Söding et al. “HHsenser: exhaustive transitive profile search using
HMM-HMM comparison.” In: Nucleic Acids Res. (2006), W374–8.
[169] A. Biegert et al. “The MPI Bioinformatics Toolkit for protein sequence
analysis.” In: Nucleic Acids Res. (2006), W335–9.
[170] J. Söding, A. Biegert and A. N. Lupas. “The HHpred interactive server
for protein homology detection and structure prediction”. In: Nucleic
Acids Res. (2005), W244–W248.
[171] L. J. McGuffin, K. Bryson and D. T. Jones. “The PSIPRED protein struc-
ture prediction server”. In: Bioinformatics (2000), pp. 404–405.
[172] C. Cole, J. D. Barber and G. J. Barton. “The Jpred 3 secondary structure
prediction server”. In: Nucleic Acids Res. (2008), W197–W201.
[173] P. Rice, I. Longden and A. Bleasby. “EMBOSS: the European molecular
biology open software suite”. In: Trends Genet. (2000), pp. 276–277.
[174] M. Goujon et al. “A new bioinformatics analysis tools framework at
EMBL–EBI”. In: Nucleic Acids Res. (2010), W695–W699.
[175] H. McWilliam et al. “Analysis tool web services from the EMBL-EBI”.
In: Nucleic Acids Res. (2013), W597–W600.
[176] T. Frickey and A. Lupas. “CLANS: a Java application for visualizing
protein families based on pairwise similarity”. In: Bioinformatics (2004),
pp. 3702–3704.
[177] S. F. Altschul et al. “Basic local alignment search tool”. In: J. Mol. Biol.
(1990), pp. 403–410.
[178] Y. Liu, B. Schmidt and D. L. Maskell. “MSAProbs: multiple sequence
alignment based on pair hidden Markov models and partition function
posterior probabilities”. In: Bioinformatics (2010), pp. 1958–1964.
[179] R. C. Edgar. “MUSCLE: multiple sequence alignment with high accur-
acy and high throughput”. In: Nucleic Acids Res. (2004), pp. 1792–1797.
142
Bibliography
[180] R. C. Edgar. “MUSCLE: a multiple sequence alignment method with re-
duced time and space complexity”. In: BMC bioinformatics (2004), p. 113.
[181] C. Notredame, D. G. Higgins and J. Heringa. “T-Coffee: A novel method
for fast and accurate multiple sequence alignment”. In: J. Mol. Biol.
(2000), pp. 205–217.
[182] M. E. Oates et al. “D2P2: database of disordered protein predictions”. In:
Nucleic Acids Res. (2013), pp. D508–D516.
[183] M. Sickmeier et al. “DisProt: the database of disordered proteins”. In:
Nucleic Acids Res. (2007), pp. D786–D793.
[184] F. M. Disfani et al. “MoRFpred, a computational tool for sequence-based
prediction and characterization of short disorder-to-order transitioning
binding regions in proteins”. In: Bioinformatics (2012), pp. i75–i83.
[185] G. Yachdav et al. “PredictProtein—an open resource for online predic-
tion of protein structural and functional features”. In: Nucleic Acids Res.
(2014), W337–W343.
[186] A. Lupas, M. Van Dyke and J. Stock. “Predicting coiled coils from pro-
tein sequences.” In: Science (1991), pp. 1162–1164.
[187] M. Delorenzi and T. Speed. “An HMM model for coiled-coil domains
and a comparison with PSSM-based predictions”. In: Bioinformatics
(2002), pp. 617–625.
[188] H. Dinkel et al. “ELM–the database of eukaryotic linear motifs.” In: Nuc-
leic Acids Res. (2012), pp. D242–51.
[189] H. Dinkel et al. “The eukaryotic linear motif resource ELM: 10 years and
counting.” In: Nucleic Acids Res. (2014), pp. D259–D266.
[190] J. C. Obenauer, L. C. Cantley and M. B. Yaffe. “Scansite 2.0: Proteome-
wide prediction of cell signaling interactions using short sequence mo-
tifs”. In: Nucleic Acids Res. (2003), pp. 3635–3641.
[191] M. B. Yaffe et al. “A motif-based profile scanning approach for genome-
wide prediction of signaling pathways”. In: Nat. Biotechnol. (2001),
pp. 348–353.
[192] S. Zhou et al. “SH2 domains recognize specific phosphopeptide sequen-
ces”. In: Cell (1993), pp. 767–778.
[193] Z. Songyang et al. “Recognition of unique carboxyl-terminal motifs by
distinct PDZ domains”. In: Science (1997), pp. 73–77.
[194] C. Mooney et al. “Prediction of short linear protein binding regions”. In:
J. Mol. Biol. (2012), pp. 193–204.
[195] P. V. Hornbeck et al. “PhosphoSite: A bioinformatics resource dedic-
ated to physiological protein phosphorylation”. In: Proteomics (2004),
pp. 1551–1561.
143
Bibliography
[196] U. Rothbauer et al. “A versatile nanotrap for biochemical and functional
studies with fluorescent fusion proteins.” In: Mol. Cell. Proteomics (2008),
pp. 282–9.
[197] D. Saerens et al. “Identification of a universal VHH framework to graft
non-canonical antigen-binding loops of camel single-domain antibod-
ies”. In: J. Mol. Biol. (2005), pp. 597–607.
[198] M. H. Kubala et al. “Structural and thermodynamic analysis of the
GFP:GFP-nanobody complex.” In: Protein Sci. (2010), pp. 2389–401.
[199] A. Thain et al. “A method for the separation of GST fusion proteins from
co-purifying GroEL”. In: Trends Genet. (1996), pp. 209–210.
[200] A. C. Rufer et al. “Isoform-selective interaction of the adaptor protein
Tks5/FISH with Sos1 and dynamins.” In: J. Mol. Biol. (2009), pp. 939–50.
[201] J. Cox and M. Mann. “MaxQuant enables high peptide identification
rates, individualized ppb-range mass accuracies and proteome-wide
protein quantification”. In: Nat. Biotechnol. (2008), pp. 1367–1372.
[202] J. Cox et al. “Andromeda: a peptide search engine integrated into the
MaxQuant environment”. In: J. Proteome Res. (2011), pp. 1794–1805.
[203] G. Pichler et al. “Versatile toolbox for high throughput biochemical and
functional studies with fluorescent fusion proteins”. In: PLoS One (2012),
e36967.
[204] J. Schindelin et al. “Fiji: an open-source platform for biological-image
analysis”. In: Nat. Methods (2012), pp. 676–682.
[205] S. T. Gammon et al. “Spectral unmixing of multicolored bioluminescence
emitted from heterogeneous biological sources.” In: Anal. Chem. (2006),
pp. 1520–7.
[206] K. Shalchian-Tabrizi et al. “Multigene phylogeny of choanozoa and the
origin of animals”. In: PLoS One (2008), e2098.
[207] I. Blasutig. “Phosphorylated Motif Recognition and Mechanisms of Cell
Signaling in Actin-Cytoskeletal Regulation”. PhD thesis. University of
Toronto, 2008.
[208] A. M. A. Aguinaldo et al. “Evidence for a clade of nematodes, arthro-
pods and other moulting animals”. In: Nature (1997), pp. 489–493.
[209] K. M. Halanych et al. “Evidence from 18S ribosomal DNA that the loph-
ophorates are protostome animals”. In: Science (1995), pp. 1641–1643.
[210] C. W. Dunn et al. “Broad phylogenomic sampling improves resolution
of the animal tree of life”. In: Nature (2008), pp. 745–749.
[211] M. M. Babu et al. “Intrinsically disordered proteins: regulation and dis-
ease.” In: Curr. Opin. Struct. Biol. (2011), pp. 432–40.
144
Bibliography
[212] H. Yu et al. “Structural basis for the binding of proline-rich peptides to
SH3 domains.” In: Cell (1994), pp. 933–45.
[213] X. Du, J. E. Fox and S. Pei. “Identification of a binding sequence for the
14-3-3 protein within the cytoplasmic domain of the adhesion receptor,
platelet glycoprotein Ib”. In: J. Biol. Chem. (1996), pp. 7362–7367.
[214] S.-H. Hu et al. “The Weak Complex between RhoGAP Protein AR-
HGAP22 and Signal Regulatory Protein 14-3-3 Has 1:2 Stoichiometry
and a Single Peptide Binding Mode.” In: PLoS One (2012), pp. 1–11.
[215] C. Ottmann et al. “Phosphorylation-independent interaction between
14-3-3 and exoenzyme S: from structure to pathogenesis”. In: EMBO J.
(2007), pp. 902–913.
[216] X. Yang et al. “Structural basis for protein–protein interactions in the 14-
3-3 protein family”. In: Proc. Natl. Acad. Sci. U. S. A. (2006), pp. 17237–
17242.
[217] M. Fuxreiter, P. Tompa and I. Simon. “Local structural disorder imparts
plasticity on linear motifs”. In: Bioinformatics (2007), pp. 950–956.
[218] S. H. Soderling et al. “A WAVE-1 and WRP signaling complex regulates
spine density, synaptic plasticity, and memory.” In: J. Neurosci. (2007),
pp. 355–65.
[219] Z.-B. Chen et al. “Slit-Robo GTPase-activating proteins are differen-
tially expressed in murine dorsal root ganglia: modulation by peripheral
nerve injury.” In: Anat. Rec. (2012), pp. 652–60.
[220] L. Haussmann. “Identifizierung und Charakterisierung von MEGAP-
Interaktionspartnern”. PhD thesis. Ruprecht-Karls-Universität, Heidel-
berg, 2009.
[221] Y.-K. Dai et al. “A link between the nuclear-localized srGAP3 and the
SWI/SNF chromatin remodeler Brg1.” In: Mol. Cell. Neurosci. (2014),
pp. 10–25.
[222] C. U. Stirnimann et al. “WD40 proteins propel cellular networks.” In:
Trends Biochem. Sci. (2010), pp. 565–74.
[223] G. J. Praefcke et al. “Evolving nature of the AP2 alpha-appendage
hub during clathrin-coated vesicle endocytosis.” In: EMBO J. (2004),
pp. 4371–83.
[224] L. E. Olesen et al. “Solitary and repetitive binding motifs for the AP2
complex α-appendage in amphiphysin and other accessory proteins”.
In: J. Biol. Chem. (2008), pp. 5099–5109.
[225] K. C. Slep et al. “Structural determinants for EB1-mediated recruitment
of APC and spectraplakins to the microtubule plus end”. In: J. Cell Biol.
(2005), pp. 587–598.
145
Bibliography
[226] C. Gorbea et al. “A protein interaction network for Ecm29 links the 26
S proteasome to molecular motors and endosomal components”. In: J.
Biol. Chem. (2010), pp. 31616–31633.
[227] M. E. Harbour et al. “The cargo-selective retromer complex is a recruit-
ing hub for protein complexes that regulate endosomal tubule dynam-
ics”. In: J. Cell Sci. (2010), pp. 3703–3717.
[228] E. H. Michael, Y. B. Sophia and N. Matthew. “Recruitment of the endo-
somal WASH complex is mediated by the extended’tail’of Fam21 bind-
ing to the retromer protein Vps35”. In: Biochem. J. (2012), pp. 209–220.
[229] E. Conti et al. “Crystallographic analysis of the recognition of a nuclear
localization signal by the nuclear import factor karyopherin α”. In: Cell
(1998), pp. 193–204.
[230] M. A. Andrade et al. “Comparison of ARM and HEAT protein repeats”.
In: J. Mol. Biol. (2001), pp. 1–18.
[231] C. M. Waterman-Storer, S. Karki and E. Holzbaur. “The p150Glued com-
ponent of the dynactin complex binds to both microtubules and the
actin-related protein centractin (Arp-1).” In: Proc. Natl. Acad. Sci. U. S.
A. (1995), pp. 1634–1638.
[232] E. A. Holleran et al. “βIII spectrin binds to the Arp1 subunit of dyn-
actin”. In: J. Biol. Chem. (2001), pp. 36598–36605.
[233] T. Köcher and G. Superti-Furga. “Mass spectrometry–based functional
proteomics: from molecular machines to protein networks”. In: Nat.
Methods (2007), pp. 807–815.
[234] T. De Meyer, S. Muyldermans and A. Depicker. “Nanobody-based
products as research and diagnostic tools”. In: Trends Biotechnol. (2014),
pp. 263–270.
[235] M. Lauwereys et al. “Potent enzyme inhibitors derived from dromedary
heavy-chain antibodies”. In: EMBO J. (1998), pp. 3512–3520.
[236] S. Muyldermans et al. “Camelid immunoglobulins and nanobody tech-
nology.” In: Vet. Immunol. Immunopathol. (2009), pp. 1–6.
[237] D. C. Worth et al. “Drebrin contains a cryptic F-actin-bundling activity
regulated by Cdk5 phosphorylation.” In: J. Cell Biol. (2013), pp. 793–806.
[238] Y. K. Mok et al. “Dramatic stabilization of an SH3 domain by a single
substitution: roles of the folded and unfolded states.” In: J. Mol. Biol.
(2001), pp. 913–28.
[239] D. Grabs et al. “The SH3 domain of amphiphysin binds the proline-rich
domain of dynamin at a single site that defines a new SH3 binding con-
sensus sequence”. In: J. Biol. Chem. (1997), pp. 13419–13425.
146
Bibliography
[240] C. B. McDonald et al. “SH3 domains of Grb2 adaptor bind to PXψPXR
motifs within the Sos1 nucleotide exchange factor in a discriminate
manner”. In: Biochemistry (Mosc.) (2009), pp. 4074–4085.
[241] B. A. Ballif et al. “Identification of 14-3-3epsilon substrates from em-
bryonic murine brain.” In: J. Proteome Res. (2006), pp. 2372–9.
[242] E. L. Huttlin et al. “A Tissue-Specific Atlas of Mouse Protein Phos-
phorylation and Expression”. In: Cell (2010), pp. 1174–1189.
[243] A. Quan et al. “Phosphorylation of syndapin I F-BAR domain at two
helix-capping motifs regulates membrane tubulation.” In: Proc. Natl.
Acad. Sci. U. S. A. (2012), pp. 3760–5.
[244] H. Saitsu et al. “Early infantile epileptic encephalopathy associated with
the disrupted gene encoding Slit-Robo Rho GTPase activating protein 2
(SRGAP2).” In: Am. J. Med. Genet. A. (2011).
[245] S. Guo and S. Bao. “srGAP2 arginine methylation regulates cell migra-
tion and cell spreading through promoting dimerization.” In: J. Biol.
Chem. (2010), pp. 1–9.
[246] E. A. Golemis et al. “Interaction trap/two-hybrid system to identify in-
teracting proteins”. In: Curr. Protoc. Cell Biol. (1996), pp. 17–3.
[247] C. S. Goodyear and G. J. Silverman. “Phage-display methodology for the
study of protein-protein interactions: Overview”. In: Cold Spring Harbor
Prot. (2008), pdb–top48.
[248] H. Okada et al. “SH3 domain-based phototrapping in living cells reveals
Rho family GAP signaling complexes.” In: Sci. Signaling (2011), rs13.
[249] W. Van Criekinge and R. Beyaert. “Yeast two-hybrid: state of the art”.
In: Biol. Proced. Online (1999), pp. 1–38.
[250] J. Torres and R. Pulido. “The tumor suppressor PTEN is phosphorylated
by the protein kinase CK2 at its C terminus. Implications for PTEN sta-
bility to proteasome-mediated degradation.” In: J. Biol. Chem. (2001),
pp. 993–8.
[251] A. Brymora, V. A. Valova and P. J. Robinson. “Protein-Protein Interac-
tions Identified by Pull-Down Experiments and Mass Spectrometry”.
In: Curr. Protoc. Cell Biol. (2004), pp. 17–5.
[252] D. Saerens et al. “Engineering camel single-domain antibodies and im-
mobilization chemistry for human prostate-specific antigen sensing”.
In: Anal. Chem. (2005), pp. 7547–7555.
[253] D. Saerens et al. “Antibody fragments as probe in biosensor develop-
ment”. In: Sensors (2008), pp. 4669–4686.
[254] G.-L. Zhou et al. “Akt phosphorylation of serine 21 on Pak1 modulates
Nck binding and cell migration”. In: Mol. Cell. Biol. (2003), pp. 8058–
8069.
147
Bibliography
[255] L. J. Jensen et al. “STRING 8–a global view on proteins and their
functional interactions in 630 organisms”. In: Nucleic Acids Res. (2009),
pp. D412–D416.
[256] S. Leavitt and E. Freire. “Direct measurement of protein binding ener-
getics by isothermal titration calorimetry.” In: Curr. Opin. Struct. Biol.
(2001), pp. 560–6.
[257] T. Kaneko, L. Li and S. S.-C. Li. “The SH3 domain–a family of versat-
ile peptide- and protein-recognition module.” In: Front. Biosci. (2008),
pp. 1–15.
[258] T. Kaneko, S. S. Sidhu and S. S. Li. “Evolving specificity from variability
for protein interaction domains.” In: Trends Biochem. Sci. (2011), pp. 1–8.
[259] I. Nooren and J. M. Thornton. “Structural characterisation and func-
tional significance of transient protein–protein interactions”. In: J. Mol.
Biol. (2003), pp. 991–1018.
[260] P. Chakrabarti and J. Janin. “Dissecting protein–protein recognition
sites”. In: Proteins: Struct., Funct., Bioinf. (2002), pp. 334–343.
[261] D. Owen et al. “Crystal structure of the amphiphysin-2 SH3 domain
and its role in the prevention of dynamin ring formation”. In: EMBO
J. (1998), pp. 5273–5285.
[262] G. Cestra et al. “The SH3 domains of endophilin and amphiphysin bind
to the proline-rich region of synaptojanin 1 at distinct sites that dis-
play an unconventional binding specificity.” In: J. Biol. Chem. (1999),
pp. 32001–7.
[263] W. Jockusch et al. “Clathrin-dependent and clathrin-independent re-
trieval of synaptic vesicles in retinal bipolar cells.” In: Neuron (2005),
pp. 869–78.
[264] N. Ringstad, Y. Nemoto and P. De Camilli. “Differential expression of
endophilin 1 and 2 dimers at central nervous system synapses”. In: J.
Biol. Chem. (2001), pp. 40424–40430.
[265] P. J. Loll et al. “Structure of the SH3 domain of rat endophilin A2”. In:
Acta Crystallograph. Sect. F Struct. Biol. Cryst. Commun. (2008), pp. 243–
246.
[266] J. A. Simon and S. L. Schreiber. “Grb2 SH3 binding to peptides from Sos:
evaluation of a general model for SH3-ligand interactions.” In: Chem.
Biol. (1995), pp. 53–60.
[267] P. Chardin et al. “Human Sos1: a guanine nucleotide exchange factor for
Ras that binds to GRB2”. In: Science (1993), pp. 1338–1343.
[268] S. E. Egan et al. “Association of Sos Ras exchange protein with Grb2 is
implicated in tyrosine kinase signal transduction and transformation”.
In: Nature (1993), pp. 45–51.
148
Bibliography
[269] N. a. Li et al. “Guanine-nucleotide-releasing factor hSos1 binds to Grb2
and links receptor tyrosine kinases to Ras signalling”. In: Nature (1993),
pp. 85–88.
[270] S. Maignan et al. “Crystal structure of the mammalian Grb2 adaptor.”
In: Science (1995), pp. 291–3.
[271] C. B. McDonald et al. “Grb2 adaptor undergoes conformational change
upon dimerization”. In: Arch. Biochem. Biophys. (2008), pp. 25–35.
[272] C. B. McDonald et al. “Bivalent binding drives the formation of the
Grb2–Gab1 signaling complex in a noncooperative manner”. In: FEBS
J. (2012), pp. 2156–2173.
[273] D. M. Berry et al. “A High-Affinity Arg-X-X-Lys SH3 Binding Motif Con-
fers Specificity for the Interaction between Gads and SLP-76 in T Cell
Signaling”. In: Curr. Biol. (2002), pp. 1336–1341.
[274] V. Neduva et al. “Systematic discovery of new recognition peptides me-
diating protein interaction networks”. In: PLoS Biol. (2005), e405.
[275] M. Chaudhri, M. Scarabel and A. Aitken. “Mammalian and yeast 14-3-3
isoforms form distinct patterns of dimers in vivo”. In: Biochem. Biophys.
Res. Commun. (2003), pp. 679–685.
[276] J. Zha et al. “Serine Phosphorylation of Death Agonist BAD in Response
to Survival Factor Results in Binding to 14-3-3 Not BCL-XL”. In: Cell
(1996), pp. 619–628.
[277] G. Rena et al. “Roles of the forkhead in rhabdomyosarcoma (FKHR)
phosphorylation sites in regulating 14-3-3 binding, transactivation and
nuclear targetting.” In: Biochem J. (2001), pp. 605–12.
[278] R. Y. Tweedie-Cullen, J. M. Reck and I. M. Mansuy. “Comprehensive
mapping of post-translational modifications on synaptic, nuclear, and
histone proteins in the adult mouse brain.” In: J. Proteome Res. (2009),
pp. 4966–82.
[279] B. D. Manning and L. C. Cantley. “Hitting the target: emerging techno-
logies in the search for kinase substrates”. In: Sci. Signaling (2002), pe49.
[280] N. Blom et al. “Prediction of post-translational glycosylation and phos-
phorylation of proteins from the amino acid sequence”. In: Proteomics
(2004), pp. 1633–1649.
[281] P. Riou et al. “14-3-3 proteins interact with a hybrid prenyl-
phosphorylation motif to inhibit G proteins.” In: Cell (2013), pp. 640–
53.
[282] J. K. Campbell et al. “Activation of the 43 kDa inositol polyphosphate
5-phosphatase by 14-3-3ζ”. In: Biochemistry (Mosc.) (1997), pp. 15363–
15370.
149
Bibliography
[283] G. Zhang et al. “Overview of peptide and protein analysis by mass spec-
trometry”. In: Curr. Protoc. Prot. Sci. (2010), pp. 16–1.
[284] M. Tinti et al. “Evolution of signal multiplexing by 14-3-3-binding 2R-
ohnologue protein families in the vertebrates”. In: Open Biol. (2012),
pp. 120103–120103.
[285] K. Van Roey et al. “Short linear motifs: ubiquitous and functionally di-
verse protein interaction modules directing cell regulation”. In: Chem.
Rev. (2014), pp. 6733–6778.
[286] C. Tarricone et al. “The structural basis of Arfaptin-mediated cross-talk
between Rac and Arf signalling pathways”. In: Nature (2001), pp. 215–
219.
[287] B. Xiao et al. “Structure of a 14-3-3 protein and implications for coordin-
ation of multiple signalling pathways”. In: Nature (1995).
[288] C. Kintscher et al. “Autoinhibition of GEF activity in Intersectin 1 is me-
diated by the short SH3-DH domain linker.” In: Protein Sci. (2010), pp. 1–
11.
[289] E. M. Schmid and H. T. McMahon. “Integrating molecular and network
biology to decode endocytosis”. In: Nature (2007), p. 883.
[290] C. Chica, F. Diella and T. J. Gibson. “Evidence for the concerted evolu-
tion between short linear protein motifs and their flanking regions”. In:
PLoS One (2009), e6052.
[291] B. J. Schnapp. “Trafficking of signaling modules by kinesin motors”. In:
J. Cell Sci. (2003), pp. 2125–2135.
[292] H. Jung et al. “Remote Control of Gene Function by Local Translation”.
In: Cell (2014), pp. 26–40.
[293] P. Li et al. “Phase transitions in the assembly of multivalent signalling
proteins”. In: Nature (2012), pp. 336–340.
[294] A. Nag et al. “Aggregation of membrane proteins by cytosolic cross-
linkers: theory and simulation of the LAT-Grb2-SOS1 system”. In: Bio-
phys. J. (2009), pp. 2604–2623.
[295] A. Nag et al. “Modeling and simulation of aggregation of membrane
protein LAT with molecular variability in the number of binding sites
for cytosolic Grb2-SOS1-Grb2”. In: PLoS One (2012), e28758.
[296] S. Banjade, M. K. Rosen and A. A. Hyman. “Phase transitions of multi-
valent proteins can promote clustering of membrane receptors.” In: eLife
(2014).
[297] T. Pawson and J. D. Scott. “Signaling through scaffold, anchoring, and
adaptor proteins”. In: Science (1997), pp. 2075–2080.
150
Bibliography
[298] J. Liu, J. R. Faeder and C. J. Camacho. “Toward a quantitative theory of
intrinsically disordered proteins and their function”. In: Proc. Natl. Acad.
Sci. U. S. A. (2009), pp. 19819–19823.
[299] K. Sugase, H. J. Dyson and P. E. Wright. “Mechanism of coupled folding
and binding of an intrinsically disordered protein”. In: Nature (2007),
pp. 1021–1025.
[300] R. Mosca, R. A. Pache and P. Aloy. “The role of structural disorder in
the rewiring of protein interactions through evolution.” In: Mol. Cell.
Proteomics (2012), p. M111.014969.
[301] T. Kaneko et al. “Superbinder SH2 Domains Act as Antagonists of Cell
Signaling.” In: Sci. Signaling (2012), pp. 1–11.
[302] H. Huang et al. “Defining the specificity space of the human SRC homo-
logy 2 domain”. In: Mol. Cell. Proteomics (2008), pp. 768–784.
[303] N. J. Haslam and D. C. Shields. “Peptide-binding domains: are limp
handshakes safest?” In: Sci. Signaling (2012), pp. 1–4.
[304] N. E. Davey, G. Travé and T. J. Gibson. “How viruses hijack cell regula-
tion”. In: Trends Biochem. Sci. (2011), pp. 159–169.
[305] P. Tompa et al. “A million peptide motifs for the molecular biologist”.
In: Mol. Cell (2014), pp. 161–169.
[306] X. Xin et al. “SH3 interactome conserves general function over specific
form.” In: Mol. Syst. Biol. (2013), p. 652.
[307] A. B. Huber et al. “Signaling at the growth cone: ligand-receptor com-
plexes and the control of axon growth and guidance.” In: Annu. Rev.
Neurosci. (2003), pp. 509–63.
[308] F. M. Mason et al. “Bi-modal regulation of a formin by srGAP2.” In: J.
Biol. Chem. (2011), pp. 6577–86.
[309] M. J. Dayel et al. “Cell differentiation and morphogenesis in the colony-
forming choanoflagellate Salpingoeca rosetta”. In: Dev. Biol. (2011),
pp. 73–82.
[310] A. Sebé-Pedrós et al. “Regulated aggregative multicellularity in a close
unicellular relative of metazoa”. In: eLife (2013).
[311] P. Burkhardt et al. “Evolutionary insights into premetazoan functions of
the neuronal protein Homer”. In: Mol. Biol. Evol. (2014), msu178.
[312] A. Sebé-Pedrós et al. “Insights into the origin of metazoan filopodia and
microvilli”. In: Mol. Biol. Evol. (2013).
[313] A. de Mendoza, H. Suga and I. Ruiz-Trillo. “Evolution of the MAGUK
protein gene family in premetazoan lineages”. In: BMC Evol. Biol. (2010),
p. 93.
151
Bibliography
[314] S. R. Fairclough et al. “Premetazoan genome evolution and the regula-
tion of cell differentiation in the choanoflagellate Salpingoeca rosetta”.
In: Genome Biol. (2013), R15.
[315] X. Cai. “Evolutionary genomics reveals the premetazoan origin of op-
posite gating polarity in animal-type voltage-gated ion channels”. In:
Genomics (2012), pp. 241–245.
[316] V. C. Foletta, F. D. Brown and W. S. 3rd. “Cloning of rat ARHGAP4/C1,
a RhoGAP family member expressed in the nervous system that colocal-
izes with the Golgi complex and microtubules.” In: Brain Res. Mol. Brain
Res. (2002), pp. 1–15.
[317] C. David et al. “A role of amphiphysin in synaptic vesicle endocytosis
suggested by its binding to dynamin in nerve terminals”. In: Proc. Natl.
Acad. Sci. U. S. A. (1996), pp. 331–335.
[318] P. Wigge, Y. Vallis and H. T. McMahon. “Inhibition of receptor-mediated
endocytosis by the amphiphysin SH3 domain”. In: Curr. Biol. (1997),
pp. 554–560.
[319] Y. Chen et al. “Formation of an endophilin-Ca2+ channel complex is crit-
ical for clathrin-mediated synaptic vesicle endocytosis.” In: Cell (2003),
pp. 1–12.
[320] G. Zhang, T. A. Neubert and B. A. Jordan. “RNA binding proteins accu-
mulate at the postsynaptic density with synaptic activity.” In: J. Neurosci.
(2012), pp. 1–11.
[321] S. Chowdhury et al. “Arc/Arg3.1 interacts with the endocytic machinery
to regulate AMPA receptor trafficking.” In: Neuron (2006), pp. 445–59.
[322] H.-Y. Man et al. “Regulation of AMPA receptor–mediated synaptic trans-
mission by clathrin-dependent receptor internalization”. In: Neuron
(2000), pp. 649–662.
[323] E. Lowenstein et al. “The SH2 and SH3 domain-containing protein GRB2
links receptor tyrosine kinases to ras signaling”. In: Cell (1992), pp. 431–
442.
[324] J. I. MacDonald et al. “Direct binding of the signaling adapter protein
Grb2 to the activation loop tyrosines on the nerve growth factor receptor
tyrosine kinase, TrkA”. In: J. Biol. Chem. (2000), pp. 18225–18233.
[325] M. Rozakis-Adcock et al. “Association of the Shc and Grb2/Sem5 SH2-
containing proteins is implicated in activation of the Ras pathway by
tyrosine kinases”. In: Nature (1992), pp. 689–692.
[326] M. Rozakis-Adcock et al. “The SH2 and SH3 domains of mammalian
Grb2 couple the EGF receptor to the Ras activator mSos1”. In: Nature
(1993), pp. 83–5.
152
Bibliography
[327] N. W. Gale et al. “Grb2 mediates the EGF-dependent activation of guan-
ine nucleotide exchange on Ras”. In: Nature (1993).
[328] Z. Wang and M. F. Moran. “Requirement for the adapter protein GRB2
in EGF receptor endocytosis”. In: Science (1996), pp. 1935–1938.
[329] T. Yamazaki et al. “Role of Grb2 in EGF-stimulated EGFR internaliza-
tion”. In: J. Cell Sci. (2002), pp. 1791–1802.
[330] F. Huang and A. Sorkin. “Growth factor receptor binding protein 2-
mediated recruitment of the RING domain of Cbl to the epidermal
growth factor receptor is essential and sufficient to support receptor en-
docytosis”. In: Mol. Biol. Cell (2005), pp. 1268–1281.
[331] L. Conti et al. “Expression and activation of SH2/PTB-containing ShcA
adaptor protein reflects the pattern of neurogenesis in the mammalian
brain”. In: Proc. Natl. Acad. Sci. U. S. A. (1997), pp. 8185–8190.
[332] A. M. Cheng et al. “Mammalian Grb2 regulates multiple steps in em-
bryonic development and malignant transformation”. In: Cell (1998),
pp. 793–803.
[333] L. Brodin, P. Löw and O. Shupliakov. “Sequential steps in clathrin-
mediated synaptic vesicle endocytosis”. In: Curr. Opin. Neurobiol. (2000),
pp. 312–320.
[334] S. G. Penheiter et al. “Internalization-dependent and-independent re-
quirements for transforming growth factor β receptor signaling via the
Smad pathway”. In: Mol. Cell. Biol. (2002), pp. 4750–4759.
[335] R. Irannejad et al. “Conformational biosensors reveal GPCR signalling
from endosomes.” In: Nature (2013), pp. 534–8.
[336] P. Billuart et al. “Oligophrenin-1 encodes a rhoGAP protein involved in
X-linked mental retardation”. In: Nature (1998), pp. 923–926.
[337] A. Nakano-Kobayashi et al. “The Rho-linked mental retardation protein
OPHN1 controls synaptic vesicle endocytosis via endophilin A1.” In:
Curr. Biol. (2009), pp. 1133–9.
[338] N. N. Kasri, A. Nakano-Kobayashi and L. van Aelst. “Rapid synthesis
of the X-linked mental retardation protein OPHN1 mediates mGluR-
dependent LTD through interaction with the endocytic machinery.” In:
Neuron (2011), pp. 300–15.
[339] T. Kidd et al. “Roundabout controls axon crossing of the CNS midline
and defines a novel subfamily of evolutionarily conserved guidance re-
ceptors”. In: Cell (1998), pp. 205–215.
[340] H. Long et al. “Conserved roles for Slit and Robo proteins in midline
commissural axon guidance”. In: Neuron (2004), pp. 213–223.
153
Bibliography
[341] K. Keleman et al. “Comm sorts robo to control axon guidance at the Dro-
sophila midline.” In: Cell (2002), pp. 415–27.
[342] J. T. Kittler et al. “Constitutive endocytosis of GABAA receptors by an as-
sociation with the adaptin AP2 complex modulates inhibitory synaptic
currents in hippocampal neurons”. In: J. Neurosci. (2000), pp. 7972–7977.
[343] L. Yang and G. J. Bashaw. “Son of sevenless directly links the Robo re-
ceptor to rac activation to control axon repulsion at the midline”. In:
Neuron (2006), pp. 595–607.
[344] R. Waltereit, S. Kautt and D. Bartsch. “Expression of MEGAP mRNA
during embryonic development.” In: Gene Expression Patterns (2008),
pp. 307–10.
[345] T. Obsil et al. “Crystal Structure of the 14-3-3ζ:Serotonin N-
Acetyltransferase Complex”. In: Cell (2001), pp. 257–267.
[346] D. M. Bustos and A. A. Iglesias. “Intrinsic disorder is a key characteristic
in partners that bind 14-3-3 proteins”. In: Proteins: Struct., Funct., Bioinf.
(2006), pp. 35–42.
[347] S. Ganguly, J. Weller and A. Ho. “Melatonin synthesis: 14-3-3-dependent
activation and inhibition of arylalkylamine N-acetyltransferase medi-
ated by phosphoserine-205”. In: Proc. Natl. Acad. Sci. U. S. A. (2005).
[348] V. Cotelle et al. “14-3-3s regulate global cleavage of their diverse bind-
ing partners in sugar-starved Arabidopsis cells”. In: EMBO J. (2000),
pp. 2869–2876.
[349] P. Tompa et al. “Structural disorder serves as a weak signal for intra-
cellular protein degradation”. In: Proteins: Struct., Funct., Bioinf. (2008),
pp. 903–909.
[350] S. Datta. “Akt Phosphorylation of BAD Couples Survival Signals to the
Cell-Intrinsic Death Machinery”. In: Cell (1997), pp. 231–241.
[351] T. Benzing et al. “14-3-3 Interacts with Regulator of G Protein Signal-
ing Proteins and Modulates Their Activity”. In: J. Biol. Chem. (2000),
pp. 28167–28172.
[352] A. Brunet et al. “Akt Promotes Cell Survival by Phosphorylating and
Inhibiting a Forkhead Transcription Factor”. In: Cell (1999), pp. 857–868.
[353] S. Braselmann and F. McCormick. “Bcr and Raf form a complex in vivo
via 14-3-3 proteins.” In: EMBO J. (1995).
[354] C. Vincenz and V. Dixit. “14-3-3 proteins associate with A20 in an
isoform-specific manner and function both as chaperone and adapter
molecules”. In: J. Biol. Chem. (1996).
[355] B. Schumacher et al. “Structure of the p53 C-terminus bound to 14-3-3:
implications for stabilization of the p53 tetramer”. In: FEBS Lett. (2010).
154
Bibliography
[356] C. Petosa et al. “14-3-3ζ binds a phosphorylated Raf peptide and an un-
phosphorylated peptide via its conserved amphipathic groove”. In: J.
Biol. Chem. (1998), pp. 16305–16310.
[357] B. Wang et al. “Isolation of high-affinity peptide antagonists of 14-3-3
proteins by phage display”. In: Biochemistry (Mosc.) (1999), pp. 12499–
12504.
[358] C. J. Brown et al. “Evolutionary rate heterogeneity in proteins with long
disordered regions”. In: J. Mol. Evol. (2002), pp. 104–110.
[359] Y.-S. Lin et al. “Proportion of solvent-exposed amino acids in a protein
and rate of protein evolution”. In: Mol. Biol. Evol. (2007), pp. 1005–1011.
[360] C. Chica et al. “A tree-based conservation scoring method for short lin-
ear motifs in multiple alignments of protein sequences”. In: BMC bioin-
formatics (2008), p. 229.
[361] N. E. Davey, D. C. Shields and R. J. Edwards. “Masking residues using
context-specific evolutionary conservation significantly improves short
linear motif discovery”. In: Bioinformatics (2009), pp. 443–450.
[362] D. P. Denning and M. F. Rexach. “Rapid evolution exposes the bound-
aries of domain structure and function in natively unfolded FG nucleo-
porins”. In: Mol. Cell. Proteomics (2007), pp. 272–282.
[363] K. Linderstrøm-Lang. “Structure and enzymatic break-down of pro-
teins”. In: Cold Spring Harbor Symp. Quant. Biol. (1950), pp. 117–126.
[364] G. Markus. “Protein substrate conformation and proteolysis.” In: Proc.
Natl. Acad. Sci. U. S. A. (1965), p. 253.
[365] S. Hubbard, F. Eisenmenger and J. Thornton. “Modeling studies of the
change in conformation required for cleavage of limited proteolytic
sites”. In: Protein Sci. (1994), pp. 757–768.
[366] J. Gsponer et al. “Tight regulation of unstructured proteins: from tran-
script synthesis to protein degradation.” In: Science (2008), pp. 1365–8.
[367] U. B. Choi et al. “Beyond the random coil: stochastic conformational
switching in intrinsically disordered proteins.” In: Structure (2011),
pp. 566–76.
[368] A. C. Ferreon et al. “Modulation of allostery by protein intrinsic dis-
order.” In: Nature (2013), pp. 390–4.
[369] B. Qualmann et al. “Syndapin I, a synaptic dynamin-binding protein that
associates with the neural Wiskott-Aldrich syndrome protein.” In: Mol.
Biol. Cell (1999), pp. 501–13.
[370] R. Fricke, C. Gohl and S. Bogdan. “The F-BAR protein family Actin’ on
the membrane”. In: Comm. Integr. Biol. (2010), pp. 89–94.
155
Bibliography
[371] M. M. Kessels and B. Qualmann. “Syndapins integrate N-WASP in
receptor-mediated endocytosis.” In: EMBO J. (2002), pp. 6083–94.
[372] M. Plomann et al. “PACSIN, a brain protein that is upregulated upon
differentiation into neuronal cells.” In: Eur. J. Biochem. (1998), pp. 201–
11.
[373] M. M. Kessels and B. Qualmann. “The syndapin protein family: link-
ing membrane trafficking with the cytoskeleton.” In: J. Cell Sci. (2004),
pp. 3077–86.
[374] B. Ritter et al. “PACSIN 2, a novel member of the PACSIN family of
cytoplasmic adapter proteins”. In: FEBS Lett. (1999), pp. 356–362.
[375] B. Qualmann and R. B. Kelly. “Syndapin isoforms participate in
receptor-mediated endocytosis and actin organization.” In: J. Cell Biol.
(2000), pp. 1047–62.
[376] J. Modregger et al. “All three PACSIN isoforms bind to endocytic pro-
teins and inhibit endocytosis.” In: J. Cell Sci. (2000), pp. 4511–21.
[377] F. Simpson et al. “SH3-domain-containing proteins function at distinct
steps in clathrin-coated vesicle formation.” In: Nat. Cell Biol. (1999),
pp. 119–24.
[378] A. Quan and P. Robinson. “Syndapin - a membrane remodelling and
endocytic F-BAR protein.” In: FEBS J. (2013), pp. 1–15.
[379] E. L. Clayton et al. “The phospho-dependent dynamin–syndapin in-
teraction triggers activity-dependent bulk endocytosis of synaptic ves-
icles”. In: J. Neurosci. (2009), pp. 7706–7717.
[380] L. Mintz et al. “EHD1–an EH-domain-containing protein with a specific
expression pattern”. In: Genomics (1999), pp. 66–76.
[381] Y. Xu et al. “Mutually exclusive interactions of EHD1 with GS32 and
syndapin II.” In: Mol. Membr. Biol. (2004), pp. 269–77.
[382] U. Pohl et al. “EHD2, EHD3, and EHD4 Encode Novel Members of a
Highly Conserved Family of EH Domain-Containing Proteins”. In: Ge-
nomics (2000), pp. 255–262.
[383] B. Grant et al. “Evidence that RME-1, a conserved C. elegans EH-domain
protein, functions in endocytic recycling.” In: Nat. Cell Biol. (2001),
pp. 573–9.
[384] N. Naslavsky and S. Caplan. “EHD proteins: key conductors of endo-
cytic transport.” In: Trends Cell Biol. (2011), pp. 122–31.
[385] D. Rapaport et al. “Recycling to the plasma membrane is delayed in
EHD1 knockout mice”. In: Traffic (2006), pp. 52–60.
156
Bibliography
[386] S. X. Lin et al. “Rme-1 regulates the distribution and function of the en-
docytic recycling compartment in mammalian cells.” In: Nat. Cell Biol.
(2001), pp. 567–72.
[387] S. Caplan et al. “A tubular EHD1-containing compartment involved in
the recycling of major histocompatibility complex class I molecules to
the plasma membrane”. In: EMBO J. (2002), pp. 2557–2567.
[388] C. C. C. Yap et al. “Alterations of EHD1/EHD4 protein levels interfere
with L1/NgCAM endocytosis in neurons and disrupt axonal targeting.”
In: J. Neurosci. (2010), pp. 6646–57.
[389] Z. M. Lasiecka et al. “Neuronal early endosomes require EHD1 for
L1/NgCAM trafficking.” In: J. Neurosci. (2010), pp. 16485–97.
[390] O. Daumke et al. “Architectural and mechanistic insights into an EHD
ATPase involved in membrane remodelling.” In: Nature (2007), pp. 923–
927.
[391] J. J. Blume et al. “EHD proteins are associated with tubular and vesicular
compartments and interact with specific phospholipids.” In: Exp. Cell
Res. (2007), pp. 1–13.
[392] M. Sharma, N. Naslavsky and S. Caplan. “A role for EHD4 in the regu-
lation of early endosomal transport”. In: Traffic (2008), pp. 995–1018.
[393] C. Shah et al. “Structural Insights into Membrane Interaction and Cave-
olar Targeting of Dynamin-like EHD2.” In: Structure (2014), pp. 1–12.
[394] B. Cai, S. Caplan and N. Naslavsky. “cPLA2α and EHD1 interact and
regulate the vesiculation of cholesterol-rich, GPI-anchored, protein-
containing endosomes.” In: Mol. Biol. Cell (2012), pp. 1874–88.
[395] B. Cai et al. “Differential roles of C-terminal Eps15 homology domain
proteins as vesiculators and tubulators of recycling endosomes.” In: J.
Biol. Chem. (2013), pp. 30172–80.
[396] A. Shi et al. “A Novel Requirement for C. elegans Alix/ALX-1 in RME-
1-Mediated Membrane Transport”. In: Curr. Biol. (2007), pp. 1913–1924.
[397] T. Takeda et al. “Drosophila F-BAR protein Syndapin contributes to
coupling the plasma membrane and contractile ring in cytokinesis.” In:
Open Biol. (2013), p. 130081.
[398] L. Mayer et al. “Solute distributions and trapping efficiencies observed
in freeze-thawed multilamellar vesicles”. In: Biochim. Biophys. Acta, Bio-
membr. (1985), pp. 193–196.
[399] U. Pick. “Liposomes with a large trapping capacity prepared by freez-
ing and thawing of sonicated phospholipid mixtures”. In: Arch. Biochem.
Biophys. (1981), pp. 186–194.
157
Bibliography
[400] M. M. Kessels and B. Qualmann. “Syndapin oligomers interconnect the
machineries for endocytic vesicle formation and actin polymerization.”
In: J. Biol. Chem. (2006), pp. 13285–99.
[401] K. Sarfo, G. B. Moorhead and R. J. Turner. “A novel procedure for separ-
ating small peptides on polyacrylamide gels”. In: Lett. Pept. Sci. (2003),
pp. 127–133.
[402] S. Schael et al. “Casein Kinase 2 Phosphorylation of PACSIN 1 Regulates
Neuronal Spine Formation.” In: J. Biol. Chem. (2013), pp. 1–18.
[403] M. Jovic´ et al. “Eps15 homology domain 1-associated tubules con-
tain phosphatidylinositol-4-phosphate and phosphatidylinositol-(4, 5)-
bisphosphate and are required for efficient recycling”. In: Mol. Biol. Cell
(2009), pp. 2731–2743.
[404] F. D. Brown et al. “Phosphatidylinositol 4, 5-bisphosphate and Arf6-
regulated membrane traffic”. In: J. Cell Biol. (2001), pp. 1007–1018.
[405] D.-w. Lee et al. “ATP binding regulates oligomerization and endo-
some association of RME-1 family proteins.” In: J. Biol. Chem. (2005),
pp. 17213–20.
[406] S. S. Giridharan et al. “Cooperation of MICAL-L1, Syndapin2 and Phos-
phatidic Acid in Tubular Recycling Endosome Biogenesis.” In: Mol. Biol.
Cell (2013), pp. 1–15.
[407] B. Morén et al. “EHD2 regulates caveolar dynamics via ATP-driven tar-
geting and oligomerization.” In: Mol. Biol. Cell (2012), pp. 1–14.
[408] N. Naslavsky et al. “EHD1 and Eps15 interact with phosphatidylin-
ositols via their Eps15 homology domains.” In: J. Biol. Chem. (2007),
pp. 16612–22.
[409] J. Folch. “Brain diphosphoinositide, a new phosphatide having inositol
metadiphosphate as a constituent”. In: J. Biol. Chem. (1949), pp. 505–519.
[410] H. Brockerhoff and C. E. Ballou. “The structure of the phosphoinositide
complex of beef brain”. In: J. Biol. Chem. (1961), pp. 1907–1911.
[411] M. Plomann, J. G. Wittmann and M. G. Rudolph. “A hinge in the distal
end of the PACSIN 2 F-BAR domain may contribute to membrane-
curvature sensing.” In: J. Mol. Biol. (2010), pp. 1–8.
[412] X. Bai and X. Zheng. “Tip-to-tip interaction in the crystal packing of
PACSIN 2 is important in regulating tubulation activity.” In: Protein and
Cell (2013), pp. 1–7.
[413] D. Yarar, C. M. Waterman-Storer and S. L. Schmid. “SNX9 couples actin
assembly to phosphoinositide signals and is required for membrane re-
modeling during endocytosis”. In: Dev. Cell (2007), pp. 43–56.
158
Bibliography
[414] J. C. Stachowiak, C. C. Hayden and D. Y. Sasaki. “Steric confinement of
proteins on lipid membranes can drive curvature and tubulation.” In:
Proc. Natl. Acad. Sci. U. S. A. (2010), pp. 7781–6.
[415] T. Trudeau et al. “Structure and Intrinsic Disorder in Protein Autoinhib-
ition.” In: Structure (2013), pp. 1–10.
[416] R. Rohatgi et al. “The interaction between N-WASP and the Arp2/3 com-
plex links Cdc42-dependent signals to actin assembly”. In: Cell (1999),
pp. 221–231.
[417] R. Zaidel-Bar et al. “The F-BAR domain of SRGP-1 facilitates cell-cell ad-
hesion during C. elegans morphogenesis.” In: J. Cell Biol. (2010), pp. 1–
9.
159

A. General Supporting Information
Table A.1.: Genotypes of Escherichia coli strains.
Strain Genotype
TOP10 (Invitrogen) F- mcrA ∆(mrr-hsdRMS-mcrBC) Φ80lacZ∆M15 ∆ lacX74 recA1 araD139
∆(araleu)7697 galU galK rpsL (StrR) endA1 nupG
Bl21(DE3) Gold Hte F- lon ompT hsdSB(rB- mB-) gal dcm+ λ(DE3) endA TetR
Rosetta 2 (DE3)pLysS (Novagen) F- ompT hsdSB(rB- mB-) gal dcm λ(DE3) pLysSRARE2 (CamR)
161

B. Supporting Information srGAP3
Table B.1.: Clones obtained from other groups for subcloning.
Insert Organisma Vector Comment
14-3-3β Hs pGEX4T1 from S. Beer-Hammer, Tübingen
14-3-3γ Rn pGEX4T1 from S. Beer-Hammer, Tübingen
14-3-3 Rn pGEX4T1 from S. Beer-Hammer, Tübingen
14-3-3ζ Hs pGEX4T1 from S. Beer-Hammer, Tübingen
14-3-3η Hs pGEX2TK from S. Beer-Hammer, Tübingen
14-3-3θ/τ Hs pGEX4T1 from S. Beer-Hammer, Tübingen
Amphiphysin Rn pGEX from H. T. McMahon, Cambridge
AP2 α2 (701-938) Mm pGEX4T1 from H. T. McMahon, Cambridge
α-Cop Mm pCR-Blunt from F. Wieland, Heidelberg
Drebrin Hs pOTB7 BiocatbClone ID 3343626
EB1 Hs pDEST/N1GFP Addgenebclone 27382
Endophilin-A1 Hs pGEX from H. T. McMahon, Cambridge, clone E85001
Endophilin-A2 Hs pGEX from H. T. McMahon, Cambridge, clone E135000
mCherry 199_UAS_ERT2crep from A. Mongera, Tübingen
myc-Vps26 Hs pCIm from J. Bonifacino, Bethesda
myc-Vps35 Hs pCIm from J. Bonifacino, Bethesda
Neurochondrin Hs pcMVSport6 Biocat Clone ID 3914058
srGAP3 Hs pcDNA3.1 from G. Rappold, Heidelberg
Strap Hs pOTB7 BiocatbClone ID 3349549
α-Centractin Hs pCDNA3 from E. Holzbaur, Philadelphia
a Hs, Homo sapiens; Rn, Rattus norvegicus; Mm, Mus musculus
b Biocat GmbH, Heidelberg; addgene, https://www.addgene.org/
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Table B.2.: Generated vectors.
Name Insert Backbonea Res. Sitesa Primer (5’→ 3’)a
pEGFPC23C_fr1 3C site of pGEX6P1b pEGFPC2 BsrGI-BglII GGCTGTACAAATCGGATCTGGAAGTTC
CATTAGATCTCAGGGGCCCCTGGAAC
pEGFPC23C_fr2 3C site of pGEX6P1 pEGFPC2 BsrGI-BglII GGCTGTACAAATCGGATCTGGAAGTTC
CATTAGATCTCCAGGGGCCCCTGGAAC
pEGFPC23C_fr3 3C site of pGEX6P1 pEGFPC2 BsrGI-BglII GGCTGTACAAATCGGATCTGGAAGTTC
CATTAGATCTCCCAGGGGCCCCTGGAAC
pmCherryC2 mCherry pEGFPC2 AgeI-BsrGI CTACCGGTCGCCACCATGGTGAGCAAGGGC
CGTACTTGTACAGCTCGTCCATG
pmCherryC23C_fr1 3C site of pGEX6P1 pmCherryC2 BsrGI-BglII cut from pEGFPC23C_fr1
pmCherryC23C_fr2 3C site of pGEX6P1 pmCherryC2 BsrGI-BglII cut from pEGFPC23C_fr2
pmCherryC23C_fr3 3C site of pGEX6P1 pmCherryC2 BsrGI-BglII cut from pEGFPC23C_fr3
a Backbone: source vector, Res. Sites: restriction site used for cloning, Primer: forward/reverse.
b PreScission Protease (GE Healthcare) cleavage site.
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